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Abstract 
Complex I is the largest complex in the mitochondrial respiratory chain. Defects in 
complex I are a major cause of mitochondrial disease in humans. Mutations in the 
assembly factor NUBPL have been implicated in causing complex I deficiency. To assign 
pathogenicity to patient NUBPL variants, I used a yeast model, Yarrowia lipolytica, and 
recreated the corresponding amino acid changes in the Ind1 homolog. Using a 
combination of BN-PAGE, Western blotting and enzymatic analysis I was able to assign 
pathogenicity to four of the six variants as well as furthering our understanding of the role 
of Ind1 in complex I assembly.   
Complex I has been lost in the course of evolution in several unicellular eukaryotes, but 
never in multicellular eukaryotes. Recently, two studies found that the mitochondrial 
genes encoding complex I subunits were lacking in the genus Viscum. To investigate if 
complex I has been lost, I isolated mitochondria from European Mistletoe, Viscum album. 
My results from BN-PAGE and proteomic analysis indicate that complex I has been lost.  
Complex I requires FeS clusters, which are delivered by the mitochondrial ISC pathway. 
To better understand this process in plants, I characterised the role of FeS carrier 
proteins NFU4, NFU5 and GRXS15 in Arabidopsis thaliana.  NFU4 and NFU5 were 
found to be genetically redundant but when combined as a double mutant were embryo 
lethal. This suggest that NFU4 and NFU5 play an important role in FeS assembly. 
Mutants in GRXS15 had a severe growth phenotype, but normal levels of respiratory 
complexes, suggesting GRXS15 plays a secondary role in FeS cluster assembly. 
Understanding complex I will be important in the future for helping to treat human 
mitochondrial disorders. In addition, studying complex I in plants, including in non-model 
organisms, helps further our understanding of its function and evolution. 
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1 Function of respiratory complex I in plants and in 
human disease 
1.1 Mitochondrial research 
Mitochondria have played an important role in the development of modern cell biology 
and biochemistry. Inside mitochondria resides the biochemical machinery needed for 
respiration, some of life’s most important and central chemical reactions. This has led 
mitochondria to be frequently referred to as “the powerhouses of the cell”. Unravelling 
the mechanisms and intricate machinery involved in respiration was one of the great 
achievements of 20th century science. It was a central subject and many of the great 
minds of the age spent careers teasing out and unravelling the details. Indeed, numerous 
Nobel prizes were awarded for subjects relating to respiration and mitochondria. These 
include Otto Warburg in 1931, for his work on respiratory enzymes, Hans Krebs in 1953 
for work on the Krebs cycle, Peter Mitchell in 1978 for developing the chemiosmotic 
theory and Paul Boyer and John Walker in 1997 for their work on ATP synthase. 
Mitochondrial research in the second half of the century did not capture the imaginations 
quite as before, despite numerous important and ground-breaking discoveries. However 
mitochondrial research has undergone a renaissance since the beginning of the century, 
and once again is a subject of central interest. 
1.2 The respiratory chain and oxidative phosphorylation 
Mitochondria are semi-autonomous organelles which have two membranes, the inner of 
which forms the characteristic cristae and encloses the mitochondrial matrix. 
Mitochondria are the home of oxidative phosphorylation, which is involved in cellular ATP 
production. ATP synthesis is a prime example of the chemiosmotic theory, put forward 
by Peter Mitchell in 1961, and is widely considered to be one of the great scientific 
breakthroughs of the 20th century. Stated simply, the process of oxidative 
phosphorylation is as follows: pyruvate, generated from glycolysis, undergoes oxidative 
decarboxylation, to form acetyl-CoA and CO2, which in turn is sequentially oxidised and 
decarboxylised by the Krebs, or tricarboxylic (TCA), cycle, which has been described as 
“an asset-stripping merry-go round of linked reactions” (Lane 2005). Electrons harvested 
from the Krebs cycle electrons are then fed into the respiratory chain (see next 
paragraph). The electrons are then passed along the chain in a succession of linked 
redox reactions (i.e. each electron carrier is first reduced, and then oxidised by the next 
link in the chain). The chain ends with the reduction of oxygen. These successive redox 
Chapter 1 Introduction 
 
 
2 
 
reactions are coupled to the transport of protons across the inner mitochondrial 
membrane, from the matrix to the inter-membrane space. This proton gradient produces 
the proton-motive-force (see next paragraph) which is then used by the enzyme complex 
ATP synthase to generate ATP, the common currency of energy in the cell, which allows 
energy to be stored and then used at a later time, often in a different part of the cell. The 
action of ATP synthase, using the proton-motive force to generate ATP, is often 
metaphorically compared to a hydro-electric dam, where potential energy is converted 
into electrical energy, which can then be put to use. 
A basic summary of the process belies the underlying complexity of this remarkable 
piece of biochemistry. Looking at intricate mechanisms of the respiratory chain allows 
for a greater appreciation and understanding. The respiratory chain is composed of five 
macro-molecular complexes (the first four complexes are sometimes called the electron 
transport chain) named: complex I (also known as NADH dehydrogenase and 
NADH:ubiquinone  oxidoreductase), complex II (succinate dehydrogenase or 
succinate:ubiquinone oxidoreductase), complex III (cytochrome bc1 complex or 
ubiquinone:cyctochrome c oxidoreductase), complex IV (cytochrome c oxidase) and 
complex V (ATP synthase). These are composed of approximately 90 proteins, the 
number varies species to species, encoded by either the mitochondrial or nuclear 
genome (Table 1.1). The entry point for electrons is through complex I or complex II. 
Electrons that enter complex I are carried from the Krebs cycle by the reduced form of 
the electron acceptor nicotinamide adenine dinucleotide (NADH), which is then oxidised, 
donating two electrons to the Flavin mononucleotide (FMN) cofactor of complex I. These 
electrons are then passed along an iron-sulfur (FeS) cluster chain, before reducing 
ubiquinone to ubiquinol. Also, electrons can enter complex II via succinate, which is 
oxidised, donating its electrons to a flavin adenine dinucleotide (FAD) cofactor. These 
again are passed along an FeS cluster chain, and reduce ubiquinone to ubiquinol. 
Additionally, ubiquinone can be reduced by another pathway, fatty acid β-oxidation. 
Ubiquinone is a small lipid-soluble benzoquinone and so can diffuse through the lipid 
bilayer to the next electron carrier, complex III. Complex III transfers electrons from 
ubiquinol, via heme cofactors and a FeS cluster, to another mobile electron carrier, 
cytochrome c in the intermembrane space. It accepts an electron using its heme cofactor 
and transfers it to the final complex in the electron transport chain, complex IV. Complex 
IV transfers electrons from cytochrome c via heme and copper groups, to molecular 
oxygen, O2, the final electron acceptor, thereby reducing it to H2O. The transfer of 
electrons is coupled to proton pumping by complexes I, III and IV. This creates a proton-
motive force (∆p), also called the chemiosmotic, or electrochemical, gradient. The 
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proton-motive force is made from the energy stored in electrical charge separation and 
the pH difference across the inner mitochondrial membrane. The electrochemical 
gradient in respiring mitochondria is typically between 150 and 200 mV. The proton-
motive force is used by the fifth respiratory complex, ATP synthase, to generate ATP 
through rotational catalysis. Theoretically the complete oxidation of one pyruvate 
molecule can lead to the generation of 12 ATP molecules.  
The details of oxidative phosphorylation have been steadily unpicked over the last 50 
years. Now this knowledge is found in every textbook and undergraduate course. 
However, the respiratory chain is not a closed area of research. Many new discoveries 
are being, and are waiting to be, made. For example, advances in structural biology have 
revealed in detail the mechanism by which these respiratory complexes function. Just in 
the last year high resolution cryo-electron microscopy structures of the largest complex, 
complex I, were solved (Zhu et al. 2016; Fiedorczuk et al. 2016). It is this complex which 
will be the focus of this thesis.  
1.3 Complex I 
1.3.1 Structure and function of complex I 
Complex I, also known as NADH dehydrogenase and NADH:Ubiquinone 
oxidoreductase, is the largest of the respiratory complexes. As mentioned, complex I is 
the major entry point for electrons into the respiratory chain. Complex I oxidises NADH, 
taking two electrons, which it uses to reduce ubiquinone to ubiquinol. This redox reaction 
is coupled to the transfer of protons across the mitochondrial inner membrane against 
the chemiosmotic gradient. It is generally thought that four protons are translocated for 
every NADH oxidised (i.e. for every two electrons (Hirst 2013; Jones et al. 2017).  This 
accounts for approximately 40% of the protons pumped across the inner mitochondrial 
membrane during oxidative phosphorylation (Berrisford et al. 2016).  
Complex I is composed of 40+ protein subunits, the exact composition varies from 
species to species, which are formed into an L-shaped molecule, with one arm extending 
into the mitochondrial matrix and the other residing in the mitochondrial inner membrane. 
In humans, there are 44 different subunits. The number 45 is commonly quoted as well. 
It was previously thought that there were 45 subunits, beginning with the initial discovery  
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Figure 1.1: Function of complex I 
Schematic outlining the function of complex I. The N, NADH binding, Q, ubiquinone binding, and 
P, proton translocation, modules are highlighted. The P module is further divided into the proximal, 
PP, and distal, PD, sections. FeS clusters are indicated in red, and proton translocation indicated 
by the purple arrows. 
 
 
Table 1.1: Subunit composition of the respiratory chain in Homo sapiens 
Complex Number of subunits Nuclear encoded Mitochondrially 
encoded 
I 44 37 7 
II 4 4 0 
III 11 10 1 
IV 13 10 3 
V 18 16 2 
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Figure 1.2: Structure of complex I from Bos taurus 
Complete structure of complex I from Bos taurus (Protein Data Bank code: 5LDW) at 4.27Å. Core 
subunits, outlined in table 1.2, are highlighted in colour and labelled. Accessory subunits are in 
grey. Two orientations are shown, with the view on the right rotated 90° and then viewed from 
behind the ND1 subunit. 
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Table 1.2: Core subunits of complex I 
* Subunits encoded in the mitochondrial genome in Arabidopsis thalaiana 
Genomic origin Module Bos 
taurus 
Homo 
sapiens 
Yarrowia 
lipolytica 
Arabidopsis 
thaliana 
Cofactors and 
transmembrane α-
helices (TMHs) 
Nuclear  N 75 kDa NDUFS1 NUAM 75 kDa [2Fe-2S], 2 x [4Fe-4S] 
  51 kDa NDUFV1 NUBM 51 kDa Flavin, [4Fe-4S] 
  24 kDa NDUFV2 NUHM 24 kDa [2Fe-2S] 
 Q PSST NDUFS7 NUKM PSST/ 20 kDa [4Fe-4S] (cluster N2) 
  TYKY NDUFS8 NUIM TYKY/ 23 kDa 2 x [4Fe-4S] 
  49 kDa NDUFS2 NUCM Nad7/ 49 kDa*  
  30 kDa NDUFS3 NUGM Nad9/ 30 kDa*  
Mitochondrial  P ND1 ND1 NU1M Nad1 8 TMHs 
  ND2 ND2 NU2M Nad2 11-14 TMHs 
  ND3 ND3 NU3M Nad3 3 TMHs 
  ND4 ND4 NU4M Nad4 14 TMHs 
  ND5 ND5 NU5M Nad5 16 TMHs 
  ND6 ND6 NU6M Nad6 5 TMHs 
  ND4L ND4L NULM Nad4L 3 TMHs 
 
 
Table 1.3: Complex I subunits in Homo sapiens, Yarrowia lipolytica and 
Arabidopsis thaliana 
Based on Angerer et al. 2011, Subrahmanian et al 2016. and Wirth et al. 2016 
Species Subunit number Nuclear encoded Mitochondrial 
encoded 
Homo sapiens 44 37 7 
Yarrowia lipolytica 42 35 7 
Arabidopsis thaliana 49 40 9 
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that there were 45 subunits in Bos taurus complex I (Carroll et al. 2006), but two recent 
studies in 2012 (Balsa et al. 2012) and 2013 (Pitceathly et al. 2013) suggest that one of 
these, NDUFA4, is in fact a subunit of complex IV. Later it was found that although there 
are 44 different subunits, in the structure of Bos taurus complex I there are two copies of 
the SDAP (human NDUFAB1) subunit (Vinothkumar et al. 2014), bringing the total 
number of individual subunits to 45. The numbers 44 and 45 both continue to be 
commonly cited, but for the remainder of this thesis 44 will be used. 37 of these subunits 
are encoded in the nuclear genome and 7 in the mitochondrial genome. This implies 
coordination between two separate genomes for proper assembly and function of 
complex I, which adds an extra layer of complexity to its biogenesis. The subunits that 
are encoded by the mitochondrial genome vary from species to species, but always 
include ND1, ND4 and ND5 (Brandt 2006). The hydrophobic properties of the 
mitochondrially encoded subunits has often been given as the reason they are retained 
in the mitochondrial genome. It was suggested that their hydrophobicity could make their 
import into the mitochondria difficult, but recently it has been suggested their 
hydrophobicity could also lead to mis-targeting to the endoplasmic reticulum (Björkholm 
et al. 2015). 
The 40+ subunits of complex I can be divided into two classes: the core, or central, 
subunits and the accessory, or supernummary, subunits. There are 14 core subunits and 
these are invariant between species (Table 1.2). These subunits are required for 
catalysis, and are therefore highly conserved. Indeed, homologs of these subunits exist 
in bacteria, and they form the minimal functioning form of the enzyme.  The core subunits 
form into two main domains. The seven hydrophilic subunits, which are nuclear encoded, 
constitute the redox domain, sometimes called the peripheral, or matrix, arm, which 
extends into the matrix of the mitochondria (Figure 1.1 and 1.2). The redox domain is 
further divided into the N, NADH binding, i.e. the electron input, and the Q, ubiquinone 
binding, i.e. the electron output, module (Brandt 2006). It is this domain which contains 
the cofactors of complex I, which are needed for the redox reactions (see next 
paragraph). 
In humans, the redox domain of complex I contains 9 cofactors, which are used to 
perform complex I’s redox reactions. These are a Flavin mononucleotide (FMN), and 8 
FeS clusters (see section 1.7). The FMN participates in NADH oxidation, and passes the 
electrons to the FeS clusters. The FeS clusters are arranged in a chain, analogous to an 
electrical wire, along which the electrons are passed. It consists of 1 [2Fe-2S]2+/1+ and 6 
[4Fe-4S]2+/1+ clusters, named after their identification by electron paramagnetic 
resonance (EPR) in the 1970’s (Ohnishi 1998). In addition is a [2Fe-2S]2+/1+ positioned 
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outside the FeS cluster chain, called N1a, whose function is still uncertain, although it 
has recently been suggested to confer stability to complex I and aide incorporation of the 
N1b cluster (Dörner et al. 2017). The final FeS cluster in the chain, called the N2 cluster, 
donates electrons to ubiquinone, thereby reducing it to ubiquinol. The N2 cluster is 
attached to the PSST subunit and is positioned ~12Å away from ubiquinone, which sits 
in a cavity in the complex created by subunits 49 kDa and PSST (Wirth et al. 2016). The 
ubiquinone headgroup interacts with residues H92 and Y141 (human numbering) of 
subunit NDUFS2 (bovine 49 kDa). However, the exact position and interactions of 
ubiquinone in complex I remains uncertain and is still being studied. Additionally, the 
mechanism coupling the redox reactions to proton translocation is currently undefined 
(Hirst 2013). 
The seven hydrophobic subunits, which are mitochondrially encoded, the ND subunits, 
make up the membrane domain, sometimes called the P, the proton translocation, 
module, and are embedded in the mitochondrial inner membrane (Figure 1.1 and 1.2). 
The P module is further divided into the proximal P module (PP), which is connected into 
the Q module, and the distal P module (PD). Three ND subunits, ND5, ND4 and ND2, 
are homologous to the Mrp Na+/H+ antiporter family, and are probably involved in proton 
pumping (Mathiesen & Hägerhäll 2002; Hunte et al. 2010; Moparthi et al. 2011; 
Zickermann et al. 2015). Additionally, domains from subunits ND1, ND6 and ND4L form 
a fourth pathway for proton translocation (Hirst 2013). 
The two ‘arms’ of complex I, the matrix arm and membrane arm, are held together by 
the interactions of subunits on the interface between them. Hydrogen bonds and salt 
bridges form between the membrane domain subunit, ND1, and the redox domain 
subunit 49 kDa, PSST and TYKY. Additionally, a protein loop from the membrane domain 
subunit ND3 extends up and interacts with the interface of subunits 49 kDa and PSST 
(Hirst 2013). 
In addition to the core subunits are the accessory, or supernummerary, subunits (Kmita 
& Zickermann 2013). These are mostly absent from the bacterial complex I, and result 
in an approximate doubling of the mass of the eukaryotic complex (Wirth et al. 2016). In 
humans, there are 30 of these, but the number varies between species. For example, in 
the aerobic yeast Yarrowia lipolytica there are 28 accessory subunits (Kmita & 
Zickermann 2013), while the model plant Arabidopsis thaliana has 35 (Subrahmanian et 
al. 2016) (Table 1.3). In eukaryotes, these are all encoded by the nuclear genome. 
Accessory subunits are defined as those that do not participate directly in catalysis. 
Some of these may play structural roles, or may help complex I assembly or regulation, 
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or may protect against reactive oxygen species. The function of accessory subunits is 
still not well understood. A recent study used gene editing technology to create knock-
out mutants of all accessory subunits in human cell lines, and showed that 25, out of 30, 
are essential for proper formation of complex I (Stroud et al. 2016). This study provides 
a striking example of the importance of accessory subunits, and highlights the need for 
further study of their function.  
The nomenclature of complex I subunits has long been a complicated issue. There is no 
unified naming convention, and subunits often have different names. The first described 
subunits were from Bos taurus, and were so called by their apparent size on a SDS-
PAGE gel (e.g. 75 kDa subunit). It has become convention to refer to subunits by their 
homology to the Bos taurus subunits. Here, subunits will be mainly referred to by their 
preferred names in the individual species of study. Table 1.2 can be used to track which 
subunit is homologous to which. 
Great advances have been made in the last decade in elucidating the structure of 
complex I. Obtaining a precise structure is essential for fully understanding the reaction 
mechanism of complex I, for example by showing the exact position of key catalytic 
residues or clearly defining reaction chambers. Structures of complex I have been 
obtained from diverse phylogenetic groups across the eukaryotes and bacteria, with 
structures from the bacteria, Thermus thermophilus (Baradaran et al. 2013), the fungi 
Yarrowia lipolytica (Zickermann et al. 2015) and mammals, from Bos taurus (Zhu et al. 
2016) and Ovis aries (Fiedorczuk et al. 2016). Great progress has been made, moving 
from structures of individual domains up to high resolution structures of the entire 
complex. The similarity of structure across these diverse group once again highlights the 
conservation of complex I structure and function.  
1.3.2 Complex I assembly  
Given complex I’s large size, the origin of subunits from two genomes and the cofactors 
that need to be properly inserted, complex I assembly is a complicated, multi-stage 
process that is tightly controlled. This complicated process has been recently reviewed 
in (Sánchez-Caballero et al. 2016) and (Formosa et al. 2017) and will be outlined below.  
Note, the exact sequence of events varies between species (Vogel et al. 2007), but the 
process is best studied in humans and so will be described first. 
The seven mitochondrially encoded subunits require the correct transcription and 
translation of the mitochondrial genome, itself a complex process with many parts. 
Mitochondrial ribosomes are located in close proximity to the inner mitochondrial 
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membrane. This allows co-translational insertion into the membrane, with the help of the 
OXA1 protein (Sánchez-Caballero et al. 2016). The remainder of complex I subunits, as 
well as the 16 assembly factors, are encoded in the nuclear genome. These are 
translated in cytosolic ribosomes before transport into the mitochondria. Most, but not 
all, of these proteins contain N-terminal mitochondrial targeting sequences (MTS) to 
ensure proper delivery, which are later removed. Proteins are imported via the 
translocase of the outer membrane (TOM) complex (Formosa et al. 2017). Some are 
laterally sorted into the inner mitochondrial membrane by the translocase of the inner 
membrane (TIM23) complex. Subunits bound for the matrix are then transported by the 
TIM23 complex, in association with the presequence translocase associated motor 
(PAM) (Sánchez-Caballero et al. 2016). The import across the mitochondrial inner 
membrane requires the proton gradient generated by the respiratory complexes. Other 
subunits, that sit on the IMS side of complex I, do not engage with TIM23, but rather 
undergo oxidative folding (Formosa et al. 2017). 
Complex I is then assembled in a modular way, with different modules (e.g. N, Q, P) 
being assembled independently and then brought together in the mature complex (Figure 
1.3). The modules themselves are made from discrete assembly intermediates. Assisting 
in this process are a number of helper proteins, called assembly factors, which are 
needed for assembly, but are not present on the mature complex (see next paragraph). 
The sequence of complex I assembly has been painstakingly unravelled over the last 
decade, since assembly intermediates were first identified in human patients (Triepels et 
al. 2001; Antonicka et al. 2003). The preferred method to study this process has 
historically been 1D-BN-PAGE and 2D-BN/SDS-PAGE, often followed by 
immunolabelling with specific antibodies. However, these approaches had three main 
drawbacks. First, studies were limited by available antibodies, meaning only a subset of 
proteins could be tracked. Second, migration profiles differed from lab to lab based on 
differences in solubilisation techniques used, often leading to confusingly contradictory 
molecular sizes given for assembly intermediates. Finally, by studying the assembly 
intermediates seen only in mutants, as mutants are by definition abnormal, the sequence 
of events may deviate from that seen in normal function. Recent advances in proteomics 
has allowed the advent of complexome profiling, which has revolutionised our ability to 
track the assembly of large numbers of proteins (Wessels et al. 2009; Heide et al. 2012; 
Wessels et al. 2013). The most extensive and up-to-date complexome profile on human 
complex I assembly was performed in 2016 (Guerrero-Castillo et al. 2016). Here the 
authors were able to track de novo assembly, in real time, in a wild-type setting.  
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Figure 1.3: Complex I assembly in Homo sapiens 
Schematic outlining the assembly of complex I. Complex I modules are made separately, and 
brought together in a particular order. Based on the model from Guerro-Castillo et al. 2016.  
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Table 1.4: Complex I assembly factors in Homo sapiens 
Gene name Other gene names Putative role in complex I 
assembly 
Reference  
ACAD9  Insertion of ND2 Nouws et al. 2010 
ATP5SL   Stroud et al. 2016 
DMAC1 TMEM261, C9orf123  Stroud et al. 2016 
ECSIT  Insertion of ND2 Vogel et al. 2007b 
FOXRED1 FP634  Calvo et al. 2010; Fassone et 
al. 2010; Formosa et al. 2015 
NDUFAF1 CIA30, CGI-65 Insertion of ND2 Janssen et al. 2002; Vogel et 
al. 2005 
NDUFAF2 NDUFA12L Binding of N module Ogilvie et al. 2005 
NDUFAF3 C3orf60 Binding of Q with Pp-a Saada et al. 2009 
NDUFAF4 C6orf66, HRPAP20 Binding of Q with Pp-a Saada et al. 2008 
NDUFAF5 C20orf7 Hydroxylase activity Sugiana et al. 2008 
NDUFAF6 C8orf38 Squalene/ phytoene  
synthetase activity 
Pagliarini et al. 2008 
NDUFAF7 C2orf56, PRO1853 Methyltransferase activity Carilla-Latorre et al. 2010 
NDUFAF8 C17orf89  Floyd et al. 2016 
NUBPL C14orf127 FeS cluster insertion Sheftel et al. 2009 
TIMMDC1 C3orf1, UNQ247/PRO284 Insertion of ND1 Andrews et al. 2013 
TMEM126B HT007  Heide et al. 2012 
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Treatment with chloramphenicol, which stopped synthesis of mtDNA encoded subunits, 
depleted existing respiratory complexes. This block was then removed, and the 
assembly of complex I tracked at time-points over a 24-hour period. This provided a 
model of unrivalled detail, which is the basis for Figure 1.3.  
As mentioned, complex I assembly is helped by assembly factors. The first of these were 
identified in the yeast Neurospora craasa, in 1998, with the discovery of CIA30 and 
CIA84 (Küffner et al. 1998).  Since then numerous other assembly factors have been 
identified. The number varies from group to group. In humans, there are currently 16 
known assembly factors (Table 1.4) but this number increases every year as more are 
discovered (Stroud et al. 2016; Formosa et al. 2017). Many of these form tight 
interactions with complex I subunits, thus aiding in their detection and discovery. For 
example, there are nine assembly factors that bind to specific assembly intermediates 
(Andrews et al. 2013; Rhein et al. 2016). However, there are likely many others, which 
form only weak or transient interactions. It is probable that as analytical techniques grow 
more sensitive, more of these weak interacting assembly factors will be discovered. The 
roles of assembly factors vary. For example, some play structural, or scaffold, roles 
where they are needed to hold together or correctly insert subunits into the correct 
position, for example the assembly factor NDUFAF2 binds to an assembly intermediate 
of complex I, acting as a “place-holder”, until it is replaced by subunit NDUFA12 
(Formosa et al. 2017). Others perform modifications to subunits, for example NDUFAF5 
which adds a hydroxyl group to Arg-73 of the NDUFS7 subunit (Rhein et al. 2016). An 
additional group of proteins exist which are implicated in complex I assembly but either 
have not been confirmed or are not exclusive complex I assembly factors. For example, 
TMEM70 was recently implicated in complex I assembly (Guerrero-Castillo et al. 2016), 
but is also a complex V assembly factor (Formosa et al. 2017).  
The process of complex I assembly is well characterised in humans, but varies in other 
groups. In fact, the sequence of events in mammals may be an evolutionary abnormality, 
as most other eukaryotes bring together the modules in a different order. For example, 
in algae, plants and yeast the N and Q module are brought together prior to attachment 
to the membrane arm (Vogel et al. 2007; Subrahmanian et al. 2016; Etienne Meyer, 
personal communication) (Figure 1.4). This means that an assembly defect seen in one 
group, may not translate well for another group, and so care should be taken in making 
comparisons. 
Given that complex I assembly in the aerobic yeast Yarrowia lipolytica will be 
investigated in chapter 3, a brief outline of the assembly pathway in this organism will be  
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Figure 1.4: Comparison of complex I assembly in Homo sapiens and Yarrowia 
lipolytica 
Schematic outlining the sequence of events in assembly of complex I in (A) Homo sapiens and 
(B) Yarrowia lipolytica.  
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given (Figure 1.4). With no specific studies having being carried out in Yarrowia lipolytica, 
this pathway has to be inferred from fragmentary experimental observations of assembly 
intermediates formed in individual mutants and the process in other yeast species. 
Indeed, it is probably close to that seen in Neurospora crassa, which is quite different 
from that seen in humans (Videira & Duarte 2002; Vogel et al. 2007). The main difference 
is that, whilst in human the N-module is attached last, in yeast the N and Q module are 
first attached to each other, before being attached to the, possibly partial, membrane arm 
(Mimaki et al. 2012). However, care must be taken as a recent study on assembly in 
Neruospora crassa suggests that the process may be similar to mammals (Pereira et al. 
2013). This highlights how little we currently know about complex I assembly in yeasts 
and non-mammalian model species. In addition, only two assembly factors have been 
studied in Yarrowia lipolyitca, Ind1 and N7BML (Bych et al. 2008; Kmita et al. 2015), 
compared to 16 in humans. 
1.4 Disease 
1.4.1 Mitochondrial disorders 
Mitochondrial disease is an umbrella term for a clinically heterogenous set of disorders 
arising from mitochondrial dysfunction. Symptoms can affect single or multiple organs 
and can arise either in infancy or adulthood (Alston et al. 2017). Symptoms commonly 
include lactic acidosis, cardiomyopathy, leukodystrophy, skeletal myopathy, blindness 
and deafness (Fassone & Rahman 2012; Nouws et al. 2012; Vafai & Mootha 2012; 
Alston et al. 2017). Mitochondrial disorders are one of the most common inborn errors of 
metabolism (Calvo & Mootha 2010). Respiratory chain defects are estimated to affect 
approximately 1 in 5000 live births (Skladal et al. 2003). It is often said that these 
disorders predominantly affect tissues or organs with a high energy demand, such as 
CNS, heart, muscle, where mitochondria are more abundant (Alston et al. 2017; Craven 
et al. 2017). However, some caution that this is simplistic, and a more nuanced view 
takes into account nonlinear modes of pathogenesis and threshold effects (Vafai & 
Mootha 2012). Mitochondrial disorders often occur from respiratory chain dysfunction 
(Calvo & Mootha 2010) (see next paragraph), but can result in dysfunction of any 
mitochondrial pathway. As of the end of 2016, 281 genes (Craven et al. 2017), out of a 
total of 1,158 mitochondrial proteins (Mitocarta 2.0; Calvo et al. 2016), have mutations 
linked to human disease. Mitochondrial disorders can arise from mutations in either 
mtDNA or nuclear genes. The human mitochondrial genome is 16,569 bp and contains 
37 genes, 13 of which encode proteins, structural subunits of the respiratory chain, as 
well as 2 ribosomal RNA and 22 tRNA genes. It was first sequenced in 1981 (Anderson 
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et al. 1981), and the first disease causing mutations were identified in 1988 (Holt et al. 
1988; Wallace et al. 1988). Since then, pathogenic mutations have been found in every 
one of these genes (Alston et al. 2017). More common, given that the large majority of 
mitochondrial proteins are nuclear encoded, are nuclear gene mutations. The first of 
these were identified in 1995, where a patient with Leigh syndrome was found to have a 
mutation in SDHA, which encodes a subunit of complex II (Bourgeron et al. 1995). Since 
then over 250 have been discovered, with more being identified every year. Indeed, 
many genes with previously unknown functions in mitochondrial biology are being 
discovered in connection with disease, thereby adding to the inventory of disease 
causing genes. 
1.4.2 Respiratory chain defects  
Given the central role of mitochondria in cellular energy metabolism, it is unsurprising 
that the majority of mitochondrial disorders are caused by defects in the respiratory 
chain. Respiratory chain defects can result from mutations in structural subunits, but also 
in assembly factors, and in the numerous mitochondrial processes that affect respiratory 
chain function, for example mitochondrial DNA metabolism, protein import and cofactor 
biogenesis. As of 2016, pathogenic mutations have been found in 46 of the 90 respiratory 
chain structural subunit genes (Alston et al. 2017), as well as numerous others in 
assembly factors. 
Complex I deficiency is the most common respiratory chain defect (Fassone & Rahman 
2012; Mimaki et al. 2012; Rodenburg 2016) and is estimated to make up between a 
quarter and a third of all cases (Loeffen et al. 2000; Bugiani et al. 2004; Fassone & 
Rahman 2012). This may be because, as the largest respiratory complex, complex I has 
the largest probability of accruing pathogenic mutations (Rodenburg 2016). The first 
nuclear DNA mutation leading to complex I deficiency was in the NDUFS8 subunits 
(Loeffen et al. 1998). Since then mutations have been found in genes coding for all the 
core subunits, and an increasing number in accessory subunits and assembly factors 
are found each year. As of 2017, disease causing mutations have been found in 26 of 
44 structural subunits, and 10 of 16 assembly factors (Alston et al. 2017; Craven et al. 
2017; Formosa et al. 2017; Dr. Charlotte Alston, personal communication). Clinical 
symptoms are similar to other mitochondrial disorders, making genotype-phenotype 
correlations hard, although the majority of complex I cases do have brain MRI 
abnormalities and 80% of paediatric cases develop Leigh syndrome (Koene et al. 2012; 
Fassone & Rahman 2012; Rodenburg 2016). However, for the most part, there are no 
symptoms specific for mutations in a single gene. The one exception, is in the complex 
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I assembly factor NUBPL, which will be the subject of chapter 3, where patients display 
distinct MRI patterns (Kevelam et al. 2013). Complex I deficiency is fatal in the majority 
of cases with 75% of cases fatal before 10 years old, and 50% before 2 years (Koene et 
al. 2012). Complex I deficiency has also been implicated in common disorders such as 
diabetes, Alzheimer’s and Parkinson’s disease (Nouws et al. 2012). Complex I deficiency 
was first implicated in the latter after it was noticed a high number of people using the 
illicit drug MPTP (1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine), a known inhibitor of 
complex I, developed Parkinson’s disease (Langston et al. 1983).  
One of the recent research trends has been the mutually beneficial relationship between 
clinical and fundamental research in mitochondrial biology. Next generation sequencing 
technology has revolutionised the field (Craven et al. 2017) allowing new options which 
include whole genome sequencing, whole exome sequencing and sequencing a target 
panel of candidate genes (Alston et al. 2017). Indeed, whole genome or exome 
sequencing is now an achievable and affordable option for individual patients.  
Discovery of new complex I disorders represents a good example of the new role 
technology plays, and highlights the innovative ways scientists have tackled the problem 
of identifying new disease causing mutations. For example, (Stroud et al. 2016) identified 
the assembly factor DMAC1, through CRISPR/Cas9 gene editing and profiling (Heide et 
al. 2012) using complexome profiling to identify the assembly factor TMEM126, and 
(Floyd et al. 2016) used proteomic profiling of protein-protein interactions to identify the 
assembly factor NDUFAF8. 
Despite great advances in our understanding of mitochondrial diseases, treatment 
options are limited. Mitochondrial disorders are incurable and so must instead be 
managed. Future priorities must focus on better treatment options, or indeed a cure. 
Genome editing technologies may play a large part in this. 
1.5 Evolution 
1.5.1 Mitochondrial evolution and mitochondrion-related organelles 
Mitochondrial evolution began with the endosymbiosic integration of an α-proteobacteria 
into a eukaryotic cell (Margulis 1970; Margulis 1981; Gray et al. 1999). The exact timing, 
either early or late in eukaryotic evolution, and state of the engulfing eukaryotic cell has 
long been debated and remains a contentious issue (Poole et al. 2014; Pittis & Gabaldón 
2016). However, currently opinion has centred around the fact that all extant eukaryotes 
have, or had, mitochondrially related organelles. The majority of eukaryotes possess 
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“canonical” mitochondria that engage in aerobic respiration, and so use OXPHOS to 
generate ATP, with oxygen as the final electron acceptor.  
However there also exist non-canonical mitochondria. These are often the products of 
reductive evolution. Anaerobic mitochondria generate ATP using an electron transport 
chain and proton gradient, but do not need oxygen. Other terminal electron acceptors 
are used, for example fumarate (Tielens et al. 2002). There are also mitochondrion-
related organelles (MROs) which evolved from mitochondria (Burki 2016). These are the 
product of reductive evolution and lack many features often associated with 
mitochondria, for example a mitochondrial genome, a membrane bound electron 
transport chain and invaginated inner mitochondrial membranes forming cristae. Their 
seemingly primitive appearance delayed appreciation that they were related to 
mitochondria. This led some to hypothesise that there existed a group of eukaryotes that 
lack mitochondria and diverged before mitochondria were acquired, the so-called 
Archezoa. The discovery of MROs meant that the Archezoa hypothesis is now 
considered false (Hjort et al. 2010). These MROs come in two main types. First, 
hydrogenosomes are simply defined as double-membrane bound organelles that 
produce hydrogen (Hjort et al. 2010). They oxidise pyruvate to acetate, H2 and CO2, thus 
making ATP by substrate-level phosphorylation (Embley & Martin 2006). 
Hydrogenosomes have been found in many diverse groups including the Trichomonads, 
Chytridomycetes and Ciliates. Second, mitosomes have undergone even more reductive 
evolution than hydrogenosomes (Embley & Martin 2006). They are found in different 
groups, for example are present in Giardia lamblia and Entamoeba histolytica. 
Mitosomes were first identified in Entamoeba histolytica (Clark & Rogert 1995; Tovar et 
al. 1999).  Mitosomes cannot synthesis ATP, but rather must import it. In addition, 
mitosomes have lost their genomes, as their individual genes became unnecessary, or 
were transferred to the nucleus.  
Despite their structural and metabolic diversity, all mitochondria and MROs contained at 
least partial machinery for FeS cluster biosynthesis, the ISC pathway (see section 1.7). 
It was proposed that FeS biogenesis was the defining feature of this organelle (Lill 2009), 
and that no organism could lose the mitochondria as they are required for FeS clusters. 
It was therefore thought that all eukaryotes contain mitochondria or MROs. However, an 
exciting and unexpected discovery in 2016 changes this. An anaerobic microbe, 
Monocercomonoides sp., was found which apparently contained no mitochondria or 
MROs (Karnkowska et al. 2016). This raises the question as to how Monocercomonoides 
sp. produce FeS clusters, which are essential to life? It appears that they contain the 
alternative sulfur mobilisation (SUF) pathway, which here operates in the cytosol, 
Chapter 1 Introduction 
 
 
19 
 
acquired through lateral gene transfer from bacteria. The SUF and the ISC pathway 
presumably co-existed in the Monocercomonoides sp. ancestor, creating redundancy 
and allowing the ISC pathway, along with the mitochondria, to be lost as they were no 
longer required. The intriguing example of Monocercomonoides sp. may be the 
exception that proves the rule. It reinforces the idea of FeS biosynthesis being the 
minimal function of the mitochondria, as only when this barrier is removed through 
redundancy, can mitochondria be lost (Burki 2016). It shows mitochondria themselves 
are not essential, but rather the biosynthetic pathways they contain. 
1.5.2 Evolution of complex I 
The evolution of respiratory complex I in eukaryotes is mainly the story of the evolution 
of the accessory subunits. Normally, bacterial complex I is made up of 14 subunits, the 
minimal enzyme, the same core 14 subunits found in all eukaryotes. For example, 
complex I in E. coli is made up of 13 subunits, although one of these is a fusion between 
two core subunits (NuoC and NuoD) (Berrisford et al. 2016). These subunits are 
necessary and sufficient for the enzymatic activity of complex I (Letts & Sazanov 2015). 
However, recently it has been shown that some bacterial complexes also contain 
accessory subunits. For example, complex I from Thermus thermophilus contains 16 
subunits (Baradaran et al. 2013). Also, Paracoccus denitrificans complex I comprises 17 
subunits, three of which are homologous to mammalian accessory subunits (B17.2, 
AQDQ/18, 13 kDa) (Yip et al. 2011). Given that Paracoccus denitrificans is an α-
proteobacteria, a close relative of the mitochondria’s ancestor, it implies that the 
evolution of accessory subunits started prior to endosymbiosis. 
However, despite the evolution of some accessory subunits in bacteria, accessory 
subunits are largely a eukaryotic innovation. To the minimal enzyme were added the 
accessory subunits, 30 in the case of humans, resulting in an approximate doubling in 
size of complex I (Wirth et al. 2016). 21 of the accessory subunits were evolved early in 
eukaryotic evolution, as they are present in all eukaryotic lineages (Gabaldón et al. 
2005). The remaining subunits are lineage specific and evolved later. For example, there 
are 5 subunits in Yarrowia lipolytica, not present in the mammalian complex, and 8 
subunits present in the mammalian complex not present in Yarrowia lipolytica. Another 
striking example of lineage specific complex I evolution is seen in plants, where complex 
I contains an extra domain: the carbonic anhydrase domain. This is attached to the 
membrane arm and extends into the mitochondrial matrix (Subrahmanian et al. 2016). It 
was first seen in single particle electron microscopy imaging of complex I in Arabidopsis 
thaliana (Dudkina et al. 2005). This domain contains five gamma-type carbonic 
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anhydrase proteins (Fromm et al. 2016b). Carbonic anhydrases are enzymes that 
catalyse a hydration reaction of CO2 to HCO3-, although no carbonic anhydrase activity 
has been shown yet for the complex I CA domain (Subrahmanian et al. 2016). Much of 
the variety seen in eukaryotic complex I is due to different complements of accessory 
subunits. 
1.5.3 Loss of complex I 
Despite lineage specific innovations, complex I structure, function and composition 
remains remarkably conserved across the eukaryotes. However, there are examples 
where complex I has been lost altogether. Some of these cases have occurred in 
anaerobic and parasitic eukaryotes, which have highly reduced mitochondria (see 
section 1.5.1). Five lineages of aerobic eukaryotes appear to have lost complex I in the 
course of evolution. These are the Cryptomycotan Rozella allomycis (James et al. 2013); 
the lineage which contains dinoflagellates, apicomplexans, Chromera and Oxyrrhis 
(Flegonotov et al. 2015), two groups of yeast (Gabaldón et al. 2005) and the parasitic 
plant genera, Viscum (Skippington et al. 2015; Petersen et al. 2015; Skippington et al. 
2017). The first four examples are unicellular. However, Viscum is a multicellular plant 
species, where loss of complex I is unprecedented and surprising. It will be the focus of 
chapter 4, and more details can be found in the chapter introduction.  
1.6 Cofactors  
Mitochondria are commonly referred to as the “powerhouses of the cell”. This is a useful 
moniker, and still retains relevance. However, our current understanding of mitochondrial 
biology allows us to move beyond this name and look at mitochondrial function in its 
entirety (Pagliarini & Rutter 2013). The human mitochondrial proteome is currently 
thought to consist of 1,158 proteins (Mitocarta 2.0; Calvo et al. 2016). Of these only ~150 
are directly involved in oxidative phosphorylation and ATP production. What do the 
remaining ~1000 proteins do? Many are involved with mtDNA metabolism, transport, 
homeostasis, and cofactor biosynthesis. Many of these will impact, indirectly, on 
OXPHOS, but many are quite separate. The last of these, cofactor biosynthesis, is one 
of the most important.  
Cofactors, also referred to as prosthetic groups, are needed in biochemistry in order to 
augment the function of proteins. Amino acids are often chemically limited, and so 
cofactors give a protein biochemical versatility. Organic cofactors include nucleotides 
(for example FMN and FAD, already encountered in the respiratory chain), vitamins (for 
example biotin) and metal-organic compounds (for example molybdenum cofactor). 
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Inorganic cofactors include metal ions (for example Zn2+, Cu1+/2+, Fe2+/3+) and FeS 
clusters. Cofactors are especially important in redox reactions.  
The respiratory chain contains many different cofactors (FeS, FMN, FAD, heme, copper). 
FeS clusters are present in complex I (8 clusters in humans), complex II (3 clusters in 
humans) and complex III (Rieske FeS subunit). Therefore, in understanding complex I, 
II and III assembly and regulation it is important to understand the biosynthesis of FeS 
clusters, which will be the focus of the remainder of this introduction. 
1.7 Iron-sulfur clusters 
1.7.1 Iron-sulfur cluster function 
FeS clusters were first discovered in the 1960s (Rouault 2015). They are excellent 
acceptors and donors of electrons, with redox potentials between -500 mV and +300 
mV, and so are often found in redox enzymes (Lill 2009). Indeed, complex I is the largest 
FeS cluster containing enzyme known (Beinert 2000). They also have roles as catalysts 
in enzymatic reactions, in sensing intracellular or environmental conditions to regulate 
gene expression, and in stabilisation of protein structure (Lill & Muhlenhoff 2008). They 
are thought to be one of the most ancient cofactors, and may play a role in the early 
evolution of life (Russell & Martin 2004). FeS clusters come in many forms but the most 
common are rhombic [2Fe-2S]1+/2+ and cubane [4Fe-4S]1+/2+. Interconversion of cluster 
types has been observed, demonstrating the modular nature of the clusters (Beinert et 
al. 1997). Cubane clusters are less stable than rhombic ones, and FeS clusters are 
generally easily destabilised in the presence of oxygen. FeS clusters are usually 
coordinated by cysteine residues, but can also be bound by histidine, arginine, serine, 
and other small molecules (Lill & Muhlenhoff 2008). For example, in the Rieske FeS 
cluster in complex III, one of the Fe atoms is coordinated by two histidine residues (Maio 
& Rouault 2015). The number of FeS proteins in a cell is hard to estimate, but they 
participate in many essential cellular processes, including DNA metabolism and 
photosynthesis in plants. 
1.7.2 Iron-sulfur cluster assembly 
After their initial discovery in the 1960’s, in vitro work showed that FeS clusters could 
assemble spontaneously on proteins, through chemical reconstitution (Lill 2009). 
However, work in the 1990s showed that the process in vivo required catalysis and 
required the involvement of a large number of proteins (Lill & Muhlenhoff 2008).  Our 
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understanding of the assembly of FeS clusters has advanced greatly in the last two 
decades, with mitochondria playing a key role in this.  
 
Figure 1.5: FeS assembly pathways in the eukaryotic cell 
Schematic showing the FeS assembly pathways found in eukaryotic cells. The SUF pathway is 
predominantly found in photosynthetic eukaryotes. The connection between the mitochondrial 
ISC and cytosolic CIA pathway is mediated by the ABC transporter ABCB7/Atm1/ATM3.  
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FeS cluster assembly has been extensively studied in bacteria, especially Escherichia 
coli and the nitrogen fixing (azototrophic) Azotobacter vinelandii. Three distinct pathways 
for FeS biogenesis have been identified (Lill 2009; Rouault & Maio 2017): the NIF 
(nitrogen fixation), which is specific for the maturation of FeS clusters in the enzyme 
nitrogenise; the ISC (iron-sulfur cluster) and the SUF (sulfur-mobilisation) pathway. The 
ISC and the SUF pathway were transferred during endosymbiosis and can now be found 
in eukaryotes, along with a third pathway, the CIA (cytosolic FeS protein assembly) 
pathway (Lill & Muhlenhoff 2008). The ISC pathway is found in the mitochondria, and 
provides FeS clusters for mitochondria proteins, including the respiratory chain (Figure 
1.5). The SUF pathway is found in plastids, for example the chloroplasts in plants, and 
so is only present in some eukaryotic lineages. The SUF pathway provides the FeS 
clusters needed for plastid processes, for example photosynthesis. The eukaryotic 
innovation, the CIA pathway, is needed for FeS clusters used in the cytosol and the 
nucleus. The CIA pathway requires the mitochondrial ISC pathway, and is connected to 
it by the mitochondrial ISC export system, made up of the ABC transporter 
ABCB7/Atm1/ATM3.  
The generation of an FeS cluster in any of these pathways, can be broken down into two 
basic steps (Lill 2009; Maio & Rouault 2015): 1) de novo assembly of the nascent FeS 
cluster and 2) transfer of the FeS cluster to recipient apoproteins. During step 1 a 
cysteine desulphurase acquires a protein-bound persulfide (S0) from cysteine which is 
then reduced to a sulphide (S2-) before being transferred to a scaffold protein and is 
combined with Fe, to form the nascent FeS cluster. The scaffold protein provides a 
platform for this reaction to take place and contains cysteine residues to bind the FeS 
cluster in a labile manner. In step 2 this labile FeS cluster is then transferred to recipient 
enzymes with the help of numerous carrier proteins, thereby converting apoproteins to 
holoproteins. These FeS carriers, also called transfer proteins or intermediate scaffolds, 
ensure correct dissociation of the nascent FeS cluster from the scaffold, correct targeting 
to a specific recipient enzyme, and then correct transfer of the FeS cluster onto the 
acceptor site of the recipient enzyme. The details of the second step are less well 
understood than the first step. These steps are common to all pathways, although the 
protein machineries involved can be quite different. Here I will focus on the mitochondrial 
ISC pathway. 
1.7.3 The mitochondrial ISC pathway 
The mitochondrial ISC pathway is required for mitochondrial, and also cytosolic and 
nuclear, FeS proteins. The pathway has been steadily elucidated over the past decade, 
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predominantly in the model yeast, Saccharomyces cerevisiae, but also in human cell 
cultures. The details differ quite substantially between Saccharomyces cerevisiae and 
mammals, making a unified eukaryotic model hard to create.  I will first briefly outline the 
model in Saccharomyces cerevisiae.  
The process can broadly be split into four steps (Braymer & Lill 2017) (an expansion on 
the two basic steps outlined in section 1.72). In stage 1, [2Fe-2S] are synthesised de 
novo on the scaffold protein Isu1, in complex with the cysteine desulfurase, Nfs1, and 
two helper proteins Isd11 and Acp1. The ferredoxin Yah1 as well as Yhf1 (frataxin in 
humans), which has been proposed as an iron donor or regulator, are involved at this 
stage as well. In stage 2, Isu1 releases the [2Fe-2S] cluster, which is then taken by the 
monothiol glutaredoxin, Grx5 for downstream trafficking. The release of the cluster from 
Isu1 is helped by two chaperone proteins, Ssq1 (a Hsp70 protein) and Jac1. Grx5 then 
either directs the cluster to a target [2Fe-2S] protein, feeds it into late ISC machinery for 
[4Fe-4S] cluster synthesis, or, in this model, directs the cluster to form a sulfur 
intermediate (X-S) for export to the cytosol and the involvement in the CIA pathway. 
Additionally, the [2Fe-2S] cluster may be directed to target proteins before involvement 
with Grx5. In stage 3, [4Fe-4S] clusters are synthesised by the late ISC machinery, 
combining [2Fe-2S] clusters from Grx5. This is achieved by a complex of proteins 
consisting of Iba57, Isa1 and Isa2. In stage 4, [4Fe-4S] clusters are trafficked and 
inserted into target [4Fe-4S] proteins, facilitated by ISC targeting factors. These include 
Bol1, Bol3, Nfu1 and Ind1. Note, the role of the plant homologs of Grx5 (GRXS15), Isu1 
(ISU1) and Nfu1 (NFU4 and NFU5) will be investigated in chapter 5. The human homolog 
of Ind1 is NUBPL, and has already been mentioned in the complex I assembly section. 
It will be the focus of chapter 3. Some inconsistencies exist in the model. For example, 
Bol1 and Bol3 have been shown to interact with Grx5, from an earlier part in the process 
(Melber et al. 2016; Uzarska et al. 2016), which would suggest that either Grx5 plays an 
additional role in the late ISC machinery, or that the Bol proteins also affect [2Fe-2S] 
cluster synthesis.  
Indeed, the model for the mammalian ISC pathway differs in many respects. Some of 
these are due to lineage specific differences, but in other ways it is an alternative model 
of FeS cluster assembly. The main difference is, in the mammalian model, the complex 
of HSC20-HSPA9-ISCU1 (Isu1-Ssq1-Jac1 in yeast) plays a more central role (Maio & 
Rouault 2015; Rouault & Maio 2017). This complex is responsible for inserting FeS 
clusters into almost all recipient proteins, with FeS carrier proteins playing a more 
marginal role. Here, the transfer of [2Fe-2S] and [4Fe-4S] clusters are not separate. 
Another difference is that there is evidence of an additional cytosolic localisation of many 
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ISC components. It is therefore proposed that the CIA pathway plays a less important 
role, and that the cytosolic ISC pathway supplies FeS clusters for nuclear and cytosolic 
FeS proteins (Rouault 2012; Maio & Rouault 2015). The differences between the two 
models will be more fully addressed in the discussion. 
1.7.4 Iron-sulfur assembly in plants 
The FeS assembly pathways seen in plants are broadly similar to those seen in yeast 
and humans, except with the addition of the SUF pathway in the chloroplasts (Couturier 
et al. 2013; Balk & Schaedler 2014). Plants provide a good, but underexplored, study 
system for understanding FeS assembly. It provides an opportunity to address 
inconsistencies in the current models. For example, Nfu1 is essential in humans but 
yeast mutants only have a mild phenotype. Studying Nfu in another eukaryotic model, 
like plants, is therefore valuable. Also, given that the main model, Saccharomyces 
cerevisiae, lacks complex I, it provides a good opportunity to explore FeS provision for 
respiratory complexes. 
Recent work in plants has focused on the CIA pathway, for example looking at NBP35 
(Bastow et al. 2017) and AE7 (Luo et al. 2012), as well as the connection between the 
cyctolic and mitochondrial pathways (Bernard et al. 2009; Schaedler et al. 2014). The 
pathways are connected by the ABC half-transporter, ATM3, and studies have helped 
identify the previously unknown exported sulfur compound (X-S) as glutathione 
polysulfide. 
Apart from a recent study on the Arabidopsis thaliana Ind1 homolog, INDH (Wydro et al. 
2013), and two studies of the Grx5 homolog, GRXS15 (Moseler et al. 2015; Stroeher et 
al. 2015), relatively little work has been done on the mitochondrial ISC pathway in plants 
in recent years. Homologs of the main ISC components are found but the pathway is 
less well resolved. One difference, for example, is that there are two NFU proteins, NFU4 
and NFU5, as opposed to the one found in yeast and humans. Also, there are three 
versions of Isu1 (ISU1, ISU2 and ISU3). These differences, and the poor resolution of 
the pathway provide a good opportunity to explore the functions of late acting FeS carrier 
proteins in the Arabidopsis thaliana model system. 
1.7.5 Iron-sulfur assembly and human disease 
Mitochondrial disorders, which have been covered in section 1.41, are often caused by 
dysfunction in the respiratory chain. Recent findings have shown that defects in cofactor 
biosynthesis also contribute to disease. This can affect indirectly the respiratory chain, 
but also enzymes used by other mitochondrial metabolic systems. 
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Numerous human patients have been identified with defects in FeS assembly, especially 
in the mitochondrial ISC pathway. As of the end of 2016, 11 genes in the ISC pathway 
have been discovered with pathogenic mutations (BOLA3, FDX1L, FXN, GLRX5, IBA57, 
ISCA2, ISCU, LYRM4, NFU1, NFS1 and NUBPL) (Craven et al. 2017). Of these, NUBPL 
will be investigated in chapter 3, while the plant homologs of ISCU, NFU1 and GLRX5 
will be investigated in chapter 5.  
As well as OXPHOS disorders, specific syndromes have been associated with 
mitochondrial ISC defects, for example sideroblastic anemia associated with a mutation 
in GLRX5 and Friedreichs ataxia, associated with mutations in FXN (Stehling et al. 
2014). Given the connection between the ISC and CIA pathway, defects in the ISC 
pathway can affect nuclear FeS proteins involved with DNA metabolism and so can also 
be linked to cancer (Sheftel et al. 2012). Studying the diseases resulting in ISC 
dysfunction can prove valuable in understanding their function. 
1.8 Objectives 
Mitochondrial research is once again a subject of central interest. Great advances have 
been made in the fields of complex I structure, function and assembly, mitochondrial 
disorders, mitochondrial evolution and FeS cluster biogenesis. This thesis aims to 
contribute to all these areas. 
First, in chapter 3, the role of the complex I assembly factor NUBPL in complex I 
assembly and disease will be investigated. This will have relevance for clinicians, but will 
also contribute to our understanding of its role in assembly. Patient mutations in NUBPL 
will be recreated and studied in the model yeast Yarrowia lipolytica. 
Second, in chapter 4, the evolutionary mystery of the loss of complex I in the multicellular 
plant species Viscum album will be investigated using proteomic and biochemical 
techniques. If it has indeed lost complex I, it will raise questions about whether complex 
I is essential for multicellular aerobic life. 
Thirdly, in chapter 5, the FeS assembly pathway in plant mitochondria will be investigated 
to better understand cofactor provision for the mitochondria and respiratory complexes. 
The roles of the FeS carrier proteins, NFU4 and NFU5, will be studied for the first time 
in Arabidopsis thaliana. 
These three topics will enhance our understanding of the function and evolution of 
complex I and mitochondria. By studying mechanistic details, but then setting them in 
the context of evolution a fuller understanding can be achieved. 
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2 Materials and methods 
2.1 Bioinformatics 
2.1.1 Databases 
Arabidopsis thaliana http://www.arabidopsis.org 
Yarrowia lipolytica http://www.genome.jp/kegg-bin/show_organism?org=yli 
 http://fungi.ensembl.org/Yarrowia_lipolytica/Info/Index 
ExAC http://exac.broadinstitute.org/ 
Protein sequences http://www.uniprot.org/ 
2.1.2 Alignments 
Nucleic and amino acid alignments were performed using ClustalOmega (Sievers et al. 
2011), hosted at http://www.ebi.ac.uk/Tools/msa/clustalo/. Alignments were coloured 
using BoxShade v.3.21 (Kay Hoffman and Michael Baron), hosted at 
http://www.ch.embnet.org/software/BOX_form.html. 
2.1.3 Homology modelling 
Homology modelling was performed using the INTFold server (McGuffin et al. 2015), 
hosted at http://www.reading.ac.uk/bioinf/IntFOLD/. Structures were visualised using 
CCP4mg (McNicholas et al. 2011). 
2.1.4 Illustration of complex I structure 
Complete structure of complex I from Bos taurus, Protein Data Bank code: 5LDW, was 
visualised and illustrated with the UCSF Chimera package (Pettersen et al. 2004). 
2.1.5 Prediction of functional effects of human nsSNPs 
Prediction of the functional effects of human nsSNPs was performed with the PolyPhen-
2 tool (Adzhubei et al. 2010), hosted at http://genetics.bwh.harvard.edu/pph2/. 
2.2 Chemicals 
Chemicals were obtained from: Alfa Aesar (Heysham, UK), Amersham (LittleChalfont, 
UK), AMSBio (Abingdon, UK), Anachem (Luton, UK), Bio-Rad Laboratories Ltd (Hemel, 
Hempstead, UK), Biochem (Cosne-Cours-sur-Loire, France), Cayman Chemical (USA), 
DBC Foodservice (Petersfield, UK), Duchefa (Haarlem, Netherlands), Expedeon 
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(Swavesey, UK), Formedium (Hunstanton, UK), Melford (Ipswich, UK), Qiagen 
(Manchester, UK), Roche (Burgess Hill, UK), Sigma-Aldrich/Fluka (Dorset, UK), Thermo 
Fisher Scientific (Loughborough, UK), VWR/BDH (Lutterworth, UK). 
2.3 Organisms 
2.3.1 Arabidopsis thaliana 
Table 2.1: List of Arabidopsis thaliana lines  
Line Gene ID Background Stock centre ID Reference 
grxs15-3 
UBQ10:GRXS15 
K83A 
AT3G15660 Col-0 N/A Moseler et al. 2015 
grxs15 amiRNA AT3G15660 Col-0 N/A Stroher et al. 2015 
indh AT4G19540 Col-0 GK_956A05 Wydro et al. 2013 
isu1-1 AT4G22220 Col-0 SALK_006332 N/A 
ndufs4 AT5G67590 Col-0 SAIL_596_E11 Meyer et al. 2009 
nfu4-1 AT3G20970 Col-0 SALK_035493 N/A 
nfu4-2 AT3G20970 Col-0 SALK_061018 N/A 
nfu4-4 AT3G20970 Col-0 SAIL_1233_C08 N/A 
nfu5-1 AT1G51390 Col-0 WiscDsLoxHs069_06B N/A 
nfu5-2 AT1G51390 Col-4 SK24394 N/A 
nfu5-3 AT1G51390 Ler GT_3_2834 N/A 
rug3-1 AT5G60870 Col-0 SALK_092071 Kühn et al. 2011 
 
2.3.2 Yarrowia lipolytica 
Table 2.2: List of Yarrowia lipolytica strains 
Strain Background Reference 
ind1∆ GB10 Bych et al. 2008 
ind1∆ + IND1-N272QfsX31 GB10 Wydro et al. 2013 
nubm∆ GB10 Ulrich Brandt 
nucm∆ GB10 Ulrich Brandt 
nucm∆ + NUCM-Y144F GB10 Tocilescu et al. 2010 
nukm∆ GB10 Ulrich Brandt 
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GB10 strain: ura3-302, leu2-270, lys11-23, NUGN-Htg2, NDH2i, MatB. 
2.3.3 Escherichia coli 
Table 2.3: List of Escherichia coli strains 
Strain Antibiotic 
sensitivity 
Genotype 
DH5α Carbenicillin F– Φ80lacZΔM15 Δ(lacZYA-argF) U169 recA1 endA1 hsdR17 
(rK–, mK+) phoA supE44 λ– thi-1 gyrA96 relA1 
Top10 Carbenicillin F– mcrA Δ(mrr-hsdRMS-mcrBC) Φ80lacZΔM15 
ΔlacX74 recA1 araD139 Δ (ara leu) 7697 galU galK rpsL 
(StrR) endA1 nupG 
Rosetta 
+pLYS +pISC 
Carbenicillin, 
chloramphenicol, 
tetracycline 
F- ompT hsdSB (rB- mB-) gal dcm (DE3) pRARE (CamR) 
 
2.4 Molecular techniques: Polymerase Chain Reaction 
2.4.1 DNA extraction from Arabidopsis thaliana 
DNA was extracted from Arabidopsis thaliana leaf tissue as described in (Kasajima et al. 
2004). Briefly, to leaf tissue, 200 µl of buffer (Edwards solution: 200 mM Tris-HCL, pH 
7.5, 250 mM NaCl, 25 mM EDTA, 0.5% (w/v) SDS (Edwards et al. 1991), diluted 1:10 in 
TE buffer (10 mM Tris-HCL, pH 8.0, 1 mM EDTA) was added, and then the tissue ground 
with a mini-pestle in a 1.5 ml tube. Debris was removed by centrifugation at 16,100 x g 
for 5 minutes. 1 µl of supernatant was then used for genotyping PCR. 
2.4.2 DNA extraction from Yarrowia lipolytica 
Yarrowia lipolytica cells were collected by centrifugation at 3,500 x g and resuspended 
in 0.9 ml solution 1 (0.9 M sorbitol, 0.1 M EDTA, 0.01 M KPi-buffer, pH 7.4). 0.1 ml of 
solution 2 was added (2 mg ml-1 zymolyase, 10 µ ml-1 β-mercaptoethanol), mixed, and 
incubated for 30 minutes at 37°C. Cells were collected by centrifugation and 
resuspended in 0.4 ml TE (10 mM Tris-HCL, pH 8.0, 1 mM EDTA). 30 µl TES was added 
and incubated for 30 minutes at 60°C. 80 µl 5 M potassium acetate was added and 
incubated on ice for 1 hour. After centrifugation at 16,100 x g, 1 ml ethanol was added 
to the supernatant. After another round of centrifugation, the DNA was washed in 70% 
(v/v) ethanol, and resuspended in TE buffer. 
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2.4.3 RNA extraction from Arabidopsis thaliana 
RNA extraction from Arabidopsis thaliana was performed using a RNeasy® Plant Mini 
Kit (Qiagen) according to the manufacturer’s instructions. 
2.4.4 RNA extraction from Yarrowia lipolytica 
RNA extraction from Yarrowia lipolytica was performed using a RNeasy® Mini Kit 
(Qiagen) according to the manufacturer’s instructions. 
2.4.5 cDNA synthesis and reverse transcription 
For Arabidopsis thaliana and Yarrowia lipolytica RT-PCR, extracted RNA was converted 
to cDNA by reverse transcription.  Briefly, between 0.7 and 2.4 μg of RNA were used 
(equal amounts taken for each sample set). RNA was mixed with 0.7 μl dT (20)VN 
primer, and made up to 12 μl with dH2O. Samples were incubated for 5 minutes at 70°C, 
then cooled on ice.  4 μl of 5xRT buffer (M-MLV Reverse Transcriptase kit, Invitrogen), 
2 μl 10 mM dNTPs and 1 μl RNAse OUT (Invitrogen) were added to samples, which were 
then incubated for 5 minutes at 37 C. 1 μl reverse transcriptase (M-MVL Reverse 
Transcriptase kit, Invitrogen) was added, and then samples were incubated for 60 
minutes at 42°C followed by 10 minutes at 70°C. 30 μl dH2O were added to give a final 
volume of 50 μl. 1 μl was then used as a template for polymerase chain reaction (see 
section 2.4.6). 
2.4.6 Polymerase chain reaction 
Polymerase chain reactions were all performed on Eppendorf Nexus thermocyclers. 
Reactions were made up with polymerase, an appropriate polymerase buffer, dNTPs, 
oligonucleotides and a DNA template. Different polymerases were used for different 
types of PCR, for example for genotyping PCR, a lab home-brew stock of EcoTaq 
polymerase and for cloning Phusion® High-Fidelity DNA polymerase (NEB). 
Thermocycling protocols were adjusted for different polymerases. Denaturation steps 
were performed at 94 °C (Eco-Taq) or 98 °C (Phusion), annealing temperatures were 
adjusted to be appropriate for particular oligonucleotides, and elongation steps were 
performed at 72 °C. Typically between 30-35 thermocycles were performed. Touchdown 
PCR was performed for certain genotyping reactions. 
2.4.7 DNA extraction from agarose gel 
DNA was extracted from agarose gel slices using a QIAquick® PCR purification kit 
(Qiagen) according to the manufacturer’s instructions. 
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2.4.8 Agarose gel electrophoresis 
DNA fragments were separated in a 1% (w/v) agarose gels, containing 0.04 % (w/v) 
ethidium bromide. Gels were electrophoresed at 100 V, in TAE buffer (40 mM Tris, 20 
mM acetic acid, 1 mM EDTA). DNA bands were visualised in a UV transluminator (G:Box, 
Syngene). 100 bp and 1 kb ladders (NewEngland Biolabs) were used to estimate DNA 
band size.  
2.4.9 Oligonucleotides 
Oligonucleotides were obtained from Eurofins MWG Operon and were used at a 
concentration of either 10 or 25 µM. 
Table 2.4: Primers used for RT-PCR 
Oligonucleotide Gene 5’-3’ sequence Species 
IND1-RT-F 
IND1 
CGTCTCCGTGAACACAGCAC Yarrowia lipolytica 
IND1-RT-R CACGCCACTGCCTTGTTAG  
ACT1-RT-F 
ACT1 
TATGTGCAAGGCCGGTTTCG Yarrowia lipolytica 
ACT1-RT-R TCGATGGGGTATCGGAGGGT  
PYC1-RT-F 
PYC1 
TTCCTGAGACCAAGGTGGATC Yarrowia lipolytica 
PYC1-RT-R CTTGAATCGGTGCATAGAGAGCC  
NFU4-RT-F 
NFU4 
AGGTCGCAAGGTCGTTTCTG Arabidopsis thaliana 
NFU4 -RT-R AGCCCAGAAACAACACCAAG  
NFU5-RT-F 
NFU5 
AGCTTCCGTAACTTGTTCTCC Arabidopsis thaliana 
NFU5-RT-R AGATGTTCCCTCCTCTTCAC  
ACT2-RT-F 
ACT2 
CCCAAAGGCCAACAGAGAGA Arabidopsis thaliana 
ACT2-RT-R ACCATCACCAGAATCCAGCA  
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Table 2.5: Primers used for genotyping 
Mutant Genotype Oligonucleotide 5’-3’ sequence 
nfu4-1 
Wild type 
nfu4-1 LB CCCAGTTGCTTTAATGAGCTG 
 nfu4-1 RB AACTGTACGCCAAACGTGAAC   
 
T-DNA 
LBb1 GCGTGGACCGCTTGCTGCAACT 
 nfu4-1 RB  
nfu4-2 
Wild type 
nfu4-2 LB TCTCCAATCCCTCAACAAATG   
 nfu4-2 RB TCTGACGAAAACAATCCATCC   
 
T-DNA 
LBb1 GCGTGGACCGCTTGCTGCAACT 
 nfu4-2 RB  
nfu4-4 
Wild type 
nfu4-4 LB TCTTGATTCTCCAATGGTTGC   
 nfu4-4 RB CAAGCCTGAGATATTTGCAGC   
 
T-DNA 
LB3 TAGCATCTGAATTTCATAACCAATCTCGATACAC 
 nfu4-4 RB  
nfu5-1 
Wild type 
nfu5-1 LB TTCACCATCGAATTCTTGCTC 
 nfu5-1 RB CGTCGCTCTCTGTTTATCTCG   
 
T-DNA 
L4 TGATCCATGTAGATTTCCCGGACATGAAG 
 nfu5-1 RB  
nfu5-2 
Wild type 
nfu5-2 LB TTCTTAAGCTCTGGTCCCTCC 
 nfu5-2 RB CGAGATAAACAGAGAGCGACG 
 
T-DNA 
pSKTAIL-L3 ATACGACGGATCGTAATTTGTCG 
 nfu5-2 RB  
nfu5-3 
Wild type 
nfu5-3 LB ACAGATGAACTTGGACAACCG 
 nfu5-3 RB CGTCGCTCTCTGTTTATCTCG 
 
T-DNA 
Ds3-1 ACCCGACCGGATCGTATCGGT 
 nfu5-3 RB  
isu1-1 Wild type isu1-1 F1 GAACCATCTAAACCGTCCACGT 
  isu1-1 R1 GGGTGAAAGGCAAAGCTATGGAG 
 T-DNA LBb1.3 ATTTTGCCGATTTCGGAAC 
  isu1-1 R1  
 
  
Chapter 2 Materials and Methods 
 
 
33 
 
Table 2.6: Primers used for mutagenesis 
Amino 
acid 
change 
DNA change Oligonucleotide 5’-3’ sequence 
L102P t305c L102P-F CTGAGGGTAGGACTCCCCGATGTGGACATCTTC 
  L102P-R GAAGATGTCCACATCGGGGAGTCCTACCCTCAG 
D103Y g307t D103Y-F CCGAAGATGTCCACATAGAGGAGTCCTACCCTC 
  D103Y-R GAGGGTAGGACTCCTCTATGTGGACATCTTCGG 
G136D g407a, g408t G136D-F CCCATGCTCATGACCTGTATATCGAATTTCGACATTGGAATC 
  G136D-R GATTCCAATGTCGAAATTCGATATACAGGTCATGAGCATGGG 
M180V a538g M180V-F GGGTGGCAAGTCCACCACCAGAACGTCCA 
  M180V-R TGGACGTTCTGGTGGTGGACTTGCCACCC 
M180A a538g, t539c M180A-F CCGGGTGGCAAGTCCGCCACCAGAACGTCCAA 
  M180A-R TTGGACGTTCTGGTGGCGGACTTGCCACCCGG 
L191F c571t, g573c  L191F-F AGTTTGGGCAATAGTGAATTGAACGTCTCCCGTTCCGG 
  L191F-R CCGGAACGGGAGACGTTCAATTCACTATTGCCCAAACT 
G285C g853t G285C-F GCTCACAGTCAGACAAGTGTGTTCCTGTTGCTGTG 
  G285C-R CACAGCAACAGGAACACACTTGTCTGACTGTGAGC 
 
Table 2.7: Primers used for cloning and sequencing 
Oligonucleotide Purpose 5’-3’ sequence 
AM1 Cloning of IND1 TGGCCATGCTTCTACACCCTCC 
AM2 Cloning of IND1 TGCTGCCGTCGCTGGTGCCTTT 
AM27 Cloning Ind1 protein 
expression vectors 
GGCCATGGAAAACCCCCTGGGTATC 
AM28 Cloning Ind1 protein 
expression vectors 
GGCTCGAGCTATTTTTCAAATTGAGG 
KB86 Sequencing Ind1-strep-
pUB26 and variants 
CTGCAGGTACACCCAACTGCTCAGC 
KB87 Sequencing Ind1-strep-
pUB26 and variants 
GGCATATGGAAAACCCCCTGGGTATC 
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2.5 Molecular techniques: Plasmid construction 
2.5.1 Restriction digest 
Restriction digest was performed according to manufacturer’s instructions (mainly New 
England Biolabs). 
2.5.2 Plasmid isolation 
Plasmid isolation was performed using a QIAprep® Spin Miniprep kit (QIAGEN), 
according to the manufacturer’s instructions. 
2.5.3 DNA sequencing 
Sequencing was performed by Source Bioscience and Eurofins MWG Operon. For 
sequencing of pGEM®-T Easy vectors, primers SP6 and T7 were used and provided by 
sequencing company.  
2.5.4 Ligation 
Ligation was performed using T4 ligase, according to manufacturer’s instructions. 
2.5.5 Mutagenesis 
For Yarrowia lipolyitca vectors, IND1-strep sequence was isolated from the pUB4-IND1-
strep (Bych et al. 2008, also, called pKB73 by Dr. Katrine Bych. In table 2.8 as pAM3) 
by PCR, using primers AM1 and AM2. In the last three cycles the mixture was spiked 
with Taq-polymerase, to A-tail the PCR product. The PCR product was inserted into an 
pGEM®-T Easy vector (Promega), according to the manufacturer’s instructions, to make 
plasmid pAM1. Mutagenesis primers, table 2.6, were designed using the online 
QuikChange primer design tool, hosted at http://www.genomics.agilent. 
com/primerDesignProgram.jsp. pAM1 was used as a template for site-directed 
mutagenesis PCR, which was carried out using a Quikchange® II mutagenesis kit 
(Agilent), as per the manufacturer’s instructions. Mutagenesis was confirmed by 
sequencing. The mutated IND1-strep sequence was then subcloned out of the pGEM®-
T Easy vector, and inserted into pUB4-IND1-strep, between XbaI and NsiI restriction 
sites. Plasmids were confirmed by sequencing and diagnostic restriction digest. 
2.5.6 Protein expression vectors 
For protein expression in E. coli, IND1-strep, excluding the first 36 amino acids, in the 
pET15b vector (Novagen) was used (Bych et al. 2008, also, called pKB71 by Dr. Katrine 
Bych). For expressing Ind1-L102P and Ind1-D103Y, sequence was isolated from the 
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Yarrowia lipolytica vectors, pAM8 and pAM13, by PCR, using primers AM27 and AM28. 
These sequences were then inserted into the pKB71 vector, between the NcoI and XhoI 
restriction sites. Plasmids were confirmed by sequencing and diagnostic restriction 
digest. Plasmids expressing Ind1-G80S and Ind1-K81Q had previously been made by 
Dr. Stefan Kerscher (called pKB86 and pKB87 by Dr. Katrine Bych) 
2.5.7 Plasmid created and used in this study 
Table 2.8: List of plasmids 
Vector name My reference Source 
Ind1-strep-pUB4 pAM3 Bych et al. 2008 
Ind1-N271QfsX31-strep-pUB4 pAM4 Wydro et al. 2013 
pUB26 pAM5 Ulrich Brandt 
Ind1-L102P-strep-pUB4 pAM8 Created in this study 
Ind1-G285C-strep-pUB4 pAM9 Created in this study 
Ind1-L191F-strep-pUB4 pAM12 Created in this study 
Ind1-L191F-strep-pUB4 pAM13 Created in this study 
Ind1-G136D-strep-pUB4 pAM24 Created in this study 
Ind1-M180V-strep-pUB4 pAM25 Created in this study 
Ind1-M180A-strep-pUB4 pAM26 Created in this study 
∆36-Ind1-G80S-strep-pET15b pAM22 Stefan Kerscher 
∆36-Ind1-K81Q-strep-pET15b pAM23 Stefan Kerscher 
∆36-Ind1-strep-pET15b pAM32 Bych et al. 2008 
∆36-Ind1-L102P-strep-pET15b pAM33 Created in this study 
∆36-Ind1-D103Y-strep-pET15b pAM34 Created in this study 
 
2.6 Genetic transformation 
2.6.1 Escherichia coli transformation 
Aliquots of competent Escherichia coli cells (DH5α or TOP10) were thawed on ice. 50-
100 ng plasmid was added, mixed, and incubated on ice for 30 minutes. Cells were then 
heat-shocked at 42°C for 45 seconds, before being put on ice for a further 2 minutes. 0.5 
ml SOC medium (for 1 L: 20 g tryptone, 5 g yeast extract, 0.5 g NaCl pH 7.0, 0.186 g 
KCL, 20 mM glucose, 2 mM MgCl2) was added, and the mixture incubated at 37°C for 1 
hour. Cells were then collected by centrifugation, resusepnded in 100 µl SOC, and 
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spread on selective LB agar plates (for 1 L: 10 g tryptone, 5 g yeast extract, 10 g NaCl 
pH 7.0, 15 g agar) Transformants were visible after 1 day of growth at 37°C 
2.6.2 Yarrowia lipolytica transformation 
Yarrowia lipolytica cells were transformed as described in (Chen et al. 1997). Briefly, 
cells were grown overnight in Y½D, at 28°C, and collected by centrifugation, or 
alternatively harvested from a fresh Y½D plate. Cells were resuspended in 100 µl one-
step buffer (45% PEG4000, 0.1 M lithium acetate pH 6.0, 0.1M dithiothreitol, 25 µg/100 
µl single-stranded carrier DNA) and 200-500 ng plasmid was added. The mixture was 
vortexed and then incubated at 39°C for 1 hour. The mixture was spread on a Y½D plate 
containing 75 µg ml-1 Hygromycin B. Transformants were visible after 2-3 days growth at 
28°C. 
2.6.3 Antibiotics 
Table 2.9: List of antibiotics 
Antibiotic Concentration (µg ml-1) Solvent 
Carbenicillin  100 H2O 
Chloramphenicol 34 EtOH 
Hygromycin 75 H2O 
Tetracyclin 5 70% EtOH 
 
2.7 Arabidopsis thaliana growth and manipulation 
2.7.1 Growth on MS plates 
Arabidopsis thaliana seeds were vernalised for 24 hours at 4°C and then were sterilised 
by incubation for 2 x 2 hours in chlorine gas (created by adding 100 ml bleach to 6 ml 5 
M HCL). Seeds were grown on ½MS agar plates (½ MS salts, 0.8% (w/v) agar, 0.05% 
(w/v) MES-KOH, pH 5.7). When mutants with severe growth phenotypes were grown, 
1% (w/v) sucrose was added to the plates to aid germination. Growth conditions were 16 
hours light, 8 hours dark, 22°C, at light intensity 120-160 µmol photons m-2 s-1. 
2.7.2 Growth on soil 
Arabidopsis seeds were planted directly on soil after vernalisation for 24 hours at 4°C. 
Growth conditions were 16 hours light, 8 hours dark, 22°C at light intensity 180-200 µmol 
photons m-2 s-1. 
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2.7.3 Growth in hydroponic culture 
After sterilisation Arabidopsis thaliana seeds were planted in a 250 ml flask in 50 ml 
hydroponic growth medium (½ MS salts, 1% (w/v) sucrose 0.015% (w/v) agar, 0.05% 
(w/v) MES-KOH, pH 5.8). These were left stationary for 5 days, followed by 7 day shaking 
at 70 rpm. Growth conditions were 16 hours light, 8 hours dark, 22°C, at light intensity 
120-160 µmol photons m-2 s-1. 12 days after planting mitochondrial purification was 
performed (see section 2.91). 
2.7.4 Callus cell lines 
Arabidopsis thaliana were grown on vertical ½MS agar plates until the roots were 2-3 cm 
in length. These were then cut off and placed on callus induction agar plates (0.386 % 
(w/v) Gamborg B5 medium (incl. vitamins), 2% (w/v) glucose, 0.05% (w/v) MES-KOH, 
pH 5.7, 0.8% (w/v) agar, 0.5 mg/L of 2,4-dichlorophenoxyacetic acid, 0.05 mg/L kinetin) 
and left for 3-4 weeks at 22°C. Callus tissue was then transferred to fresh callus induction 
plates, and sub-cultured every two weeks.  
2.7.5 Cross pollination 
Arabidopsis thaliana crosses were carried out as described on the Arabidopsis Stock 
Centre website (http://arabidopsis.info/Info Pages?template= crossing;web_section= 
arabidopsis).  
2.8 Yarrowia lipolytica growth 
2.8.1 Agar plates 
Yarrowia lipolytica cells were grown on Y½D agar plates (1% (w/v) yeast extract, 1% 
(w/v) glucose, 2% (w/v) agar) at 30°C. When Yarrowia lipolytica cells contained a 
plasmid, 75 µg ml-1 Hygromycin B was added for selection. 
2.8.2 Liquid culture 
Yarrowia lipolytica cells were grown in Y½D liquid cultures (1% (w/v) yeast extract, 1% 
(w/v) glucose) at 28°C at 200 rpm. When Yarrowia lipolytica cells contained a plasmid, 
75 µg ml-1 Hygromycin B was added for selection. 
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2.9 Mitochondrial purification 
2.9.1 Mitochondrial purification from Arabidopsis thaliana leaves or 
hydroponic culture 
Mitochondria were isolated from Arabidopsis thaliana leaves or hydroponically grown 
seedlings as described in (Sweetlove et al. 2007) with minor modifications. Briefly, plant 
material was homogenised using a 2 cm Polytron® blender in 3 volumes of ice cold 
extraction buffer (0.3 M sucrose, 25 mM Na2P2O70NaOH, pH 7.5, 2 mM EDTA, 10 mM 
KH2PO4, 0.5% (w/v) PVP-40, 0.2% (w/v) BSA, fresh 4 mM cysteine). The samples were 
then filtered through 2 layers of muslin and 1 layer of miracloth (Millipore). Differential 
centrifugation was performed at 2,000 x g for 5 minutes and 12,500 x g for 20 minutes. 
Pellets were resuspended in ice cold wash buffer (0.3 M sucrose, 10 mM TES-KOH, pH 
7.5), before another round of differential centrifugation. Samples were then layered on 
continuous Percoll density gradients (see next paragraph; Figure 2.1A) and centrifuged 
at 40,000 x g for 40 minutes, with the breaks set on low. The mitochondria fraction (Figure 
2.1B) was then collected and washed twice with wash buffer and centrifugation at 16,000  
  
Figure 2.1: Mitochondrial purification using a Percoll gradient 
(A) Schematic of Percoll gradient, showing distribution of light and heavy solution  
(B) Percoll gradient after centrifugation. Arabidopsis thaliana sample has been separated into 
chloroplast thylakoid and mitochondrial fractions. 
  
Thylakoid 
fraction
Mitochondrial
fraction
A B
Light solution
Heavy solution
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x g for 20 minutes. Further wash steps can be performed with a table top microcentrifuge 
as necessary. Protein concentration was then determined (see section 2.10.2). 
Percoll gradients were made by adding 0.2% BSA (w/v) to 2 x wash buffer (to give 2 x 
gradient buffer) before adding Percoll to a final concentration of 28% (w/v) (for 150 mL: 
75 ml 2 x gradient buffer, 42 ml Percoll and 33 ml dH2O). This makes the “light solution”.  
Half of this was taken and PVP-40 was added, to a concentration of 4.4% (w/v), which 
was then renamed the “heavy solution”. 16 ml each of the “heavy” and “light” solution 
were mixed with a gradient former (BioRad, model 385) to form a gradient. With some 
purifications, a 5 ml Percoll pad was made below the gradient (for 5 ml: 2 ml Percoll, 2.5 
ml 2 x wash buffer, 0.5 ml dH2O). Mitochondria were stored at -80°C. 
2.9.2 Mitochondrial purification from Arabidopsis thaliana callus 
Mitochondria were isolated from Arabidopsis thaliana callus culture using a protocol 
based on (León et al. 2007), adapted by Janneke Balk and Pia Sharma, 2008. Briefly, 
callus material was homogenised with a pestle and mortar with glass beads and 2 
volumes ice cold extraction buffer (0.03 M MOPS-KOH, pH 7.5, 0.3 M mannitol, 1 mM 
EDTA, 0.1% (w/v) BSA, 0.6% (w/v) PVP-40, 4 mM cysteine). The samples were then 
filtered through 2 layers of miracloth (Millipore). Differential centrifugation was performed 
for 20 minutes at 1,000 x g and 20 minutes at 12,500 x g. Pellets were resuspended in 
ice cold wash buffer (0.03 M MOPS-KOH, pH 7.5, 0.3 M mannitol, 1 mM EDTA) before 
another round of differential centrifugation. Pellets were resuspended in wash buffer and 
protein concentration was determined (see section 2.10.2). Mitochondria were stored at 
-80°C. 
2.9.3 Yarrowia lipolytica mitochondrial membranes 
Unsealed mitochondrial membranes were isolated based on the protocol in (Kerscher et 
al. 1999), with minor modifications. Briefly, Yarrowia lipolytica cells were grown in a 25 
ml starter culture, Y½D containing 75 µg ml-1 Hygromycin B, at 28°C, two days before 
the mitochondrial purification. The day before, the 25 ml starter culture was added to a 
0.5 L culture, and grown overnight at 28°C. Cells were harvested by centrifugation at 
3,500 x g, after growth had reached log stage. Pellet weights were typically between 2-
8 g. Cells were washed with dH2O. To X g cells was added 2X g fine glass beads, 2 mM 
PMSF and 2X ml ice cold mito-membrane buffer (0.6 M sucrose, 20 mM MOPS-NaOH, 
pH7.5, 1 mM EDTA). Cells were disrupted by 15 rounds of 1 minute vortexing and 1 
minute incubation in ice. Differential centrifugation was performed at 3,500 x g for 10 
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minutes and 40,000 x g for 120 minutes. Pellets were resuspended in mito-membrane 
buffer and stored at -80°C. 
2.10  SDS-PAGE and Western blotting 
2.10.1 Total protein isolation Arabidopsis thaliana and Viscum album 
Leaf, or bud, tissue was frozen in liquid nitrogen and pulverised with a mini-pestle in a 
1.5 mL tube. Lysis buffer (50 mM Tris-HCL pH 8.5, 5% glycerol (v/v), 1% SDS (w/v), 10 
mM EDTA, 1 mM PMSF) was added, and mixed in. Debris was removed by 
centrifugation at 16,100 x g for 10 minutes at 4°C, and the supernatant taken for SDS-
PAGE. 
2.10.2 Protein determination 
Protein concentration was determined using Bio-Rad Protein Assay Dye Reagent. 1-2 µl 
of sample was added to dH2O, to make up to 100 µl. 1 mL of dye (diluted 1 in 5 from 
concentrate) was added. Absorption at 595 nm was measured using a Thermo 
Spectronic spectrophotometer. Results were compared to a calibration curve, made at 
the same time, of Bovine Serum Albumin (BSA), ranging from 2-16 µg/µL. 
2.10.3 SDS-PAGE 
SDS-PAGE was performed according to (Laemmli 1970). Briefly, SDS-PAGE gels were 
made according to table 2.10, using a mini-gel system (Bio-Rad) with 0.75 mm spacers. 
Gel acrylaminde percentages were set to 12.5 or 15%, as appropriate for optimal target 
protein separation. Samples were mixed with 4 x sample buffer (0.5 M Tris-HCL, pH 6.8, 
8% (w/v) SDS, 40% (v/v) glycerol), to give a final concentration of 1 X buffer. Samples 
were typically between 5-50 µg/ lane, depending on sample type and target protein. Gels 
were run at ~10 mA through the stacking gel, and 20-30 mA through the separating gel, 
until the dye front exited the base of the gel. 
Table 2.10: SDS-PAGE gel composition 
Solution Composition 
Separating gel (for 15%) 2.5 mL 30% acrylamide 0.8% bis-acrylamide, 1.25 mL 1.5 M Tris-HCL, 
pH8.8, 0.4% SDS, 1.25 mL dH2O, 50 µL 10% APS, 5 µL TEMED. 
Stacking gel 0.375 mL 30% Acrylamide 0.8% Bis-Acrylamide, 0.625 mL 0.5 M Tris-HCL, 
pH6.8, 0.4% SDS, 1.5 mL dH2O, 25 µL 10% APS, 2.5 µL TEMED. 
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2.10.4 Immunoblotting and ECL detection 
Protein was transferred from the SDS-PAGE gel to a nitrocellulose membrane (0.2 µm, 
Protran™) using a semi-dry blotting chamber (Biometra, Analytik Jena) and transfer 
buffer (0.048 M Tris, 0.039 M glycine, 0.0375 (w/v) SDS, 20% (v/v) methanol), for 30-35 
minutes at 175-190 mA, as described (Towbin et al. 1979). After protein visualisation 
(see section 2.10.5), membranes were blocked for 1-12 hours with Tris-Buffered Saline 
(TBS) solution (50 mM Tris-HCL pH 7.5, 150 mM NaCl), containing 5% (w/v) milk powder 
and 0.1% (v/v) Tween-20 (TBS-TM). The membrane was then incubated in primary 
antibody for 2 hours. Antibodies raised in rabbits were made up to the correct dilution in 
TBS-TM. Antibodies raised in mice were made up to the correct dilution in Phosphate-
Buffered Saline (PBS) solution, containing 1% BSA. Residual primary antibody was 
washed with 3 x10 minute washes, with TBS-TM or PBS, as appropriate. Membranes 
were then incubated with the appropriate secondary antibody horseradish peroxidase 
conjugate (Goat anti-rabbit IgG, H&L, HRP or Goat anti-mouse IgG, H&L, HRP) made 
up in TBS-TM or PBS as appropriate, for 45 minutes. After final washing, membranes 
were incubated with Enhanced ChemiLuminesence (ECL) reagents (1:1 mixture of 
solution 1 and solution 2, see table 2.11) for 1 minute. Membranes were dried with filter 
paper before detection with a ImageQuant LAS500 (GE Healthcare) or high performance 
chemiluminescence film (Amersham Hyperfilm™ ECL) and x-ray film processor machine 
(Konica Minolta SRX-101A). Numerous exposures were taken, for different lengths of 
time. 
Table 2.11: ECL reagents 
Solution Composition 
Solution 1 0.1 M Tris-HCL, pH 8.0, 10 μl m-1 luminol stock, 4.4 
μl ml-1 coumaric acid stock 
Solution 2 0.1 M Tris-HCL, pH 8.0, 0.018% H2O2 
Luminol stock 4.4% 3-aminophthalhydrazine (w/v) in DMSO  
Coumaric acid stock 1.5% p-coumaric acid (w/v) in DMSO 
 
2.10.5 Ponceau and IntstantBlue™stain 
Total protein was stained to control for equal loading and transfer using either Ponceau 
S stain or InstantBlue™ (Expedeon). For Ponceau, after transfer the nitrocellulose 
membrane was incubated with Ponceau S solution (0.1% Ponceau S (w/v), 5% acetic 
acid (v/v)), before being washed off with dH2O. Pictures were then taken before 
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continuation of immunoblotting. For in gel protein staining, the SDS-PAGE gel was 
incubated the SDS-PAGE gel was incubated for ~12 hours in IntstantBlue™ (Expedeon), 
before being dried in and imaged. 
2.10.6 Antibodies 
Table 2.12: List of antibodies 
Protein Organism Rabbit (R) 
or Mouse 
(M) 
Dilution Apparent size 
(kDa) 
(approximate) 
Source 
Aconitase S. cerevisiae R 1:2000 80 R. Lill 
Aconitase 1 A. thaliana R 1:5000 98 Agrisera 
Cox2 A. thaliana R 1:2000 30 Agrisera 
E1α (PDH) Z. mays M 1:1000 45 C. Leaver, T. Elthon 
GRXS15 A. thaliana R 1:1000 15 N. Rouhier 
H-protein A. thaliana R 1:1000 Various O. Keech 
Ind1 Y. lipolytica R 1:2000 30 R. Lill 
INDH A. thaliana R 1:2000 30 R. Lill 
ISU1 A. thaliana R 1:5000 15 S. Lobreaux 
Lipoate N/A R 1:3000 Various Abcam- ab58724 
Nad1 A. thaliana R 1:5000 N/A E. Meyer 
Nad9 Wheat R 1:5000 23 N/A 
NBP35 A. thaliana R 1:2000 38 R. Lill 
NFU4 A. thaliana R 1:5000 Various N. Rouhier 
NUBM Y. lipolytica M 1:20 50 V. Zickermann 
NUCM Y. lipolytica M 1:20 50 V. Zickermann 
Porin Z. mays M 1:1000 32 C. Leaver, T. Elthon 
Sdh2 S. cerevisiae R 1:5000 28 R. Lill 
TOM40 A. thaliana R 1:5000 36 J. Whelan 
 
2.11 Blue Native PAGE 
2.11.1 Arabidopsis thaliana and Viscum album 
To make samples, 100 µg pellet Arabidopsis thaliana or Viscum album mitochondria was 
resuspended in 90 µl ACA750 (750 mM ACA, 50 mM Bis-Tris-HCL, pH 7.0, 0.5 mM 
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EDTA). 10 µl of 10 % (w/v) n-dodecylmaltoside (DDM) in dH2O was added, mixed, and 
incubated on ice for 5 minutes followed by centrifugation at 16,100 x g, at 4°C, for 10 
minutes. 95 µl supernatant was then added to 5 µl 5% Serva blue solution (ACA750 with 
5% (w/v) Coomassie G250). 25 µl (25 µg) was loaded per lane. 5 µl NativeMark™ was 
used as a molecular weight marker. All BN-PAGE performed used NativePage™ 4-16% 
Bis-Tris gels (Invitrogen), with 1 mm spacers. Anode buffer was 50 mM Bis-Tris-HCL, 
pH7.0, cathode buffer was 50 mM Tricine, 15 mM Bis-Tris-HCL, pH7.0. To the cathode 
buffer 0.02% Coomassie G250 was added to make “dark” solution. This was diluted 10 
times to make “light” solution (for 1 L: 100 ml dark solution, 200 ml 5 x cathode buffer, 
700 ml dH2O). Gels were run in a XCell SureLock™ chamber at 4°C at 100 V (max 10 
mA) for 45 minutes with “dark” solution”, before being exchanged for “light” solution and 
being run for then ~2.5 hours at 250 V (max 15 mA), until the dye front exited the bottom. 
2.11.2 Yarrowia lipolytica 
To make samples, unsealed mitochondrial membranes were mixed with solubilisation 
buffer (90% of ACA750, 10% of 10 % (w/v) DDM) and incubated on ice for 5 minutes 
followed by centrifugation at 16,100 x g, at 4°C, for 10 minutes. A Bradford assay was 
carried out on the supernatant (see section 2.10.2), and 25 µg taken. This was then 
made up to 95 µl with solubilisation buffer and added to 5 µl 5% Serva blue solution. 25 
µl (6.25 µg) was loaded per lane. BN-PAGE was then carried out as described in section 
2.11.1. 
2.11.3 Transfer to PVDF membrane and immunolabelling 
Protein was transferred from the BN-PAGE gel to a PVDF membrane (0.2 micron, 
Millipore™) using wet, or tank, transfer (Towbin et al. 1979) and BN cathode buffer, for 
600 minutes at 40 mA, (maximum voltage 100 V). After transfer the membrane can be 
used for Coomassie staining (see section 2.11.4), complex III direct detection (see 
section 2.11.6) or immunolabelling (see section 2.10.4). 
2.11.4 Coomassie stain 
BN gels or PVDF membrane were stained in Coomassie solution (45% (v/v) MeOH and 
5% (v/v) acetic acid, 0.05% Coomassie R250) for 1-12 hours. Gels were destained using 
a solution of 45% (v/v) MeOH and 5% (v/v) acetic acid.  
2.11.5 Complex I, II and IV activity stain 
BN gels were stained for complex I, II and IV activity as described in (Sabar et al. 2005). 
Briefly, BN gels were equilibrated in buffer for 10 minutes before incubation in staining 
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solution (Table 2.13). After desired staining intensity was reached (20 minutes for 
complex I, up to 2 hours for complex IV), the reaction was stopped using a solution of 
45% (v/v) MeOH and 5% (v/v) acetic acid. Destaining using a solution of 45% (v/v) MeOH 
and 5% (v/v) acetic acid was performed for optimal enzyme stain visualisation. 
Table 2.13: BN-PAGE in gel activity stains 
Respiratory complex and 
enzyme activity 
Buffers pH Substrates Reagents 
(%(w/v) 
Complex I  
(NADH dehydrogenase) 
0.1 M Tris HCL 7.4 0.2 mM NADH 0.1 NBT 
Complex II  
(succinate dehydrogenase) 
50 mM KH2PO4, 0.1 mM 
ATP, 0.2 mM PMS 
7.4 10 mM succinate 0.2 NBT 
Complex IV  
(cytochrome c oxidase) 
50 mM KH2PO4 7.4 1 mg ml-1 cytochrome c 0.1 DAB 
 
2.11.6 Complex III detection 
Complex III can be detected by ECL (see section 2.10.14), immediately after transfer to 
a PVDF membrane (see section 2.11.3), as described (Feissner et al. 2003; Sun et al. 
2015). 
2.12 Spectrophotometric enzyme assays 
2.12.1 Complex I NADH:HAR oxidoreductase assays 
NADH:HAR oxidoreductase activity was assayed as described in (Abdrakhmanova et al. 
2005) and (Tocilescu et al. 2007). Briefly, NADH:HAR oxidoreductase activity was 
measured as NADH oxidation (ε340-400 nm = 6.22 mM-1 cm-1) in the presence of the artificial 
electron acceptor hexaammineruthenium(III) chloride (HAR). A 1 ml, 10 mm, quartz 
cuvette (Hellma® Analystics) was used and measurements made on a UV/Vis 
spectrophotometer (Jasco, V-550). Activity for 25 µg mitochondria was measured in 20 
mM HEPES-NaOH, pH 8.0, 2 mM NaN3, 0.2 mM NADH, 2 mM HAR and 40 µg ml-1 
alamethicin. Measurement started after addition of HAR. 
2.12.2 Complex I dNADH:DBQ oxidoreductase assay 
dNADH:DBQ oxidoreductase activity was assayed as described in (Abdrakhmanova et 
al. 2005) and (Tocilescu et al. 2007). Briefly, dNADH:DBQ oxidoreductase activity was  
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Figure 2.2: Histochemical stains of the mitochondrial respiratory chain 
Schematic showing histochemical stain activities. Adapted from Sabar et. al., 2005. Nitro-blue 
tetrazolium (NBT) gets reduced to formazan by the action of complex I. NBT gets reduced to 
formazan by the action of complex II, along with the artificial electron carrier phenazine 
methosulphate (PMS). 3,3’-Diaminobenzidine (DAB) is oxidised by cytochrome c, which is 
connected to the action of complex IV. 
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measured as dNADH oxidation activity (ε340-400 nm = 6.22 mM-1 cm-1) in the presence of 
the ubiquinone analogue n-decylubiquinone (DBQ) as an electron acceptor. A 1 ml, 10 
mm, quartz cuvette (Hellma® Analystics) was used and measurements made on a 
UV/Vis spectrophotometer (Jasco, V-550). Activity for 50 µg mitochondria was measured 
in 20 mM MOPS-NaOH, pH 7.4, 50 mM NaCl, 2 mM KCN, 0.1 mM dNADH and 0.1 mM 
DBQ. Measurement started after addition of DBQ. 0.01 mM of the complex I inhibitor 
Piericidin A was added at the end to ensure that dNADH:DBQ oxidoreductase activity is 
due to complex I. 
2.13 Microscopy 
2.13.1 Light microscopy 
Light microscopy for Arabidopsis thaliana silique dissection was carried out on a Leica 
M205FA light microscope. 
2.13.2 Differential Interference Contrast 
Arabidopsis thaliana embryos were prepared and imaged as described in (Andriotis et 
al. 2010), with help from Dr. Vasilios Andriotus. Briefly, seeds were cleared overnight in 
Hoyer’s solution (Liu & Meinke 1998), without gum Arabic. Cleared seeds were then 
viewed under Differential Interference Contrast (DIC) optics on a Leica DM600. 
2.14  Proteomics 
2.14.1 Sample preparation and mass spectrometry 
Mitochondrial samples from Viscum album were digested with trypsin. Briefly, samples 
were dissolved in a solution of 6 M urea, 2 M thiourea, pH 8.0. To this was added 1 µL 
reduction buffer (6.5 mM DTT) per 50 µg protein and the mixture was incubated for 30 
minutes at room temperature. 1 µL alkylation buffer (27 mM idoacetamide) per 50 µg 
protein was added and the mixture was incubated for 20 minutes at room temperature in 
the dark. 0.5 µL LysC (0.5 µg/µL) per 50 µg protein was added and incubated for 3 hours 
at room temperature. Samples were diluted 4X with 10 mM Tris-HCL, pH8.0, and to this 
1 µL trypsin per 50 µg protein was added and incubated overnight at 37 °C. Next, the 
samples were acidified to a final concentration of 0.2% trifluoroacetic acid. Samples were 
then purified using ZipTip® (Promega) tips. Shotgun proteomics was then performed 
using a Thermo Q-Exactive Plus mass spectrometer, performed with help from Dr. 
Etienne Meyer. 
 
Chapter 2 Materials and Methods 
 
 
47 
 
2.14.2 Analysis 
The output from mass spectrometry was analysed using the MASCOT server, using the 
following settings: enzyme: trypsin, allow up to 1 missed cleavage; fixed modification: 
carbamidomethyl; variable modification: methionine oxidation; peptide tolerance: 10 
ppm; MS/MS tolerance: 0.6 Da; peptide charge: 2+, 3+ and 4+. Two databases were 
used to identify peptide fragments. The first was based on the Arabidopsis thaliana TAIR 
10 gene annotation, with modifications made by Dr. Etienne Meyer to account for 
contaminants and edited organellar proteins. The second was based on the 
mitochondrial genome of Viscum album, sequenced by Petersen et al. 2015 (GenBank 
KJ129610), reannotated by Skippington et al. 2017.  
2.15  Protein expression 
Ind1-strep was expressed and purified as described in (Bych et al. 2008), using plasmids 
from section (table 2.8). Briefly, plasmids were transformed into Escherichia coli Rosetta 
pISC pLYS. Colonies were grown overnight at 37 °C in LB media, with correct antibiotics, 
then diluted 50 x in 100 ml Terrific broth (for 100 ml:4.76 g Teriffic broth, 0.8 ml 50% (v/v) 
glycerol), and grown until OD600= 0.6. Protein expression was induced by addition of 1 
ml L-1 benzylalcohol, 50 µM Fe-ammonium citrate, 100 µM L-cysteine and 1.2 ml L-1 
IPTG. Cells were then grown at 20 °C overnight. Cells were collected by centrifugation 
at 5000 x g and flash frozen in liquid nitrogen. Cells were then resuspended in buffer W 
(100 mM Tris-HCL, pH 8.0, 150 mM NaCl) with 0.2% DDM. Cells were then sonicated, 
and separated into soluble and insoluble fractions by centrifugation at 16,100 x g. 
Western blot analysis was performed to confirm protein expression.
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3 Using Yarrowia lipolytica as a model to understand 
pathogenic mutations in NUBPL associated with 
complex I deficiency 
3.1 Introduction 
Defects in the mitochondrial respiratory chain underlie a large proportion of mitochondrial 
disorders (Calvo & Mootha 2010). Respiratory chain disorders are serious genetic 
diseases with an estimated prevalence of 1 in 5000 live births (Skladal et al. 2003) and 
1 in 4300 in the adult population (Gorman et al. 2015) making them the most common 
inborn error of metabolism (Calvo & Mootha 2010). Complex I deficiency is the most 
common respiratory chain defect (Fassone & Rahman 2012; Mimaki et al. 2012; 
Rodenburg 2016) and is estimated to make up between a quarter and a third of all cases 
(Loeffen et al. 2000; Bugiani et al. 2004; Fassone & Rahman 2012). This may be 
because, with the largest number of subunits, complex I may be the most likely to be 
affected by genetic mutations (Rodenburg 2016). Clinical presentation usually occurs in 
infancy or early adulthood. Symptoms include Leigh syndrome, skeletal muscle 
myopathy, cardiomyopathy, hypotonia, stroke, ataxia and lactic acidosis (Fassone & 
Rahman 2012; Koene et al. 2012; Nouws et al. 2012; Alston et al. 2017). Such clinical 
heterogeneity, along with the varied genetic causes, make diagnosis challenging. 
Of the 44 structural subunits, 37 are encoded in the nuclear genome and 7 in the 
mitochondrial genome. Disease causing mutations have been identified in 26 out of 44 
subunit-encoding genes (Rodenburg 2016; Alston et al. 2017; Craven et al. 2017).  
However, this only provides a diagnosis for about 50% of cases (Calvo & Mootha 2010; 
Nouws et al. 2012). The remaining 50% are made up of other mutations, some of which 
affect other mitochondrial processes, such as mitochondrial DNA metabolisms, and 
some of which are complex I assembly factors.  
Assembly factors are defined as proteins which are required for the correct assembly 
and function of complex I, but are not present in the mature structure. The first assembly 
factors were discovered in the model yeast Neurospora crassa in 1998 (Küffner et al. 
1998), but since then numerous others have been discovered in humans (Mimaki et al. 
2012; Nouws et al. 2012). Disease causing mutations have been discovered in 10 out of 
16 currently known assembly proteins (Alston et al. 2017; Formosa et al. 2017). 
Discovery of these mutations has been greatly accelerated by advances in next 
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generation sequencing technologies, including whole exome sequencing (WES) 
technologies, which make it practical and affordable to sequence whole patient exomes 
(Haack et al. 2010; Alston et al. 2017). This has led to a greater understanding of the 
causes of mitochondrial disorders and an overall improvement in genetic diagnosis of 
patients. 
One assembly factor of complex I is NUBPL (NUcleotide Binding Protein-Like). It was 
first identified in the aerobic yeast Yarrowia lipolytica where it is called Ind1 (Iron sulfur 
protein required for NADH dehydrogenase) (Bych et al. 2008). Yarrowia lipolytica has 
been used extensively in biotechnology but it has also been developed as model 
organism to study complex I biology (Kerscher et al. 2002; Kerscher et al. 2004). This 
has been necessary because the usual yeast model Baker’s yeast, Saccharomyces 
cerevisae, has lost complex I. A genomic deletion strain of IND1 displayed a major 
decrease in fully assembled complex I, to approximately 28% of wild type (Bych et al. 
2008). Given Ind1’s homology to NBP35 and CFD1, cytosolic scaffold proteins involved 
in FeS cluster assembly, and its ability to coordinate a labile [4Fe-4S] cluster in vitro, it 
was suggested to be responsible for inserting FeS clusters of Complex I. Phylogenetic 
analysis of IND1 showed that it is present in almost all eukaryotes, and closely matches 
the distribution of Complex I (Bych et al. 2008). The IND1 homologue (INDH) in the model 
plant Arabidopsis thaliana is also required for complex I assembly (Wydro et al. 2013). 
Studies investigating the human homologue of IND1, initially called huIND1 but now the 
official name is NUBPL, in HeLa cells showed that siRNA knockdown lead to substantial 
decreases in complex I and its subunit levels, as well as accumulation of complex I 
membrane arm assembly intermediates (Sheftel et al. 2009). Following that, mutations 
in NUBPL were found associated with complex I deficiency (Calvo et al. 2010; Tenisch 
et al. 2012; Kevelam et al. 2013). Recently a large scale mutant screen for respiratory 
defect phenotypes, based upon a mutant’s inability to grow on galactose, identified 
NUBPL (Arroyo et al. 2016). Combined, these studies all indicate a role for NUBPL 
complex I assembly, confirming its conserved function across eukaryotes. 
To date, 13 patients have been found with mutations in NUBPL (Table 3.1). Patients 
display various symptoms including mitochondrial encephalomyopathy and neurological 
defects. Magnetic resonance imaging (MRI) patterns of NUBPL patients are unique and 
distinct from other complex I deficiency patients and so can be used diagnostically 
(Kevelam et al. 2013). All patients to date have been compound heterozygous, where 
they inherit one copy of NUBPL with a branch-site mutation c.815-27T>C, and one copy 
of NUBPL with either a large deletion or a missense mutation resulting in an amino acid 
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exchange. The c.815-27T>C mutation affects a splice recognition site in the intron and 
leads to aberrant mRNA splicing (Tucker et al. 2012). Approximately 30% of wild-type 
NUBPL transcript remains but two mis-spliced transcripts are also produced. One of 
these disappears by nonsense mediated decay. The other, which skips exon 10 and 
fuses exon 9 and 11 as well as introducing a frameshift, is predicted to lead to a new 
protein product, D273QfsX31. A study in Yarrowia lipolytica where the mutant protein 
was recreated in the yeast homolog Ind1, as N271QfsX31, suggests that c.815-27T>C 
is pathogenic (Wydro & Balk 2013). Ind1 variant N271QfsX31 was unable to support 
wild-type levels of complex I assembly. Interestingly c.815-27T>C is often co-inherited 
with a missense c.G166A mutation (p.G56R), which, on its own, is not thought to be 
pathogenic (Tucker et al. 2012; Wydro & Balk 2013). As well as the c.815-27T>C 
mutation causing an estimated 70% decrease in wild-type NUBPL transcript, the 
remaining protein product D273QfsX31 is unstable, as NUBPL protein is almost 
undetectable in patient fibroblasts (Tucker et al. 2012). In Yarrowia lipolytica the Ind1 
variant N271QfsX31 protein is also unstable and degrades (Wydro & Balk 2013). 
Therefore, if the mutation in the second allele affects a crucial amino acid and renders 
the protein non-functional, then complex I assembly would be severely impaired in the 
patient.  
Studying patient mutations in a Yarrowia lipolytica model is useful for clinicians and 
clinical scientists. Complex I defects seen in patient tissue biopsies can often not be 
replicated in cultured fibroblasts making characterisation of patient’s mutations hard. 
Data from WES show a large number of polymorphisms, many of which are benign 
variants, and it can be hard to pick the causal one. For example, a study claimed that 
27% of suggested disease causing mutations were in fact polymorphisms, sequencing 
errors, or did not have sufficient evidence of pathogenicity (Bell et al. 2011). Therefore, 
functional characterisation of patient mutations is essential to assign pathogenicity. 
Yarrowia lipolytica is a model which is well characterised, amenable to genetic 
manipulation, easy and cheap to grow, and is therefore ideal for this task. 
Here, in an effort to assign pathogenicity to six NUBPL mutations, four of which are newly 
identified and unpublished, I recreated the corresponding mutations in the Yarrowia 
lipolytica homolog, Ind1, and studied their effect. This approach has been previously 
used to model the effect of pathogenic mutations on complex I structural subunits, in 
both Yarrowia lipolytica and Neurospora crassa models (Ahlers et al. 2000; Kerscher et 
al. 2004; Duarte et al. 2005; Ferreira et al. 2011; Varghese et al. 2015; Gerber et al. 
2016). 
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3.2 Results 
3.2.1 Selection of NUBPL mutations for study  
To date, 13 patients with mitochondrial disorders have been identified who have 
mutations in NUBPL (Table 3.1). In addition, many more mutations in NUBPL have been 
uncovered by large scale exome sequencing projects (exac.broadinstitute.org).  
Mutations that result in frameshifts, large scale insertions or deletions (patients 2,5,7 and 
10) are almost certainly deleterious and so were not selected for further study. Mutations 
that affect splicing would be hard to recreate in Yarrowia lipolytica IND1, which is a single 
exon gene. One exception to this is the branch-site mutation c.815-27T>C which results 
in a decreased amount of wild-type mRNA and a truncated protein product D273QfsX31. 
This was previously recreated in Ind1, by gene synthesis, resulting in Ind1 N271QfsX31 
(Wydro & Balk 2013) and found to be deleterious. It will be used as a control throughout. 
Mutations resulting in a single amino acid change at a conserved position were chosen 
for study (Table 3.2): L104P (patient 8,9,12), D105Y (patient 3,4), G138D (ExAC 
database), L193F (patient 6) and G287C (patient 11). L104P and D105Y affect residues 
in the highly-conserved Switch I motif in the P-loop which is needed for NTP hydrolysis; 
G138D and L193F affect residues in the unstudied MRP domain and G287C introduces 
and additional cysteine to the C-terminus. G138D is not associated with a clinical case 
but is present in exome databases at high incidence (Table 3.4). G136D has also been 
suggested to be connected to Parkinson’s disease (Dr. Eli Hatchwell and Dr. Peggy Eis, 
personal communication). Therefore, because of current research on the connection 
between mild complex I defects and Parkinson’s disease, it was included in this study. 
In order to identify the corresponding amino acids in Yarrowia lipolytica Ind1, an 
alignment of amino acid sequences of NUBPL and Ind1 was made using Clustal Omega 
(Figure 3.1, Table 3.2).  A homology model of Ind1 was made and positions of amino 
acids studied here marked (Figure 3.2). These protein variants will be studied in the 
remainder of this chapter in order to assess their effect on Ind1 function. 
3.2.2 Bioinformatic analysis of NUBPL variants 
Before biochemical analysis, much can be learned from bioinformatic analysis. In order 
to predict the effect of NUBPL variants the prediction programme PolyPhen-2 was used.  
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Table 3.1: Overview of NUBPL mutations associated with complex I deficiency 
This table combines both published and unpublished reports. The genotype is given as HM for 
homozygous, or HT for heterozygous. Inheritance is given as paternal or maternal, where known. 
Nomenclature according to Human Genome Variation Society.  
Patient Country of 
origin 
cDNA Protein Site Paternal 
or 
Maternal 
Reference 
1 Argentina c.166G>A p.G56R Exon 2 N/A Kevelam et al. 2013 
  c.815-27T>Cd p.D273QfsX31 Intron 9 N/A  
2 Germany c.166G>A p.G56R Exon 2 Paternal Kevelam et al. 2013 
  c.815-27T>Cd p.D273QfsX31 Intron 9 Paternal  
  c.667_668insCC
TTGTGCTG 
p.Q223Afs*4 Exon 8 Maternal  
3,4 Canada c.166G>A p.G56R Exon 2 Paternal Kevelam et al. 2013 
  c.815-27T>Cd p.D273QfsX31 Intron 9 Paternal  
  c.313G>T p.D105Y Exon 4 Maternal  
5 USA c.166G>A p.G56R Exon 2 Paternal Kevelam et al. 2013 
  c.815-27T>Cd p.D273QfsX31 Intron 9 Paternal  
  c.693+1G>Ae p.? Intron 8 Maternal  
6 Netherlands c.579A>C p.L193F Exon 7 Paternal Kevelam et al. 2013 
  c.166G>A p.G56R Exon 2 Maternal  
  c.815-27T>Cd p.D273QfsX31 Intron 9 Maternal  
7 Australia c.166G>A p.G56R Exon 2 Paternal Calvo et al 2010; 
Tucker et al 2012 
  c.815-27T>Cd p.D273QfsX31 Intron 9 Paternal  
  240-kb deletion   Exons 1-4  Maternal  
  137-kb 
duplication  
 Exon 7 Maternal  
8,9 USA c.815-27T>C p.D273QfsX31 Intron 9 Paternal Virginia Kimonis, 
pers. comm 
  c.311T>C p.L104P Exon 4 Maternal  
10 France c.815-27T>C p.D273QfsX31 Intron 9 Paternal Tenish et al. 2012 
  c.205_206delGT p.V69Yfs*80  Maternal  
11 Germany c.166G>A p.G56R 
 
 
Exon 2 
 
N/A Holger Prokisch, 
pers. comm 
 
  c.815-27T>C p.D273QfsX31 
 
Intron 9 
 
N/A  
  c.859G>T 
 
p.G287C 
 
Exon 10 N/A  
12
  
USA c.815-27T>C p.D273QfsX31 
 
Intron 9 
 
N/A Baylor Miraca 
Genetics 
Laboratories 
 
  c.166G>A p.G56R 
 
Exon 2 
 
N/A  
  c.311T>C p.L104P 
 
Exon 4 
 
N/A  
13 USA c.545T>C p.V182A Exon 7 N/A Daryl Scott, pers. 
comm 
  c.815-27T>C p.D273QfsX31 
 
Intron 9 
 
Paternal  
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Table 3.2: Protein variants in Homo sapiens NUBPL and Yarrowia lipolytica Ind1 
NUBPL amino acid variant Corresponding Ind1 amino acid variant 
L104P L102P 
D105Y D103Y 
G138D G136D 
L193F L191F 
G287C G285C 
D273QfsX31 N271QfsX31 
 
Table 3.3: PolyPhen-2 predictions of effect of NUBPL variants 
NUBPL amino acid variant Polyphen-2 
 Class Score 
L104P Probably damaging 1.000 
D105Y Probably damaging 1.000 
G138D Probably damaging 0.999 
V182A Possible damaging 0.923 
L193F Probably damaging 1.000 
G287C Probably damaging 1.000 
 
 
Table 3.4: Allele frequency of mutations leading to NUBPL variants from ExAC 
Variant  Allele Count 
 
Total Alleles 
 
Allele Frequency 
 
L104P 25 120170 2.08 x 10-4 
D105Y 1 120200 8.319 x 10-6 
G138D 88 117184 7.51 x 10-4 
V182A 348 120522 2.887 x 10-3 
c.815-27T>C 436 117040 3.725 x 10-3 
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Figure 3.1: Alignment of NUBPL and Ind1 
Alignment of amino acid sequences of NUBPL from Homo sapiens (Uniprot: Q8TB37) and Ind1 
from Yarrowia lipolytica (Uniprot: Q6CE48) using Clustal Omega and Boxshade for colouring. 
Amino acid changes that are investigated in this study are indicated with red boxes. The start of 
the mature N-terminus is indicated with green boxes. The Walker A (P-loop), Switch I, MRP 
signature, ParA domain and CxxC signature are indicated. 
 
 
Figure 3.2: Homology model of Ind1 and amino acids investigated in this study 
Homology model of Ind1 using IntFOLD server using template 3vx3A.pdb (HYPB from 
Thermococcus kodakarensis KOD1). Mutations recreated in this study are indicated with a red 
sphere 
 
  
HsNUBPL    1 MGIWQRLLLFGGVSLRAGGGATAPLGGSRAMVCGRQL---------------SGAGSETL 
YlInd1     1 ---------MRGF------RLIAPIQRSIAIISRLQPITANFHSSPALRSHENPLGIPKS 
 
 
HsNUBPL   46 KQRRTQIMSRGLPKQKPIEGVKQVIVVASGKGGVGKSTTAVNLALALAANDSSKAIGLLD 
YlInd1    46 PASAPRIPRKTTRRPEPIAGVKKTIVVSSAKGGVGKSTVSVNTALSLAK--RGLRVGLLD 
 
 
HsNUBPL  106 VDVYGPSVPKMMNLKGNPELSQSNLMRPLLNYGIACMSMGFLVEESEPVVWRGLMVMSAI 
YlInd1   104 VDIFGPSIPTMFGLSGEPRMTHEGKLIPMSKFGIQVMSMGFLVDPNKAVAWRGLLVQKAL 
 
 
HsNUBPL  166 EKLLRQVDWGQLDYLVVDMPPGTGDVQLSVSQNIPITGAVIVSTPQDIALMDAHKGAEMF 
YlInd1   164 EQLLQDVDWGTLDVLVMDLPPGTGDVQLTIAQTVKIDGAIIVSTPQDVALVDVVRGLDLF 
 
 
HsNUBPL  226 RRVHVPVLGLVQNMSVFQCPKCKHKTHIFGADGARKLAQTLGLEVLGDIPLHLNIREASD 
YlInd1   224 EKTYTKVLGLVQNMSVFVCPNCNHETHIFGVDGAVSKAKSRGLGVLGNVPLDPQICSQSD 
 
 
HsNUBPL  286 TGQPIVFSQPESDEAKAYLRIAVEVVRRLPSPSE 
YlInd1   284 KGVPVAVSGGV--QAKYYDKIAEGVAEQLGV--- 
 
 
CxxC
Walker A (P-loop) Switch I
MRP signature ParA domain
L191
G285
G136
L102
D103
M180
N271
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PolyPhen-2 predicts whether mutations will be deleterious or not based upon sequence 
conservation (Adzhubei et al. 2010). Analysis of NUBPL protein variants by Polyphen-2 
returns a result of “probably damaging” for all of them (Table 3.3). Therefore, the base 
assumption before performing experiments is that all mutations will be deleterious. 
Additional insight can be gained from a population genetics approach. The prevalence 
of NUBPL mutations in populations can hint at their severity. Deleterious mutations are 
usually present at lower levels than less deleterious, or benign, mutations. Alternatively, 
high levels of a mutation can be due to positive selection. In order to assess the severity 
of NUBPL mutations, prevalence was assessed using data from ExAC 
(exac.broadinstitute.org), which provides global and population level data (Table 3.4). 
Variant D105Y had the lowest allele frequency, by two orders of magnitude, followed by 
L104P and G138D. This suggests that these three mutations are the most highly 
deleterious. The highest allele frequency was for the branch site mutation, c.815-27T>C, 
which was present at a frequency of 3.725 x 10-3, a remarkably high prevalence for a 
potentially deleterious mutation. Three individuals were identified which were 
homozygous for this variant. However, no clinical data exists on these individuals. 
The low global prevalences of these mutations hide regional differences. For example, 
G138D has a higher allele frequency in non-Finnish Europeans (1.152 x 10-3) than 
globally (7.510 x 10-4). The biggest difference is found with c.815-27T>C which has allele 
frequencies in European populations (non-Finnish) of 4.945 x 10-3 and in Finnish 
Europeans of 1.255 x 10-2. This last figure would imply around 1% of the Finnish 
population have this allele. As (Tucker et al. 2012) pointed out, such prevalence would 
make it the most common autosomal recessive respiratory chain mutation. Indeed, 
based upon data from HapMap and the 1000 genomes project, (Tucker et al. 2012) 
calculated that approximately 1 in 14,000 individuals would be heterozygous for this 
mutation. If such individuals had OXPHOS disorders it would represent a third of all 
cases (given that the prevalence of respiratory chain defects is calculated at 1 in 5000 
live births). A caveat is that these conclusions assume c.815-27T>C is pathogenic in its 
own right. However, the low levels of wild-type NUBPL transcript may allow for sufficient 
complex I levels for normal function. Such high frequencies could occur due to genetic 
drift or there may be some selective advantage conveyed by the mutation, for instance 
related to adaptation to the cold climate. Taken together these data support the idea that 
mutations in NUBPL are likely deleterious.  
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Figure 3.3: Expression of variant Ind1 proteins in Yarrowia lipolytica 
(A) SDS-PAGE followed by immunolabelling of Ind1 in protein samples of mitochondrial 
membranes from strains expressing wild-type Ind1 and the indicated protein variants, in the ind1Δ 
background. Antibodies against the mitochondrial protein aconitase (Aco1) and subunit 2 of 
succinate dehydrogenase (Sdh2) were used to confirm equal loading and transfer.  
(B) Transcript levels of the L102P variant compared to wild-type IND1 by RT-PCR. A PCR 
reaction for PYC1/ YALI0_C24101g, containing an intron, showed that the cDNA samples were 
free from genomic DNA and equal in cDNA content. ACT1 was used as an additional control for 
the amount of cDNA template.  
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3.2.3 Protein stability of Ind1 variants 
In order to study the effect of protein variants on NUBPL, the equivalent change was 
made on the corresponding residue in Yarrowia lipolytica Ind1. The five mutations 
outlined above were introduced by site-directed mutagenesis into a plasmid carrying a 
strep-tagged version of the IND1 gene under the control of its native promoter and 
transformed into Yarrowia lipolytica strain GB10 with a genomic deletion of the IND1 
gene (Bych et al. 2008). This strain was previously engineered to contain the NDH2i 
gene, encoding an alternative NADH dehydrogenase targeted to the matrix side of the 
inner mitochondrial membrane which allows the strain to bypass the absolute 
requirement of respiratory complex I (Kerscher et al. 2001). As mentioned, the previously 
reported branch-site mutation resulting in human D273QfsX31, and Yarrowia lipolytica 
N271QfsX31, was included for comparison (Wydro & Balk 2013). 
In order to test whether any of the protein variants affect protein stability, mitochondrial 
membranes of each strain were isolated and subjected to Western blot analysis to 
visualize Ind1 protein levels. Protein expression from a gene in a plasmid, even under 
its native promoter, will likely differ from a stable chromosomal expression, for example 
expression levels could be many times higher. This could create an artificial context in 
which to compare protein stability, where the levels of expressed proteins exceed the 
constitutive machinery needed for protein degredation.  Therefore, care should be taken 
not to over-interpret the results. Here, western blot analysis can only show whether or 
not the proteins have been completely degraded, and act as an additional control that 
the Ind1 variants are properly expressed, but comparing relative levels may not be 
relevant to the native context. The D103Y, G136D, L191F and G285C variants displayed 
levels of Ind1 protein similar to ind1Δ + IND1 (henceforth referred to as complimented 
wild type, cWT) (Figure 3.3A). In humans, analysis of patient fibroblasts with variant 
D105Y showed a substantial decrease in NUBPL protein levels (Kevelam et al. 2013). 
The L102P substitution resulted in lower levels of Ind1 protein (Figure 3.3A), to 
approximately 45% of cWT levels. The decrease in L102P protein was similar to that 
seen in N271QfsX31. The N271QfsX31 protein is of lower molecular weight than Ind1 
protein due to the 11 amino acid-truncation of the C-terminus. Antibodies against Aco1 
and Sdh2 were used as loading controls. Additionally, the Sdh2 levels confirm that 
complex II subunit protein levels are unaffected in Ind1 mutants as previously reported 
(Bych et al. 2008). 
In order to determine the reason for low levels of the L102P protein variant, RT-PCR was 
carried out to assess the expression of IND1 (Figure 3.3B). Normal levels of IND1 
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transcript were observed in the L102P variant, indicating that the lower L102P protein 
levels are due to post translational degradation rather than decreased transcript levels. 
ACT1 transcript levels were used as a control for the amount of cDNA template. A PCR 
reaction for PYC1/ YALI0_C24101g which contains an intron, was performed to show 
that the cDNA was free from genomic DNA and equal in cDNA content. Overall these 
data suggest that, with the exception of L102P, the Ind1 variants do not affect protein 
stability.  
3.2.4  Variants L102P, D103Y and L191F are unable to support cWT 
levels of complex I assembly 
It has previously been shown that IND1 knockout strains have approximately 28% of 
intact, active, complex I compared to wild type (Bych et al. 2008).  To investigate the 
effect of the amino acid variants in Ind1 on complex I assembly, mitochondrial 
membranes were isolated and complex I content and activity assayed.  
To visualise complex I content mitochondrial membrane respiratory complexes were 
separated using blue-native PAGE (BN-PAGE) and stained for dehydrogenase activities 
with NADH and nitro-blue tetrazolium (NBT). This histochemical enzyme activity stain is 
specific to complex I and allows easy visualisation of complex I levels. It is used as a 
proxy to estimate complex I levels, but not complex I enzyme activities (Sabar et al. 
2005). Complex I levels were strongly decreased in L102P, D102Y and N271QfsX31, 
similar to the levels in the ind1Δ empty vector control (e.v.) (Figure 3.4A). L191F had a 
slight decrease in complex I levels, whereas G138D and G285C were indistinguishable 
from cWT. For comparison, a knockout strain of the NUBM (nubmΔ) subunit of complex 
I displayed no complex I. Another complex I mutant, where a key catalytic residue of the 
NUCM subunit has been mutated (Y144F) displayed complex I levels similar to cWT 
(Tocilescu et al. 2010). This is consistent with a mutation that affects catalysis, but does 
not inhibit complex I assembly. Complex V levels were unaffected by mutations in IND1, 
as has been previously reported in the ind1Δ mutant (Figure 3.4A). 
To measure oxidoreductase activity of the peripheral arm of complex I, two different 
spectrophotometric assays were used.  Electron transfer from NADH to the artificial 
electron acceptor hexaammineruthenium(III) chloride (HAR) involves only the primary 
electron acceptor FMN bound to the NUBM subunit of complex I and so serves as a 
proxy for complex I content. The L102P, D103Y, L191F, and N271QfsX31 variants 
showed a significant decrease in NADH:HAR activity, and therefore in complex I levels 
(Figure 3.4B, Table 3.5). The decrease seen in L102P, D103Y and N271QfsX31 is  
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Figure 3.4: Complex I levels and oxidoreductase activity in Ind1 variants 
(A) Complex I levels shown by BN-PAGE analysis of mitochondrial membrane samples from 
Yarrowia lipolytica ind1Δ expressing IND1 and the indicated protein variants, compared to two 
well characterized complex I mutants (nubmΔ and nucmΔ + NUCM-Y144F). Complex I activity 
was visualised with NADH/NBT staining. 
(B) NADH:HAR  and (C) dNADH:DBQ oxidoreductase activity in mitochondrial membrane 
samples from the indicated strains. n=3 biological replicates. Error bars represent s.e.m. Two-
sample t-test:  * p<0.05, ** p<0.01.  
  
n
u
c
m
Δ
+
N
U
C
M
-Y
1
4
4
F
+
 e
.v
.
ind1Δ
Complex I
+
 IN
D
1
+
 N
2
7
1
Q
fs
X
3
1
+
 L
1
0
2
P
+
 D
1
0
3
Y
+
 G
1
3
6
D
+
 L
1
9
1
F
+
 G
2
8
5
C
n
u
b
m
Δ
Complex V
C
o
m
p
le
x 
I 
a
c
ti
vi
ty
 (
N
A
D
H
:H
A
R
) 
(U
/m
g
 m
it
o
c
h
o
n
d
ri
a
l p
ro
te
in
)
**
**
**
**
*
0
0.2
0.4
0.6
0.8
1
1.2
ind1Δ +
N
2
7
1
Q
fs
X
3
1
D
1
0
3
Y
e
.v.
IN
D
1
L
1
0
1
P
G
1
3
6
D
L
1
9
1
F
G
2
8
5
C
B
C
o
m
p
le
x 
I 
a
c
ti
vi
ty
 (
d
N
A
D
H
:D
B
Q
) 
(U
/m
g
 m
it
o
c
h
o
n
d
ri
a
l p
ro
te
in
)
** **
**
**
**
0
0.1
0.2
0.3
0.4
0.5
0.6
C
A
ind1Δ +
N
2
7
1
Q
fs
X
3
1
D
1
0
3
Y
e
.v.
IN
D
1
L
1
0
1
P
G
1
3
6
D
L
1
9
1
F
G
2
8
5
C
Chapter 3 Using Yarrowia lipolytica as a model to understand pathogenic mutations in 
NUBPL associated with complex I deficiency 
 
 
60 
 
Table 3.5: Complex I activity assays for Ind1 variants 
Activities are given as mean ± s.e.m (n=3). Two-sample t-test 
Protein variant NADH:HAR activity  dNADH:DBQ 
activity 
 
 Umg-1 p-value % of WT Umg-1 p-value % of WT 
Ind1 (wild type) 1.07 ± 0.06 - 100 0.47 ± 0.02 - 100 
e.v. 0.45 ± 0.08 p= 0.003 (**) 42 0.20 ± 0.02 p< 0.001 (**) 43 
N271QfsX31 0.37 ± 0.03 p< 0.001 (**) 34 0.17 ± 0.02 p< 0.001 (**) 36 
L102P 0.51 ± 0.09 p= 0.007 (**) 48 0.15 ± 0.02 p< 0.001 (**) 32 
D103Y 0.31 ± 0.01 p= 0.006 (**) 29 0.18 ± 0.02 p< 0.001 (**) 39 
G136D 0.79 ± 0.11 p= 0.088 74 0.37 ± 0.04 p= 0.084 79 
L191F 0.69 ± 0.09 p= 0.024 (*) 65 0.28 ± 0.02 p= 0.002 (**) 59 
G285C 0.91 ± 0.10 p= 0.222 84 0.31 ± 0.06 p= 0.056 65 
M180V 1.02 ± 0.13 p= 0.705 95 - - - 
M180A 1.02 ± 0.07 p= 0.780 95 - - - 
nucm∆ + Y144F - - - 0.04 ± 0.01 p< 0.001 (**) 9 
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similar to the decrease in the empty-vector control. G136D and G285C are not 
significantly decreased compared to cWT. These data are consistent with what is found 
by NADH/NBT activity staining of BN-polyacrylamide gels.  
The second assay involves electron transfer from deamino-NADH (dNADH) to n-
decylubiquinone (DBQ) which encompasses all cofactors in the matrix arm of complex I 
and is therefore a more accurate measure of the physiological NADH:ubiquinone 
oxidoreductase activity. A significant decrease in electron transfer was seen with the 
L102P, D103Y, L191F, and N271QfsX31 variants, but not in G136D and G285C (Figure 
3.4C, Table 3.5). The previously studied complex I mutant nucmΔ + NUCM-Y144F, 
which is defective in a key catalytic residue in the Q pocket, had low dNADH:DBQ activity 
(9% of cWT, Table 3.5, 5% of WT Tocilescu et al. 2010), despite wild-type levels of fully 
assembled complex I (Figure 3.4A). This is consistent with a mutant that is affected in 
catalysis, but not complex I assembly. Comparison of dNADH:DBQ activity between the 
Ind1 variants and nucmΔ + NUCM-Y144F (Tocilescu et al. 2010) shows that in the Ind1 
variants there is still substantial activity remaining. For the Ind1 variants the NADH:HAR 
and dNADH:DBQ activities  match up, suggesting that all the complex I present is 
enzymatically active. 
Taken together the data from three different techniques are in agreement and indicate 
that the L102P and D103Y mutations are severe and cause a defect in complex I 
assembly of similar severity as the knock-out mutant, whereas L191F only causes a mild 
decrease. G138D and G285C have no significant effect on complex I levels.  
3.2.5 The levels of NUBM and NUCM, two subunits of Complex I, are 
not significantly altered 
In mutants of complex I assembly, regulatory steps may be taken to either down-regulate 
subunit transcription and translation or to post-translationally degrade already 
synthesised subunits. For example, in human cells RNAi knockdown of NUBPL resulted 
in a major decrease in NDUFV1 (Human homolog of NUBM) (Sheftel et al. 2009). 
Western blot analysis was carried out on mitochondrial membranes to probe the 
presence of complex I subunits. However, I was limited by available antibodies to 
subunits NUBM and NUCM. In Yarrowia lipolytica, there is a slight decrease in NUBM 
levels in the ind1∆ mutant compared to cWT. However, in nucm∆ and nukm∆ mutants, 
both subunits from the Q module, there is a greater decrease in the levels of NUBM. 
These data suggest that if the Q-module is not assembled, NUBM is degraded, assuming 
its transcription and mitochondrial import is unaffected. In contrast, the levels of NUCM  
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Figure 3.5: Complex I subunits in complex I mutants and Ind1 variants 
(A) Protein levels of complex I subunits, NUBM and NUCM, and Ind1 visualised by 
immunolabelling of mitochondrial membrane samples separated by SDS-PAGE from Yarrowia 
lipolytica mutants as indicated. Antibodies against mitochondrial aconitase, Aco1, which was used 
to confirm equal loading and transfer.  
(B) Immunolabelling of mitochondrial membrane samples from Yarrowia lipolytica ind1Δ 
expressing Ind1 and the indicated protein variants with antibodies against complex I subunits 
NUCM, NUBM, and Sdh2, which was used to confirm equal loading and transfer. 
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are similar in nubm∆, nukm∆ and ind1∆ mutants. Therefore, NUCM is translated and 
imported in mitochondria but not assembled. 
Despite an approximately 70% decrease in complex I levels in some Ind1 variants and 
ind1∆, the protein levels of NUCM and NUBM are largely unaffected compared to cWT, 
with only small decreases observed (Figure 3.5A and 3.5B). Ind1 protein levels are 
slightly decreased in nucm∆, nubm∆ and nukm∆ compared to cWT. These data show 
that the Ind1 knock-out mutant has a minor effect on the NUBM subunit level, whereas 
in Q-module mutants there is a substantial decrease in NUBM protein levels. This implies 
Ind1 does not affect the N module as much as the Q module does. 
3.2.6 ind1∆ accumulates the Q module assembly intermediate 
Given Ind1’s similarity to FeS scaffold proteins NBP35 and CFD1 (Bych et al. 2008) it 
has a suggested function inserting FeS clusters into the matrix arm of complex I. 
However, the exact stage at which Ind1 acts has never been shown and the pattern of 
assembly intermediates has never been characterised in Yarrowia lipolytica. Some work 
has been done on other species. In INDH mutants, the plant homolog of NUBPL, 
assembly modules of the membrane arm of complex I are found (Wydro et al. 2013). 
Similarly, in humans a membrane arm assembly intermediate was observed in RNAi 
knockdown lines (Sheftel et al. 2009). To investigate how Ind1 functions in complex I 
assembly, and to see if it is similar to that seen in plants and humans, assembly 
intermediate profiles were analysed in ind1Δ and compared to deletion strains of three 
well characterised complex I subunits: the N-module subunit NUBM and the Q-module 
subunits NUCM and NUKM. 
Mitochondrial membranes were isolated from cWT, ind1Δ, nubmΔ, nucmΔ and nukmΔ 
and the respiratory complexes were separated using BN-PAGE. Gels were then stained 
for NADH/NBT activity to visualise complex I levels, or Western blotting and 
immunolabelling carried out with antibodies against NUBM and NUCM. In ind1Δ, an 
assembly intermediate was seen at approximately 500 kDa which was also seen in cWT 
(Figure 3.6). The levels of this intermediate appear equal between ind1Δ and cWT in 
figure 3.6, although in some repeats the levels are higher in cWT. This intermediate 
contains the NUBM and NUCM subunits and is therefore likely to contain the full matrix 
arm of complex I (Vogel et al. 2007), perhaps as well as the partial membrane arm. An 
additional assembly intermediate containing NUCM, but not NUBM, was seen at 
approximately 160 kDa. This intermediate is not found in cWT and likely corresponds to 
the Q module. A similar Q module assembly intermediate has been previously observed  
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Figure 3.6: Complex I assembly intermediates in Ind1 and Complex I mutants 
BN-PAGE analysis of mitochondrial membrane samples from Yarrowia lipolytica ind1Δ and 
complex I mutants; nucmΔ, nubmΔ and nukmΔ.  Top panels: Complex I activity was visualised 
with NADH/NBT staining. Middle and bottom panels: Western blotting and immunolabelling with 
antibodies against NUCM and NUBM. 
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in Yarrowia lipolytica (Kmita et al. 2015) and contains the NUCM (human NDUFS2, 
bovine 49 kDa), NUGM (NDUFS3/30 kDa), NUKM (NDUFS7/PSST) and NUFM 
(NDUFA5/ B13) subunit. Combined these subunits would have a molecular weight of 
116.42 kDa (calculated based on molecular weights in Angerer et al. 2011). Assembly 
factors would likely also be bound to this structure, resulting in a higher observed 
molecular weight ~160 kDa.  Additionally, signal was seen around 80 kDa for both 
antibodies but this most likely represents monomer and dimers and initial assembly 
products. These data suggest that while ind1Δ can assemble some fully assembled 
complex I and a 500 kDa intermediate, there is a large accumulation of the Q-module 
intermediate.  
Signal can be seen at the molecular weight corresponding to mature complex I when 
probing with the NUCM antibody in the nubmΔ strain. This is unexpected given that no 
mature complex I can be seen in this strain using NADH/NBT staining. However, long 
exposures are needed to detect the assembly intermediates. Shorter exposures show 
that this signal is less strong than that in cWT and ind1Δ as well as being at a slightly 
lower molecular weight. It is possible that a small amount of mature complex I is formed, 
below the detection limit of NADH/NBT staining. 
The Q module intermediate can also be seen in nubmΔ and nukmΔ, which did not contain 
the 500 kDa assembly intermediate (Figure 3.6). This is consistent because the Q 
module cannot dock to N-module if NUBM is lacking, or to the membrane module if 
NUKM is lacking. Therefore, a Q module, but no other, intermediate is formed. 
These data show there is a clear difference between the assembly intermediates seen 
in ind1Δ and those seen in nubmΔ, nucmΔ and nukmΔ.  
3.2.7 All Ind1 variants accumulate the Q module of complex I  
Having investigated the assembly defects in ind1Δ, I wanted to investigate the effect of 
the amino acid variants in Ind1 on complex I assembly. Complex I assembly profiles 
were analysed in Ind1 variants using BN-PAGE and Western blotting using antibodies 
against NUBM and NUCM.  
The variants, even those with normal complex I levels, have the same pattern of 
assembly intermediates containing NUCM as the empty vector control, namely 
accumulation of the Q-module containing NUCM, with some minor variations (Figure 
3.7A). The G136D and L191F variants accumulated low levels of the Q-module. D103Y 
accumulated high levels of Q module and no, or little, 500 kDa intermediate. For  
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Figure 3.7: Complex I assembly intermediates in Ind1 variants 
BN-PAGE analysis followed by Western blotting and immunolabelling with antibodies against (A) 
NUBM and (B) NUCM of mitochondrial membrane samples from Yarrowia lipolytica ind1Δ 
expressing IND1 and indicated Ind1 variants. Coomassie staining of complex V was used as a 
loading control. 
  
+
 D
1
0
3
Y
720
480
242
146
66
kDa
NUBM
+
 e
.v
.
ind1Δ
+
 IN
D
1
+
 N
2
7
1
Q
fs
X
3
1
+
 L
1
0
2
P
+
 D
1
0
3
Y
+
 G
1
3
6
D
+
 L
1
9
1
F
+
 G
2
8
5
C
720
480
242
146
66
kDa
NUCM
+
 e
.v
.
ind1Δ
+
 IN
D
1
+
 N
2
7
1
Q
fs
X
3
1
+
 L
1
0
2
P
+
 G
1
3
6
D
+
 L
1
9
1
F
+
 G
2
8
5
C
A B
CBB CBB
n
u
b
m
Δ
Chapter 3 Using Yarrowia lipolytica as a model to understand pathogenic mutations in 
NUBPL associated with complex I deficiency 
 
 
67 
 
 
Figure 3.8: Yarrowia lipolytica growth at low temperature 
Growth of Yarrowia lipolytica ind1Δ expressing IND1 and the indicated protein variants, and 
complex I mutants, nucmΔ + NUCM-Y144F, nubmΔ + e.v. and nukmΔ + e.v. at normal and cold 
temperatures.  Images show a serial dilution of cultures that were spotted onto agar plates.  
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intermediates containing the NUBM subunit, variants with low complex I levels 
(N271QfsX31, L102P and D103Y) closely resembled the empty vector control, whereas 
those with near normal complex I levels (G136D, L191F, G285C) more closely resemble 
cWT (Figure 3.7B). These data show that all Ind1 variants display assembly defects, as 
they all accumulate Q module intermediates. 
3.2.8 Ind1 variants are sensitive to cold 
During storage of Yarrowia lipolytica strains on agar plates in the cold-room, it was 
noticed that the ind1Δ mutant was sensitive to cold, exacerbating the small growth 
difference between it and the wild-type strain. We therefore tested the effect of cold 
(10°C) on the growth of Ind1 variants and different complex I mutants.  
Yarrowia lipolytica ind1Δ expressing WT Ind1 or Ind1 variants, as well as nucmΔ + 
NUCM-Y144F, nubmΔ and nukmΔ, were grown in liquid culture before being spotted 
onto agar plates in a dilution series. After incubation of the plates overnight at 30°C plates 
were either left at 30°C for a further two days or moved to 10°C for a further 10-14 days. 
At 30°C all strains grew similarly, despite slight variations in colony size (Figure 3.8, left 
panels). However, when grown at 10°C some strains displayed dramatic growth 
differences (Figure 3.8, right panels). The ind1Δ strain expressing WT Ind1, Ind1 variant 
G136D, nubmΔ and nukmΔ all displayed significant growth, although slower compared 
to those plates grown at 30°C. However, all other strains at 10°C displayed very slow, or 
no, further growth. Interestingly the complex I mutants lacking fully assembled complex 
I, nubmΔ and nukmΔ, were able to grow in cold conditions but not nucmΔ + NUCM-
Y144F, which has fully assembled complex I but is not enzymatically active. 
These data reveal a novel growth difference of certain complex I mutants grown at 
normal (30°C) or cold (10°C) conditions. Ind1 variants, except for G136D, also display 
this cold dependent growth difference. 
3.2.9 Complex I is unstable at cold temperatures for Ind1 variant 
G285C 
The Ind1 variant G285C has normal levels and activity of complex I (Figure 3.4A). 
However, it displayed a complex I assembly pattern that is different to that of cWT (Figure 
3.7B) and growth at 10°C is impaired (Figure 3.8). These observations led me to 
investigate the assembly of complex I in the G285C variant at cold compared to normal 
growth temperatures. Mitochondrial membranes were isolated from cWT and G285C  
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Figure 3.9: Cold temperatures lead to complex I instability in G285C variant 
(A) Complex I levels in mitochondrial membrane samples from Yarrowia lipolytica ind1Δ strains 
expressing wild-type IND1 or Ind1 variant G285C isolated after growth at 28°C or 10°C. Complex 
I activity was visualised by BN-PAGE followed by NADH/NBT staining (upper panel) and by 
Western blot and immunolabelling with antibodies against NUBM (lower panel).  
(B) Complex I assembly intermediates from Yarrowia lipolytica ind1Δ strains expressing wild-type 
IND1 or Ind1 variant G285C isolated after growth at 28°C or 10°C. Intermediates were visualised 
by BN-PAGE followed by Western blot and immunolabelling with antibodies against NUCM. 
(C) Protein levels of Ind1 and complex I subunits in samples used in part (A) and(B). SDS-PAGE 
was followed by Western blot and immunostaining with antibodies against Ind1, NUCM and 
NUBM. Ponceau stain used to confirm equal loading and transfer. 
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after overnight growth at 10°C, and compared to those isolated after growth at 28ºC. 
Respiratory complexes of the mitochondrial membranes were separated by BN-PAGE 
and activity stained to assess formation of complex I. cWT displayed full complex I 
formation in cultures grown at both 30°C and 10°C (Figure 3.9A). Conversely G285C 
could not support complex I assembly when grown at 10°C, with complex I levels 
decreased to around knock out mutant levels. BN-PAGE followed by Western blotting 
and immunolabelling with antibodies against complex I subunit NUBM confirmed the 
decrease in complex I levels in mitochondria isolated from G285C at 10°C (Figure 3.9A). 
SDS-PAGE and immunolabelling with the Ind1 antibody confirmed the presence of the 
Ind1 protein in the mitochondria isolated from G285C at 10°C, meaning the decrease in 
complex I levels is not due to a cold dependent degradation of the Ind1 protein (Figure 
3.9B). Next, the effect of growth in cold conditions on complex I assembly intermediates 
was assessed. BN-PAGE followed by Western blotting and immunolabelling with 
antibodies against the NUCM subunit of complex I displayed different patterns between 
mitochondria isolated at normal and cold temperatures (Figure 3.9C). G285C samples 
from cold conditions are lacking a band corresponding to the assembly intermediate at 
500 kDa, made up of the N and Q modules, and have an increase in the Q module 
intermediate at 160 kDa. This suggests at cold temperatures G285C accumulates 
greater levels of the Q module as it is unable to assemble it into the 500 kDa 
intermediate, and has lower levels of fully assembled complex I. There is still a strong 
signal at the size corresponding to complex I, however this is due to a long exposure 
time needed to see assembly intermediates.  
Taken together these data show that the G285C mutant is more severely impaired in 
complex I assembly when grown in cold conditions. This could explain why G285C has 
a growth defect at 10°C similar to that of the knock out mutant. 
3.2.10 Semi-conserved NUBPL variant V182A does not affect 
complex I assembly 
All mutations in NUBPL studied so far resulted in an amino acid exchange at a conserved 
residue in Ind1. However, for NUBPL variant V182A (Table 3.1, patient 13), there is no 
valine in Ind1 at position 180. Instead there is a methionine. However, these positions 
can be considered semi-conserved, because both valine and methionine have large 
hydrophobic side-chains. Alanine has a smaller hydrophobic sidechain.  If M180V in Ind1 
caused no deleterious effect, but a M180A did, then is would suggest that V182A in 
NUBPL is damaging.  
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Figure 3.10: Complex I levels and growth in M180 Ind1 variants 
(A) Complex I levels in mitochondrial membrane samples from Yarrowia lipolytica ind1Δ 
expressing IND1 and the indicated protein variants. Complex I activity was visualised by BN-
PAGE followed by NADH/NBT staining.  
(B) Growth of Yarrowia lipolytica ind1Δ expressing IND1 and the indicated protein variants at 
normal and cold temperatures.  Images show a serial dilution of cultures that were spotted onto 
agar plates. 
 
 
 
 
 
Figure 3.11: Ind1 and Ind1 variant protein expressed in Escherichia coli 
Ind1 and Ind1 variant protein expressed in E. coli (Rosetta + pISC + pLyS). Total protein extract 
(T) was sonicated and centrifuged to give insoluble pellet (P) and soluble supernatant (SN). SDS-
PAGE Gels were stained with instant blue (top panels) or immunolabelled with antibodies against 
Ind1 (bottom panels). 
 
  
+
 M
1
8
0
V
ind1Δ +
M180V
M180A
e.v.
Ind1
Growth at 30 C
serial dilutions
Growth at 10 C+
 e
.v
.
ind1Δ
Complex I
+
 IN
D
1
+
 M
1
8
0
A
Complex V
A B
T
o
ta
l
P
e
lle
t
S
u
p
e
rn
a
ta
n
t
T
o
ta
l
P
e
lle
t
S
u
p
e
rn
a
ta
n
t
T
o
ta
l
P
e
lle
t
S
u
p
e
rn
a
ta
n
t
T
o
ta
l
P
e
lle
t
S
u
p
e
rn
a
ta
n
t
T
o
ta
l
P
e
lle
t
S
u
p
e
rn
a
ta
n
t
P
re
-i
n
d
u
c
ti
o
n
Instant blue
Ind1
Ind1 L102P D103Y G80S K81Q
Chapter 3 Using Yarrowia lipolytica as a model to understand pathogenic mutations in 
NUBPL associated with complex I deficiency 
 
 
72 
 
In order to test this hypothesis two new Ind1 variants, M180V and M180A, were created 
as detailed in section 3.2.3. To visualise complex I levels, mitochondrial membrane 
respiratory complexes were separated using BN-PAGE and stained for NADH 
dehydrogenase activities with NADH and NBT. Complex I levels were unaffected in both 
M180V and M180A (Figure 3.10A). Additionally, spectrophotometric assays using NADH 
and HAR showed no significant difference from cWT (Table 3.5). Growth tests under 
normal and cold conditions were carried out to see if any deleterious effect of M180A 
could be detected. However, none was found as both M180V and M180A grew similarly 
to cWT under cold conditions (Figure 3.10B).  
These data suggest the change is not pathogenic. This is consistent with a subsequent 
reassessment of patient 13, who was found to possess an additional mutation leading to 
a chromosomal deletion (Daryl Scott, Peggy Eis, Virginia Kimonis personal 
communication). In that deletion were two genes, UQCRC2 and CDR2, the loss of which 
could explain the patient’s symptoms. Therefore, the mutation leading to V182A is likely 
not pathogenic, but rather a benign variant. 
3.2.11 Studies on recombinant Ind1 show L102P is insoluble 
The post-translational degradation of Ind1 variant L102P, in section 3.2.3, suggests the 
amino acid changes could affect Ind1 protein stability. In order to assess the effects of 
amino acid changes on Ind1 protein stability, recombinant Ind1-strep, along with Ind1 
variants, were expressed in E. coli (Rosetta strain with pISC pLys) and analysed by SDS-
PAGE and Western blot analysis. After induction, total protein extract was sonicated and 
centrifuged to give insoluble pellet and soluble supernatant fractions. WT Ind1 was 
present predominantly in the supernatant fraction, but also in the pellet, indicating that 
most of Ind1 produced in E. coli is soluble (Figure 3.11). Soluble Ind1 protein is also seen 
with Ind1 variant D103Y, although at lower levels. However, no Ind1 protein is seen in 
the supernatant fraction in L102P. All protein is in the pellet fraction. This indicates that 
the L102P amino acid exchange causes the protein to be insoluble, possibly through 
mis-folding. This would suggest a reason for post translational degradation. 
Two additional mutations were investigated for solubility. G80S and K81Q are located in 
the Walker A motif. They have both previously been shown to be deleterious, completely 
disabling Ind1 function (Table 3.7, Stefan Kerscher unpublished data). K81Q, similarly 
to WT and D103Y has Ind1 protein in both the pellet and supernatant fraction, whereas 
G80S, similarly to L102P, has Ind1 protein mainly in the insoluble pellet fraction (Figure 
3.11). 
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Table 3.6: Complex I activity in patients 
Taken from Calvo et al. 2010; Tenisch et al. 2012; Kevelam et al. 2013 
Patient CI fibroblasts 
(% of control) 
CI muscle 
(% of control) 
Yarrowia 
N271QfsX31 
(% of WT) 
Yarrowia 
Ind1 variant  
(% of WT) 
2 27 - 34 - 
3 64 - 34 29 
4 56 - 34 29 
6 83 67 34 65 
7 19 37 34 - 
10 - 31 34 - 
 
Table 3.7: Complex I activity assays for Ind1 variants G80S and K81Q 
Data from Dr. Stefan Kerscher 
Strain NADH:HAR activity 
(% of WT) 
dNADH:DBQ 
(% of WT) 
G80S 35 32 
K81Q 16 17 
  
Chapter 3 Using Yarrowia lipolytica as a model to understand pathogenic mutations in 
NUBPL associated with complex I deficiency 
 
 
74 
 
3.3 Discussion 
In this chapter I recreated human NUBPL variants in Yarrowia lipolytica Ind1 in order to 
study their effect and assign pathogenicity. Six mutations which result in amino acid 
changes were selected and recreated. Given the proposed function of Ind1 in complex I 
assembly, and that complex I deficiency is the cause of clinical symptoms, the first 
indicator of pathogenicity was to look at complex I levels and activity. I then discovered 
that looking at growth in the cold was also a good indicator of pathogenicity. Ind1 variants 
L102P and D103Y showed the strongest decrease in complex I, similar to levels in 
N271QfsX31 and the knock-out mutant. This suggests that these mutations completely 
abolish the function of Ind1. This is as expected given they affect highly conserved 
residues in the switch I motif which is required for the NTPase activity of Ind1. These 
results are also similar to the Ind1 G80S and K81Q variants which affect the Walker A 
motif (Table 3.7, Stefan Kerscher unpublished data). D103Y has wild-type levels of 
protein, which must all be non-functional because complex I levels are the same as in 
the knock-out mutant. L102P appears to cause post-translational degradation due to 
protein mis-folding, as the protein is insoluble. Together these data show that mutations 
to the P-loop are highly disruptive of function and L102P and D103Y are almost certainly 
pathogenic.  
The L191F and G136D variants affect residues in the MRP domain. The function of the 
MRP domain is not well defined and so it was hard to predict the effect of the mutations. 
L191F resulted in a moderate decrease in complex I levels and activity, which was clearly 
less than cWT, but above that of the knock-out mutant. Conversely G136D appeared to 
have no significant effect on complex I levels and acted like cWT in almost all tests. The 
one exception is in assembly, where Q module assembly intermediates accumulated. In 
summary L191F appears to be pathogenic. G136D appears to display assembly defects, 
but is not necessarily strongly deleterious. G136D was not associated with a clinical case 
and so, out of all the variants studied, was the one least likely to be deleterious. 
The G285C variant was the hardest to classify. It did not have a significant effect on 
complex I levels, however, it did display an accumulation of the Q module assembly 
intermediate. Unlike cWT, G285C was unable to grow in the cold and was found to be 
more severely defective in complex I assembly at this temperature. Why the assembly 
defect seen in G285C is exacerbated at cold temperatures remains an open question.  
Consequently, G285C can be classed as potentially pathogenic but requires further 
study. 
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The V182A mutation, recreated as M180V and M180A in Yarrowia lipolytica, displayed 
no deleterious effects. This patient’s symptoms were subsequently found to be caused 
by another mutation. The lack of deleterious effect found therefore serves as a good 
internal control, and lends credence to the classification of other mutations as 
pathogenic. 
Data of complex I levels exists for 5 of the 13 patients (Calvo et al. 2010; Tenisch et al. 
2012; Kevelam et al. 2013) (Table 3.6). Assays were performed on either muscle 
biopsies or fibroblasts or both. Sometimes the result differs in the same patient 
depending on tissue type looked at. For example, patient 7 has 19% complex I levels in 
fibroblasts but 37% from muscle biopsies. These levels can be compared to what was 
found in the corresponding Ind1 variants (Table 3.6). Generally, there is a poor match 
between levels seen in Yarrowia lipolytica and human. Combined with the heterogeneity 
between tissue type and method it is hard to draw any meaningful conclusions. 
In summary four of the six mutations (L104P, D105Y, L193F and G285C) were classed 
as pathogenic and one (G138D) was classed as potentially pathogenic. These results 
allow a degree of confidence that certain patient mutations are causative of complex I 
disorders. Along with previous studies (Ahlers et al. 2000; Kerscher et al. 2004; Varghese 
et al. 2015; Gerber et al. 2016) these results reconfirm the utility of Yarrowia lipolytica as 
a model for human mitochondrial disorders. Neurospora crassa has also proved useful 
as a model (Duarte et al. 2005; Ferreira et al. 2011). However, care must be taken not 
to over-interpret the results as the two organisms are separated by hundreds of millions 
of years of evolution and so an observation in one organisms might not be relevant for 
the other. In my data were two examples where an effect seen in Yarrowia lipolytica was 
not seen in humans. In human NUBPL RNAi HeLa lines the NDUFV1 subunit is 
substantially decreased (Sheftel et al. 2009), whereas in Yarrowia lipolytica ind1∆ protein 
levels of NUBM are only mildly affected. Secondly the D103Y variant appears to have 
stable protein levels in Yarrowia lipolytica, but the human patients with D105Y have 
almost no NUBPL protein (Kevelam et al. 2013). Ideally these mutations should also be 
tested in human cell lines or patient biopsies. For example, further work should be done 
on G285C in human lines to see if it results in a decrease in complex I in patient tissues. 
However, studies in a yeast model are quicker and more cost effective, and so can be 
used as a first pass screen to look for potentially pathogenic mutations. An additional 
advantage is that Yarrowia lipolytica can be studied whilst haploid, meaning the effect of 
potentially recessive mutations can more readily be studied. 
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Previously published work on the role of Ind1 in complex I assembly does not contain 
much mechanistic detail. It is observed that in the ind1∆ mutant complex I levels are 
decreased to approximately 28% of WT (Bych et al. 2008). However, since its discovery 
in 2008 much work has been done on the sequence of events in the modular assembly 
of complex I. We have a better understanding of the assembly intermediates and which 
subunits they contain. It is therefore possible to revisit the question of what role Ind1 
plays in complex I assembly. This will be discussed fully in the general discussion.  
Little previous work has focused on growth defects associated with complex I mutants in 
Yarrowia lipolytica. I decided to investigate growth phenotypes associated with complex 
I and Ind1 mutants as they could prove a good proxy of the severity of mutation.  
Ultimately serious defects in cellular systems should manifest themselves as serious 
growth defects.  At normal temperatures, 30°C, Yarrowia lipolytica containing Ind1 
variants and complex I mutants grew similarly to WT, despite a slight decrease in colony 
size. However, after being moved to cold temperatures, approximately 10°C, there were 
dramatic growth differences. WT, G136D, nubm∆ and nukm∆ were able to grow, albeit 
at a much slower rate than at normal temperatures. Conversely all other Ind1 variants 
and nucm∆ + Y144F displayed almost no growth. The reason for these different growth 
phenotypes remains unclear. An initial hypothesis was that those strains without complex 
I could not survive in the cold, possibly as a result of an inability to maintain the proton 
gradient which could be used to generate heat. However, two mutants with no assembled 
complex I, nubm∆ and nukm∆, grew, whereas another (nucm∆ + Y144F) which has fully 
assembled complex I, but which is catalytically dead, did not. Further investigation is 
needed to uncover the cause of this growth defect. 
In summary using Yarrowia lipolytica as a model to investigate pathogenic mutations in 
NUBPL is both clinically useful and viable as a research method. In the future Yarrowia 
lipolytica would be a good system to test out mutations in numerous complex I deficiency 
cases, and indeed many other more varied mitochondrial disorders. It also leads to a 
greater understanding of the role of NUBPL/Ind1 in complex I assembly, as well as the 
discovery of a novel temperature dependent growth phenotype. However, more work is 
needed to understand the process of complex I assembly in Yarrowia lipolytica, and the 
differences that exist between the human and yeast pathway, before it is possible to tell 
how relevant findings are to human disease.
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4 Life without complex I in a parasitic plant 
4.1 Introduction 
Parasitism is a life history strategy successfully employed across all domains of life 
whereby nutrition is obtained from a host (Poulin & Morand 2000). The evolution of 
parasitism is often associated with strong selection pressures which can drive the 
parasite’s adaptations in new, and often unexpected, directions. An example of this is 
organellar genome reduction, or loss, which is a recurring phenomenon among 
eukaryotic parasites. For example, the intestinal parasite Giardia lamblia has undergone 
extensive mitochondrial reductive evolution, and has lost the organeller genome 
altogether. In plants, reductive evolution of the chloroplast genome has been studied 
extensively. In some plant parasites, photosynthetic genes in the chloroplast become 
pseudogenised, or lost, as the plant becomes less dependent on its own photosynthetic 
abilities, and more dependent on the photosynthate of its host. The most striking example 
of this is in Rafflesia lagascae, which may have lost its entire chloroplast genome (Molina 
et al. 2014).  
Parasitism has evolved numerous times in plants, with current estimates suggesting it 
has evolved at least 12 to 13 times in angiosperms, making up perhaps as much as 1% 
of angiosperm species (Westwood et al. 2010). The best known and studied examples 
include the Orobanchaceae family, or Broomrapes, and the Rafflesiaceae family, which 
includes a species with the largest recorded flower, Rafflesia arnoldii. Parasites can be 
divided into two classes: facultative and obligate. Facultative parasites can complete 
their life cycle without a host, making parasitism an optional part of their lifecycle. 
Obligate parasites need a host to complete their lifecycle, and so are highly dependent 
on their host species. Plant parasites can also be divided into two classes, hemiparasites 
and holoparasites, depending on their photosynthetic capacity. Hemiparasitic species, 
which include both facultative and obligate species, retain their photosynthetic capacity. 
They often obtain other nutrition, such as water and minerals, from their hosts. 
Holoparasitic species lack photosynthetic capacity and therefore obtain all sugars from 
their host plant. Consequently, many holoparastic plants have lost the ability to make 
chlorophyll. Orobanchaceae contain species across this parasitic spectrum, including 
facultative and obligate, hemi- and holo-parasites (Westwood et al. 2010). 
The mitochondrial genomes of angiosperms are notable for their large and variable sizes 
(Mower et al. 2012; Sloan et al. 2012), with a 200-fold size range (Skippington et al. 
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2015). Plant mitochondrial genomes have many more protein coding genes than animal 
ones (Adams et al. 2002), for example the gymnosperm Cycas taitungensis has 41, and 
Arabidopsis thaliana has 31. By contrast the human mitochondrial genome has 13. 
Almost all Angiosperms encode a core set of 24 mitochondrial genes, including the 
respiratory complex subunits. A further 17 are present in some, but not all, and are mainly 
made up of ribosomal protein genes. Notably, many plant mitochondrial genomes 
encode complex II subunits, sdh3 and sdh4, in contrast to humans who encode all 
complex II subunits in the nuclear genome. Plants encode 9 complex I subunits in the 
mitochondrial genome, as opposed to 7 in humans. As well as the 7 hydrophobic 
membrane domain subunits, plant mitogenomes additionally encode Nad7 (bovine 49 
kDa subunit) and Nad9 (30 kDa subunit). 
Compared to the attention parasitic plant chloroplasts have received, the mitochondrial 
genomes of parasitic plants have been relatively understudied. Until recently only a 
couple of mitogenomes from the Rafflesiaceae family had been sequenced (Xi et al. 
2013; Molina et al. 2014). The most striking thing about these mitogenomes was the 
large degree of horizontal gene transfer. Little evidence of reductive evolution was found. 
However, two studies in 2015 changed this. The authors sequenced the mitochondrial 
genomes of four mistletoe species and discovered massive gene loss (Skippington et al. 
2015; Petersen et al. 2015). 
Mistletoes are hemiparasitic stem parasites from the order Santalales (Mathiasen et al. 
2008). One mistletoe genus, Viscum, contains approximately 100 parasitic species 
(Petersen et al. 2015). Its best-known member is the common European mistletoe, 
Viscum album, which is widely recognisable from European folklore. The first study, 
(Skippington et al. 2015), sequenced the mitogenome of a Malaysian mistletoe, Viscum 
scurruloideum. It was very small in size at 66 kb, making it the smallest recorded land 
plant mitogenome. In contrast, Viscum contain some of the largest nuclear genomes in 
plants, up to 201 Gb (Zonneveld 2010). Strikingly, the mitogenome of Viscum 
scurruloideum has lost all mitochondrial nad genes, which code for subunits of complex 
I. Given that the wholesale transfer of multiple nad genes to the nuclear genome is highly 
unlikely, this strongly implied that complex I had been lost. The loss of complex I is 
unprecedented in multicellular eukaryotes. In addition to the loss of complex I coding 
genes, numerous other genes had been lost. Out of 24 core genes found in virtually all 
angiosperm mitogenomes, 11 had been lost. In addition, out of 17 genes present in 
many, but not all, angiosperm mitogenomes, 11 had been lost. However, the 
mitogenome of Viscum scurruloideum retained a usual complement of other respiratory 
complex subunits, for example the cox and atp genes, and many ribosomal RNA genes. 
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The mitogenome of Viscum scurruloideum is therefore unusual, and led the authors to 
describe it as “wonderfully bizarre”.  
The second study, (Petersen et al. 2015), sequenced the complete mitogenome 
European mistletoe, Viscum album. This mitochondrial genome was bigger than that 
found in Viscum scurruloideum, at 565 kb. They also reported a partial genome 
mitogenome for two other Viscum species: Viscum crassulae and Viscum minimum. This 
second study also found the absence of all complex I encoding genes in the 
mitochondria. However, they did not find the usual complement of other mitochondrial 
genes, claiming the genes for all other respiratory complexes and rRNA were either lost 
or psuedogenised. This would represent a state of even higher reductive evolution from 
that seen in Viscum scurruloideum. However, the authors of the first study dispute the 
findings from Viscum album. In a subsequent reanalysis of the Viscum album 
mitogenome 21 protein coding genes were found that include a full set of respiratory 
complex II, III, IV and V genes, as well as rRNA genes (Skippington et al. 2017). This 
would suggest that both species lack complex I, but not the other respiratory complexes. 
This work has four main objectives. The first is to confirm, through biochemical and 
proteomic techniques, that complex I has been lost from Viscum album. The loss needs 
to be confirmed as it remains possible that the nad genes have been transferred to the 
nuclear genome. The second is to determine whether complexes II to V are present or 
not, thereby solving the dispute in the literature. The third is to understand how Viscum 
album has adapted to life without complex I. The fourth is to study Arabidopsis thaliana 
complex I mutants to see what lessons can be learned about coping with low levels of 
complex I. 
4.2 Results 
4.2.1 Isolation of mitochondria from Viscum album 
Mitochondria from Viscum album have, to the best of my knowledge, only been isolated 
once before (Petersen et al. 2015). However, these were used for sequencing rather 
than biochemical studies, and so yield was not a consideration. Therefore, mitochondrial 
purification protocols needed to be developed. Existing protocols for plant mitochondrial 
purification were tried and optimised in an iterative fashion. 
Material was collected from three separate Viscum album plants from three locations 
(Table 4.1) (Collected by Dr. Janneke Balk). First, a mitochondrial purification on leaves 
based on the protocol from (Sweetlove et al. 2007) was attempted. However due to the 
Chapter 4 Life without complex I in a parasitic plant 
 
 
80 
 
presence of chloroplasts, and the viscus nature of the extract, no mitochondria could be 
extracted. Next, a purification was attempted on the leaf buds (Figure 4.1A, B). The 
purification was based on a modified protocol from (León et al. 2007). Briefly, buds were 
homogenised using a pestle and mortar and glass beads. Differential centrifugation was 
then performed resulting in a pellet which contained both green (chloroplast) and brown 
(possible mitochondria) parts. This suggested that a mitochondria-rich fraction had been 
isolated, albeit with chloroplastic contamination. A sample was taken here, and will be 
referred to from now on as “crude” mitochondria. A purer mitochondrial fraction was 
obtained by taking the crude fraction and separating out mitochondria and thylakoid 
membrane vesicles from chloroplasts on a Percoll gradient, according to (Sweetlove et 
al. 2007) (Figure 4.1C). These mitochondria will be referred to as “Percoll-purified” 
mitochondria. 
In order to confirm that mitochondria had been purified, Western blot analysis with 
antibodies against the mitochondrial marker porin (also known as Voltage-Dependent 
Anion Channel (VDAC)), was performed. Porin is a good mitochondrial marker as it is 
highly conserved, making detection more likely. Both total protein from the bud and 
putative mitochondrial fraction were analysed, along with mitochondria from Arabidopsis 
thaliana callus, to act as a control. Faint bands were seen in the total protein extract but 
these were much stronger in the putative mitochondria fraction, both for crude and 
Percoll-purified mitochondria (Figure 4.2A, B). Two bands were apparent, representing 
different porin isoforms. These were of a higher apparent molecular weight than the main 
porin isoform in Arabidopsis thaliana. The enrichment of porin in the mitochondrial 
fraction suggest that mitochondria had been isolated from Viscum album.  
Further Western blot analysis was performed to see if various mitochondrial proteins 
were present in Viscum album, for example cox2 subunit of complex IV and the complex 
I assembly factor, INDH. No bands were observed in the Viscum album sample (Figure 
4.2C, D). However, the cox2 gene is present in the mitogenome and, as seen in section 
4.2.4, cox2 protein is found in Viscum album. It is therefore likely that the antibody, which 
is specific for Arabidopsis thaliana, is unable to recognise Viscum album cox2. This may 
be due to high levels of sequence divergence in Viscum album, for example Arabidopsis 
thaliana and Viscum album cox2 are 67% identical at the protein level, whereas 
Arabidopsis thaliana and Zea mays (a more evolutionarily distant species) cox2 are 88% 
identical. Additionally, no INDH protein was detected in Viscum album. Western blot 
analysis was not continued, because it was not possible to distinguish if an absent band 
meant a protein was missing or there was an antibody recognition issue. 
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Figure 4.1: Purification of mitochondria from Viscum album 
(A) Viscum album leaves and leaf bud (indicated with red arrow).  
(B) Leaf buds used in mitochondria purification. Scale bar = 1 cm. 
(C) Percoll gradient after centrifugation. Viscum album sample has been separated into thylakoid 
and mitochondrial fraction. 
 
Table 4.1: Viscum album sample collection 
Plant number Date harvested Elevation from 
sea level (m) 
Elevation from 
ground (m) 
Host plant 
1 26/3/2017 15 5.5 Acer 
campestre 
2 17/4/2017 10 2 Acer 
saccharum 
3 17/4/2017 10 3 Malus pumila 
“Bramley” 
 
 
  
A B
C
Mitochondrial fraction
Thylakoid fraction
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Figure 4.2: Western blots of Viscum album mitochondrial purifications 
(A) and (B) SDS-PAGE followed by immunolabelling of porin in Viscum album total protein and 
mitochondrial samples, and Arabidopsis thaliana callus mitochondria. Ponceau stain used to 
confirm equal loading and transfer. Mitochondrial samples from crude purification (A) and Percoll 
purification (B). 
(C) SDS-PAGE followed by immunolabelling of cox2 in Viscum album crude mitochondria and 
Arabidopsis thaliana callus mitochondria. 
(D) SDS-PAGE followed by immunolabelling of INDH in Viscum album crude mitochondria and 
Arabidopsis thaliana callus mitochondria. 
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4.2.2 BN-PAGE and in gel-activity assay indicate Viscum album 
lacks complex I 
Having purified mitochondria from Viscum album, the next stage was to determine the 
state of the respiratory chain. In order to visualise complex I content of Viscum album 
mitochondrial complexes were separated using BN-PAGE. They were then stained with 
Coomassie, to visualise protein content, or NADH and NBT, to visualise complex I levels 
(Sabar et al. 2005). This was compared to Arabidopsis thaliana callus mitochondria 
samples (Figure 4.3A). Callus provide a good comparison to buds, as both are 
meristematic tissues, with a high energy demand, and therefore contain high levels of 
mitochondria. In both crude and Percoll-purified Viscum album mitochondria an activity 
band was seen at around 146 kDa. This band was also seen in the Arabidopsis thaliana 
sample. This activity stain is caused by the dihydrolipoamide dehydrogenase (also 
known as lipoamide dehydrogenase) subunit of pyruvate dehydrogenase complex, 
which also has NADH dehydrogenase activity (Meyer et al. 2009) and can act as an 
additional confirmation that mitochondria have been isolated, as well as a loading control. 
These NADH/NBT activities were not seen in the Coomassie-stained sample, showing 
the specificity of the activity stain. In the Arabidopsis thaliana sample a clear activity band 
can be seen above 720 kDa, which represents respiratory complex I. This band is 
completely absent in both crude and Percoll purified mitochondria from Viscum album 
(Figure 4.3A, B). This indicates and absence of respiratory complex I in Viscum album. 
In the crude mitochondrial samples, additional green bands can be seen, which are 
absent from the Percoll-purified mitochondria. These are contamination from 
chloroplastic complexes. None of these display any activity, and so do not alter the 
results. These data strongly suggest that Viscum album does not contain any respiratory 
complex I. 
4.2.3 BN-PAGE and in gel-activity assays suggest Viscum album 
retains complex II, III and IV 
In- gel activity assays indicate that complex I is indeed absent in Viscum album. The next 
question is whether the other respiratory complexes are present, as suggested in 
(Skippington et al. 2015; Skippington et al. 2017), or are absent, representing complete 
loss of the respiratory chain as suggested in (Petersen et al. 2015). In order to assess 
the intactness of the respiratory chain, various BN-PAGE and in-gel activity stains were 
performed. 
To visualise complex II, Arabidopsis thaliana and Viscum album mitochondria were 
separated by BN-PAGE and activity stained with PMS and NBT (Sabar et al. 2005). A  
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Figure 4.3: Complex I activity stain is absent in Viscum album 
(A) BN-PAGE analysis of mitochondrial samples from Arabidopsis thaliana and Viscum album. 
Protein complexes were visualised with Coomassie (left-hand panel). NADH dehydrogenase 
activities were visualised with NADH and NBT staining (right-hand panel). Arabidopsis thaliana 
mitochondria were purified from callus culture. Viscum album mitochondria were Percoll-purified. 
Complex I, III and V are marked. LPD marks the position of lipoamide dehydrogenase, also known 
as dihydrolipoamide dehydrgense, a subunit of the pyruvate dehydrogenase complex. 
(B) BN-PAGE analysis of crude mitochondrial samples from Viscum album. Protein complexes 
were visualised with Coomassie (left-hand panel). NADH dehydrogenase activities were 
visualised with NADH and NBT staining (right-hand panel). Position of LPD is marked. 
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Figure 4.4: Complex II, III and IV in-gel activity in Viscum album 
(A) BN-PAGE analysis of mitochondrial samples from Arabidopsis thaliana and Viscum album. 
Complex II activity was visualised with PMS/Succinate/NBT staining. Viscum album samples from 
crude purification (Left-hand panels) and Percoll purification (Right-hand side). 
(B) BN-PAGE analysis of crude mitochondrial samples from Viscum album. Complex III activity 
was visualised using ECL reagents and high performance chemiluminescence film detection.  
Protein loading was visualised by Coomassie staining (Left-hand panel). Viscum album 
mitochondria were from a crude preparation. 
(C) BN-PAGE analysis of mitochondrial samples from Arabidopsis thaliana and Viscum album. 
Complex IV activity was visualised with DAB/cytochrome c staining.  Viscum album mitochondria 
were from a crude preparation. 
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blue activity band was seen in both crude and Percoll-purified mitochondria samples just 
above 146 kDa, indicating the presence of respiratory complex II (Figure 4.4A). 
Interestingly these were of a higher molecular weight than the Arabidopsis thaliana 
complex II. Respiratory complexes can vary in size between different groups because of 
different subunit compositions. 
In order to detect complex III, Viscum album crude mitochondria were separated by BN-
PAGE and transferred to PVDF membrane. Visualisation of complex III was achieved by 
incubation with ECL reagents and detection by high performance chemiluminescence 
film. This works due to the heme groups bound on complex II, which have peroxidase 
activity and can therefore be detected by chemiluminescence (Feissner et al. 2003; Sun 
et al. 2015).  A clear band can be seen between the 480 and 720 kDa marker indicating 
the presence of complex III (Figure 4.4B). This corresponds to a large band seen in a 
Coomassie stained lane of the same sample. The size is consistent with the size of 
complex III seen in Arabidopsis.   
In order to detect complex IV, Arabidopsis thaliana and Viscum album crude 
mitochondria were separated by BN-PAGE and activity stained with DAB and 
cytochrome c (Sabar et al. 2005). A brown precipitate can clearly be seen in the 
Arabidopsis sample at approximately 242 kDa (Figure 4.4C). A fainter band can also be 
seen in the crude Viscum album sample at the same molecular weight, indicating the 
presence of complex IV. 
In summary, these data indicate the presence of complexes II, III and IV in Viscum album, 
supporting the idea that only complex I is absent in Viscum album as suggested by 
(Skippington et al. 2015; Skippington et al. 2017). Complex V could not be assessed due 
to the potential of chloroplastic ATP synthases influencing the result. 
4.2.4 Proteomic analysis indicate that complex I is absent, but the 
rest of the respiratory chain is intact 
In- gel activity assays indicate that Viscum album lacks complex I, but not complex II, III 
and IV. A proteomic approach was performed as a complementary technique to assess 
the composition of the respiratory chain.  
Shotgun proteomics on both crude and Percoll-purified mitochondrial samples was 
performed. Peptides were digested with trypsin and run through a Thermo Q-Exactive 
Plus mass spectrometer (All proteomic work was carried out with Dr. Etienne Meyer). 
When analysing the peptide fragments, there was no Viscum album nuclear genome 
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sequence to compare them, to ascertain their identity. The Viscum album nuclear 
genome has not been sequenced due to its large size, at 201 Gb (Zonneveld 2010).  This 
problem could be overcome by comparing them to a) the Viscum album mitochondrial 
genome and, b) the Arabidopsis thaliana nuclear genome. By comparing to the Viscum 
album mitochondrial genome, the presence of mitochondrially encoded proteins could 
be shown. This as an important control as it confirms that mitochondrial genes are 
expressed and are not pseudogenised. By comparing to the Arabidopsis thaliana nuclear 
genome, proteins that are highly conserved between the two species can be identified. 
A caveat is that if a protein is not identified by this method it does not necessarily mean 
that the protein is absent in Viscum album. It could instead be that the sequence of the 
Arabidopsis thaliana and Viscum album homologs have diverged to such an extent that 
Viscum album homolog cannot be identified based on the Arabidopsis thaliana 
sequence. Using these two methods numerous mitochondrial proteins were identified in 
Viscum album samples (see appendix), as well as numerous contaminating proteins of 
chloroplastic and peroxisomal origin. 
Using the Viscum album mitochondrial genome subunits were identified from complex 
III, IV and V (Table 4.2; see appendix). Using the Arabidopsis thaliana nuclear genome 
subunits were identified from complex II, III, IV and V (Table 4.3; see appendix). No 
subunits from complex I were identified. These data indicate that the mitochondrially 
encoded genes are translated and that protein subunits from complex II, III, IV and V, 
but not complex I, are encoded in the nuclear genome (Figure 4.5A). 
Lineages that have lost complex I, for example the yeast Saccharomyces cerevisae, are 
increasingly reliant on the alternative respiratory pathway, consisting of alternative 
NADH dehydrogenases, to bypass the loss of complex I, and alternative oxidases, to 
bypass complex III and IV. The alternative dehydrogenases oxidise NADH, thereby 
regenerating the NAD+ pool, but do not translocate protons. Plants contain type II 
NAD(P)H dehydrogenases, which are alternative dehydrogenases found in plants, fungi, 
protists and bacteria, but not in animals (Rasmusson et al. 2008). It was hypothesised 
by Skippington et al. that Viscum scurruloideum would be reliant on alternative 
dehydrogenases to compensate for the lack of complex I. My proteomic results show the 
presence of two alternative dehydrogenases (NDB3 and NDC1) showing that Viscum 
album is able to make use of the alternative respiratory pathway. Two alternative 
oxidases, AOX2 and AOX1A, were also found. Alternative oxidases allow the reduction 
of oxygen without any proton translocation, and have previously been reported to be 
increased in plant complex I mutants (Fromm et al. 2016). The presence of this 
alternative respiratory pathway in Viscum album mitochondria shows that it retains the 
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Figure 4.5: Proteins in Viscum album mitochondria detected by mass 
spectrometry 
(A) Schematic of a plant respiratory chain, with proteins identified in Viscum album. The red cross 
indicates that no complex I subunits were detected. The gray and black arrows represent the flow 
of electrons and protons, respectively. Protein names in lowercase are mitochondrially encoded, 
protein names in upper case are nuclear encoded. 
(B) Schematic of a potential respiratory chain in Viscum album. The gray and black arrows 
represent the flow of electrons and protons, respectively. Adapted from James et al. 2013. 
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Table 4.2: Proteins identified by comparison to Viscum album mtDNA 
Protein group Proteins identified based on mtDNA 
Complex III cob 
Complex IV cox1 
 cox2 
 cox3 
Complex V atp1 
 atp4 
 atp8 
Ribosomal protein rps3 
 rps4 
 rpl16 
 
Table 4.3: Proteins identified by comparison to Arabidopsis thaliana database 
Protein group Proteins identified based on A.t. database 
Complex II SDH1 
 SDH2 
Complex III RIESKE 
 CYC11 
 CYC12 
Complex IV cox2 
 COX6B-2 
Complex V ATP-Synthase subunit beta-1 
 ATP1 
 ATP6-2 
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ability to bypass the requirement of complex I and also regenerate the NAD+  and 
ubiquinone pool. This would presumably come at the expense of lower ATP production, 
due to the decrease in proton translocation. 
As well as respiratory chain subunits, three ribosomal proteins encoded by the 
mitochondrial genome were identified, rps3, rps4 and rpl16 (Table 4.2). These genes 
were predicted have been lost by Petersen et al 2015, but present by Skippington et al. 
2017. Their proteomic identification shows they have not become pseudogenes, and 
also that Viscum album retains the machinery for mitochondrial translation. 
Overall the proteomic data from Viscum album supports the findings of the in-gel activity 
assays. Subunits were identified from all respiratory complexes, including the alternative 
pathways, except from complex I. This allows a reconstruction of the Viscum album 
respiratory chain (Figure 4.5B). 
4.2.5 Analysis and comparison of Arabidopsis thaliana complex I 
mutants 
Viscum album appears unique, as a multicellular organism, in having lost complex I. In 
humans, slight defects in complex I are often fatal. However, it has previously been seen 
that Arabidopsis complex I mutants can have relatively mild defects during vegetative 
growth despite having problems during germination (Wydro et al. 2013, Figure 4.6D). 
Studying how Arabidopsis thaliana mutants survive with low complex I levels, may give 
clues as to how Viscum album survives with no complex I. 
Previous BN-PAGE analysis of a mutant in the complex I assembly factor, INDH, 
suggests that this mutant completely lacks complex I (Wydro et al. 2013). However, 
mutants in the yeast homolog display residual complex I activity (Bych et al. 2008; 
chapter 3). In order to ascertain if complex I levels are absent in Arabidopsis indh, BN-
PAGE analysis was carried out on mitochondria isolated from both leaves and callus of 
indh mutants. Callus tissue is equivalent to undifferentiated, non-photosynthetic, 
meristematic tissue. In leaf-derived mitochondria no complex I activity stain was 
observed in the indh mutants (Figure 4.6A), in agreement with the findings of Wydro et 
al. 2013. However, low levels of complex I activity stain were seen in callus-derived indh 
mitochondria, indicating that this line does retain the ability to assemble low levels of 
mature complex I (Figure 4.6A). These data indicate indh plants have undetectable levels 
of complex I in leaf tissue, but do have low levels of complex I present in meristem-like 
tissues. This suggests that certain tissues are able to survive with extremely low, or 
absent, levels of complex I. 
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Figure 4.6: Comparison of complex I in Arabidopsis thaliana mutants 
(A) BN-PAGE analysis of mitochondrial samples from Arabidopsis thaliana Col-0 and indh purified 
from leaf or callus culture. NADH dehydrogenase activities were visualised with NADH and NBT 
staining  
(B) BN-PAGE analysis of mitochondrial samples from Arabidopsis thaliana Col-0, ndufs4 and 
rug3-1 purified from leaf or callus culture. NADH dehydrogenase activities were visualised with 
NADH and NBT staining.  
(C) NADH:HAR oxidoreductase activity in leaf mitochondria from Arabidopsis thaliana Col-0, 
ndufs4, rug3-1 and indh. Error bars represent s.d. 
(D) Growth of 3-week-old Col-0, indh and indh + cINDH. 
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In order to see if this tissue dependent pattern of complex I levels was unique to indh, or 
is present in different complex I mutants, BN-PAGE analysis was carried out on 
mitochondria isolated from both leaves and callus of two other complex I mutants: ndufs4 
and rug3-1. NDUFS4 encodes a structural subunit of complex I, the 18 kDa subunit, and 
has previously been studied in (Meyer et al. 2009). RUG3 encode an RNA editing factor 
of nad2, and has previously been shown to have greatly decreased complex I levels 
(Kühn et al. 2011). BN-PAGE analysis on leaf-derived mitochondria show that ndufs4 
and rug3-1 have very low levels of complex I (Figure 4.6B). Callus-derived mitochondria 
have higher levels of complex I. These data show that, similarly to indh, complex I 
mutants have very low levels of complex I in the leaves, but higher levels in meristem-
like tissue. 
In order to see if Arabidopsis complex I mutants indh, rug3 and ndufs4 completely lack 
complex I in the leaves, a spectrophotometric assay measuring electron transfer from 
NADH to the artificial electron acceptor HAR was carried out. These are more sensitive 
than BN-PAGE activity assays and so will be able to detect complex I activity 
unobservable in BN-PAGE. Low levels, between 5 and 12% of WT, of complex I activity 
were seen in all three mutants (Figure 4.6C), indicating residual complex I activity in leaf 
tissue. 
Taken together these data show that tissues are able to survive with only residual levels 
of complex I in Arabidopsis thaliana.  
4.2.6 Further characterisation of Arabidopsis thaliana indh mutant 
The role of INDH in complex I assembly was previously studied by Wydro et al. 2013. 
However, the knock-out mutant was obtained late in the study and most of the 
experiments were undertaken with a complemented line, B10, which initially had low 
levels of INDH protein, but gradually over the course of development increased to high 
levels (~250% in mature rosette leaves). Therefore, further characterisation of the indh 
knock-out mutant was desirable. 
The study found that as well as being defective in complex I assembly, indh mutants had 
a defect in mitochondrial translation. In organello translation assays revealed that total 
mitochondrial translation was substantially decreased. In addition, the protein levels of 
the mitochondrially encoded complex I subunit, nad9, was greatly decreased. The 
mitochondrially encoded complex IV subunit cox2 was decreased by 50%. In order to 
see if these findings were also seen in the knock out indh mutant, Western blot analysis 
was carried out to detect the protein levels of nad9 and cox 2. Nad9 protein levels were  
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Figure 4.7: Further characterisation of Arabidopsis thaliana indh mutant 
(A) Levels of the mitochondrial proteins INDH and Nad9 in wild type (Col-0) and indh mutant. 
TOM40 was used as a marker protein for equal transfer and loading. Mitochondria were purified 
from callus culture and analysed by immunoblotting with specific antibodies.  
(B) Complex I and Nad1 protein levels in Arabidopsis thaliana Col-0, rug3 and indh. Respiratory 
complexes were separated by BN-PAGE and stained with NADH/NBT (left-hand panel) or 
transferred to PVDF and immunolabelled with an antibody specific to Nad1. 
(C) Respiratory supercomplexes in Arabidopsis thaliana Col-0 and indh. NADH dehydrogenase 
activities were visualised with NADH and NBT staining. Mitochondria were purified from callus 
culture and respiratory complexes solubilised with digitonin. 
(D) Complex IV levels in Arabidopsis thaliana Col-0 and indh, visualised by BN-PAGE followed 
by Complex IV activity staining.   
(E) Levels of the mitochondrial proteins COX2 in Arabidopsis thaliana Col-0 and indh 
mitochondria. Mitochondria were purified from callus culture. Ponceau S stain was used as a 
control for equal transfer and loading. 
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unaffected in the indh knock-out mutant (Figure 4.7A). Cox2 protein levels were 
increased, rather than decreased, in the indh mutant (Figure 4.7E). BN-PAGE followed 
by Western blot analysis was performed to detect the presence of another 
mitochondrially encoded complex I subunit, nad1, in mature complex I. Very low levels 
of nad1 protein was observed in indh at a position corresponding to complex I (Figure 
4.7B), suggesting mitochondrial translation has not completely stopped. These results 
suggest that the role of INDH in mitochondrial translation is not as simple as previously 
thought and that further investigation is needed. 
Respiratory complexes can form ordered associations with one another and arrange 
themselves into larger complexes, often called supercomplexes. Supercomplexes 
containing complex I are not easily detectable by BN-PAGE when samples are prepared 
with DDM as the solubilising agent. However, if digitonin, one of the mildest detergents, 
is used instead respiratory supercomplexes can be separated (Wittig et al. 2006).  The 
following respiratory super-complexes containing complex I can be visualised in 
Arabidopsis: complex I and a dimer of complex III (I + III2) and a dimer of complex I and 
a tetramer of complex III (I2+ III4) (Eubel et al. 2003). In order to study the role of INDH 
in supercomplex formation mitochondria from Col-0 and indh were solubilised with 
digitonin and separated by BN-PAGE. In the indh mutant no I2+ III4 can be detected, while 
low levels of I + III2 and monomeric complex I can be (Figure 4.7C). The levels of I + III2 
are greater than monomeric complex I in the indh mutant. These data show that indh is 
unable to form I2+ III4, presumably limited by the low levels of complex I. 
It has previously been shown that in complex I mutants, other respiratory complexes can 
be upregulated to compensate for the decrease in proton pumping from complex I 
(Fromm et al. 2016; Hsu et al. 2014). In order to determine if the other respiratory 
complexes are upregulated in the Arabidopsis indh mutant, BN-PAGE and in-gel activity 
assays were undertaken. No repeatable difference was seen when a complex II activity 
stain was performed. However, a clear increase in complex IV activity stain is seen in 
indh mitochondria compared to Col-0 (Figure 4.7D). In order to confirm the increase in 
complex IV, Western blot analysis with an antibody against the complex IV subunit cox2 
was performed. An increase in cox2 subunit was observed in indh (Figure 4.7E), 
consistent with previous observations in complex I mutants (Hsu et al. 2014). These data 
suggest that complex IV is upregulated in the indh mutant. 
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4.3 Discussion 
Previous mitochondrial genome studies by two groups suggested that members of the 
genus Viscum had lost complex I, due to an absence of nad genes in the mitochondrial 
genome. It remained possible that the whole suite of mitochondrial nad genes had been 
transferred to the nuclear genome. Nuclear transfer of mitochondrial genes has 
previously been shown in angiosperms, for example the transfer of complex IV subunit 
cox2 in Legumes (Nugent & Palmer 1991). Over evolution nad gene content of the 
mitochondrial genome has changed, for example humans encode 7 nad genes, whereas 
plants encode 9. However, the authors in Skippington et al. 2015 argue that the 
mechanistic challenges in transferring all nine genes which code hydrophobic products 
would make the likelihood of this vanishingly small. Also, the presence of nad 
pseudogenes in Viscum album argues against nuclear transfer (Skippington et al. 2017). 
Therefore, they argue, the absence of nad genes in the mitogenome of Viscum 
represents a loss of complex I. Nevertheless, despite the very low probability of nuclear 
transfer, the possibility remains. It was therefore necessary to test if complex I was truly 
absent. I elected to do this through a biochemical and proteomic approach. By obtaining 
purified mitochondria and “looking” inside I would avoid the ambiguities which come from 
working with sequences. No complex I was detected in Viscum album through in-gel 
activity assays, or by proteomics. These data strongly support the conclusions from the 
mitochondrial genomic studies. However, it still remains possible, although extremely 
unlikely, that very low levels of complex I exist which are below the detection limit for the 
assays I used. This would require that, as well as all nad genes being transferred to the 
nucleus, all 40+ genes which encode complex I subunits have diverged from other 
species to such a degree, or be at such low levels, that they were not recognisable by 
proteomics using the Arabidopsis database as a template. The only way to say for 
certaint if complex I is gone would be to sequence the genome of Viscum album. This 
has not been undertaken so far due to the prohibitively large nuclear genome size, at 
201 Gb (Zonneveld 2010), although may be undertaken as part of future work. The 
assumption for the remainder of this discussion will be that complex I has indeed been 
lost. 
The loss of complex I is unprecedented in multicellular eukaryotes. All but four lineages 
of aerobic eukaryotes contain complex I. The exceptions are the Cryptomycotan Rozella 
allomycis (James et al. 2013); the lineage which contains dinoflagellates, 
apicomplexans, Chromera and Oxyrrhis (Flegonotov et al. 2015) and two groups of yeast 
(Gabaldón et al. 2005). All of these are unicellular, making the loss in Viscum, which is 
Chapter 4 Life without complex I in a parasitic plant 
 
 
96 
 
multicellular with a complex body-plan, all the more striking. Across the eukaryotes major 
changes to the respiratory chain are infrequent and almost always involving anaerobes. 
Of these most examples are parasites, illustrating again that the selection pressures in 
evolving a parasitic lifestyle can lead to organellar genome reduction.  
Despite agreement that Viscum had lost complex I, the two 2015 studies disagreed on 
the presence of other mitochondrial genes. Petersen, et al. suggested that all 
mitochondrial respiratory genes, as well as most of the other ones, in Viscum album were 
non-functional, or pseudogenised. Although two different species were studied it would 
seem unlikely that they possess radically different gene complements. The authors of 
the first study later reanalysed the Viscum album sequence data and vigorously 
disagreed with the conclusions from Petersen et al (Skippington et al. 2017). Here, I was 
able to solve this disagreement. Our data strongly support the findings from Skippington 
et al 2017, that only respiratory complex I is missing. By detecting mitochondrially 
encoded proteins by proteomics, we demonstrated that the genes are expressed. By 
detecting the respiratory complexes with in-gel assays we demonstrated that the proteins 
are functional. Therefore, despite lacking complex I, the rest of the respiratory chain 
remains intact. Although subsequent work by Dr. Etienne Meyer, who collaborated on 
this project, suggest the respiratory chain is down-regulated. However, in this case the 
remodelling of the respiratory chain in Viscum is not as severe as that seen in Chromera 
velia, a phototrophic relative of parasitic apicompexans, which has lost both complex I 
and III (Flegonotov et al. 2015). In Chromera velia, alternative dehydrogenases are used 
to bypass the requirement for complex I, and putative lactate:cytochrome c 
oxidoreductases are predicted to bypass the requirement for complex III, by transferring 
electrons from lactate to complex IV.  
As the first studied example of a multicellular eukaryote that has lost complex I it is likely 
that Viscum has evolved unique features to deal with this metabolic upheaval. For 
example, extensive metabolic rearrangement is to be expected in order to compensate 
for the substantial decrease in mitochondrial ATP production. This suggests a model 
whereby Viscum generates only small, or no, mitochondrial ATP. The proton gradient is 
maintained by complexes II-IV, but is used instead to power transport. ATP could be 
derived instead from glycolysis, or from the host. The photosynthetic rate is known to be 
low in Viscum album (Zuber 2004), making it likely that mistletoe is highly dependent on 
host nutrition, and that photosynthetically derived ATP is unlikely to fully compensate for 
the decreased levels of mitochondrial ATP. The chloroplast genome of Viscum has also 
been sequenced, and displays signs of reductive evolution, possibly signifying increasing 
nutritional dependence of the host (Petersen et al. 2015b), however it retains its 
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photosynthetic machinery. Interestingly, similar to the mitochondrial genome, the ndh 
genes, which encode subunits for the chloroplast NAD(P)H dehydrogenase complex, 
have been lost (Petersen et al. 2015b). Future work, in progress with Dr. Etienne Meyer, 
aims to characterise the metabolic rearrangements seen in Viscum album, to understand 
how mitochondrial metabolism has adapted to the loss of complex I.     
Comparisons to Arabidopsis mutants that have a low level of complex I can also be 
instructive. Results show that leaf tissue can survive with trace amount of complex I 
(Figure 4.6), and that complex IV is upregulated (Figure 4.7D). A recent proteomic study, 
(Fromm et al. 2016), characterised a complex I mutant, ca1ca2, in order to understand 
Arabidopsis’s response to complex I absence. The study found an upregulation of 
complex II, IV and alternative oxidases, as well as extensive metabolic change and 
reorganisation. For example, certain parts of the TCA cycle, glycolysis, fermentation, 
amino acid catabolism and stress responses were increased, but photosynthetic 
metabolism was decreased. It is probable that many changes seen in the Arabidopsis 
ca1ca2 mutant will also be seen in Viscum album. However, mutant physiology is by 
definition aberrant, and care should therefore be taken in applying these observations to 
Viscum, which has had millions of years of evolution to adapt to the changes brought 
about by a lack of complex I. 
Viscum sp. are currently the only parasitic plants known to have lost complex I. However, 
the mitochondria of parasitic plants remain relatively understudied. Apart from Viscum, 
only Rafflesia lagascae (Molina et al. 2014) and Rafflesia cantleyi, Rafflesia tuan-mudae 
and Sapria himalayana (Xi et al. 2013) have been studied, meaning there is a great deal 
left to be investigated. These mitochondrial genomes appeared normal in terms of gene 
content. It is likely that the same selective pressures that led to Viscum sp. losing 
complex I have been replicated elsewhere during the 13 independent origins of plant 
parasitism. If true, there exist other parasitic plants with non-canonical respiratory chains 
waiting to be discovered. To identify these, targeted sequencing of mitochondrial 
genomes of representative species from every lineage that evolved parasitism could be 
carried out, followed by nuclear genome sequencing, or RNAseq. Further biochemical 
and proteomic work, like that carried out in this study, could then be performed to 
characterise these respiratory chains. Such studies would give insight into respiratory 
chain evolution and open up fundamental questions about the requirement of respiratory 
complexes for multicellular life.
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5 Functional characterization of FeS assembly proteins 
in Arabidopsis thaliana mitochondria 
5.1 Introduction 
The FeS clusters present in respiratory complex I, II and III are assembled and inserted 
by the mitochondrial ISC pathway. The ISC pathway has been most intensively studied 
in the yeast model organism, Saccharomyces cerevisiae, or Baker’s yeast. However, 
complex I has been lost in Baker’s yeast making the effect of FeS assembly defects on 
complex I hard to study. Studies in humans have allowed the connection between FeS 
assembly and respiratory complexes to be explored. Patients with defects in components 
of the ISC pathway have been found with respiratory chain defects. However, studies in 
humans are limited by the availability of patient mutations or rely on cell culture and RNAi 
studies, which may have limited relevance to the physiology of a multi-cellular organism. 
Plants provide a good alternative system to study the impact of FeS assembly defects 
on complex I and complex II.  They are complex multicellular eukaryotes with extensive 
genetic resources, for example a good selection of T-DNA knock-out mutants. With the 
exception of the FeS assembly factor INDH (Wydro et al. 2013) the connection between 
FeS assembly and respiratory complex I and II has never been previously studied. In 
this chapter I will study four different genes which encode putative FeS assembly 
proteins, ISU1, NFU4, NFU5 and GRXS15 (Table 5.1), to ascertain the role they play in 
FeS cluster provision for the respiratory chain. Additionally, I will try to assign their role 
in FeS assembly as there is currently little agreement about which FeS carrier proteins 
affect which subset of Fe-S requiring enzymes (Figure 5.1A). 
ISU1, the plant homolog of yeast Isu1 and human ISCU (Table 5.1), is an important 
scaffold for FeS assembly and appears to have a conserved role across eukaryotes. 
Three ISU paralogs exist in Arabidopsis: ISU1, ISU2 and ISU3. Through GFP localisation 
studies ISU1, ISU2 and ISU3 have been shown to be mitochondrially targeted (Léon et 
al. 2005).  ISU1 is thought to be the main scaffold, due to its high expression levels 
relative to the other two paralogs (Léon et al. 2005). In vitro studies have shown ISU1 is 
able to bind an [2Fe-2S] cluster (Frazzon et al. 2007). ISU1 has been shown to interact 
with the cochaperone protein HSCB, and together can stimulate the ATPase activity of 
the chaperone protein HSCA1 (Xu et al. 2009). The same study also indicated that ISU1 
can be retained in the cytosol, as well as mitochondria, through interaction with HSCB, 
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similarly to the cytosolic ISC proteins seen in the mammalian system. Taken together, 
these data suggest that ISU1 plays a similar role in plants as it does in other eukaryotes. 
However, ISU1 has been minimally characterised in Arabidopsis.   
NFU (NifU-like) proteins are named after the NifU gene in the nitrogen fixation (nif) 
regulon in the nitrogen fixing bacteria Azotobacter vinelandii. Along with the cysteine 
desulphurase NifS, NifU is required for the maturation of FeS clusters for the nitrogen 
fixing enzyme, nitrogenase (Yuvaniyama et al. 2000). NifU is a modular protein with three 
parts (Agar et al. 2000). The N-terminal section contains three conserved cysteines, and 
is homologous to the FeS scaffold ISU. The central section has a ferredoxin-like domain, 
with four cysteine residues which coordinate a permanent FeS cluster (Agar et al. 2000). 
The C-terminal domain is homologous to mitochondrial NFU proteins, with 2 conserved 
cysteines. Therefore, the 3 domain Azotobacter vinelandii NifU protein is a fusion of 3 
proteins that are usually separate in bacteria, and always separate in eukaryotes, as 
ISU, FDX and NFU (Figure 5.1B). The function of NFU proteins has been studied in 
bacteria, yeast and humans and have been shown to be important for mitochondrial FeS 
cluster maturation. They have also been studied in plant chloroplasts and been shown 
to be important in the SUF FeS assembly pathway (Touraine et al. 2004). 
Saccharomyces cerevisiae contain just one NFU gene, Nfu1, which encodes a protein 
targeted to the mitochondria. Studies show that nfu1Δ strains are defective in the FeS 
containing enzymes aconitase (~20-70% of WT activity) and respiratory complex II (~30-
50% of WT activity) (Schilke et al. 1999; Navarro-Sastre et al. 2011; Uzarska et al. 2016; 
Melber et al. 2016). Additionally, nfu1Δ is defective in lipoate cofactor biosynthesis, 
possibly due to the requirement of a FeS cluster in the lipoate cofactor biosynthetic 
enzyme, lipoate synthase. Consequently, lipoate containing enzymes are severely 
affected, for example PDH (~20% of WT activity) and KGDH (~20-40% of WT activity) 
(Navarro-Sastre et al. 2011; Melber et al. 2016; Uzarska et al. 2016). When Nfu1 is 
combined as a double mutant with Isu1 in Saccharomyces the defects are more 
pronounced and growth is severely impaired (Schilke et al. 1999). The phenotypes of 
nfu1Δisu1Δ strains and the modular structure of NifU highlight the importance and 
functional closeness of both Nfu1 and Isu1 for FeS cluster maturation. Further work in 
the last decade has suggested NFU proteins act late in the FeS assembly pathway and 
are specifically involved in [4Fe-4S] cluster maturation (Melber et al. 2016). Recently 
several cases of mitochondrial disease, usually fatal, have been linked to mutations in 
the NFU1 gene (Navarro-Sastre et al. 2011; Cameron et al. 2011; Ferrer-Cortès et al. 
2013; Invernizzi et al. 2014; Nizon et al. 2014; Tonduti et al. 2015; Ahting et al. 2015; 
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Tort et al. 2016; Lebigot et al. 2017). Most NFU1 patients display infantile 
encephalopathy or pulmonary hypertension, with symptoms such as hyperglycinemia 
and lactic acidosis. Biochemical tests showed decreases in certain FeS dependent 
enzymes such as the respiratory complexes I,II and III as well as PDH. Death often 
occurs within the first fifteen months. This is in striking contrast to the relatively mild 
phenotype of yeast nfu1Δ mutants.  
The majority of eukaryotes have only one NFU gene, the product of which is targeted to 
the mitochondria. However, as previously reported, Arabidopsis thaliana has five genes 
with homology to NFU (Léon et al. 2003). NFU1, NFU2 and NFU3 encode proteins which 
are targeted to the chloroplast, and have high sequence similarity to the cyanobacterial 
homologs from Synechocyctis PCC6803. NFU2 has been shown to be important for 
[4Fe-4S] and [2Fe-2S] ferredoxin cluster assembly in the chloroplasts (Touraine et al. 
2004). NFU4 (AT3G20970) and NFU5 (AT1G51390) encode proteins which are 
predicted to be targeted to the mitochondria, which has been experimentally verified for 
NFU4, but not NFU5 (Léon et al. 2003), and have high sequence similarity to other 
eukaryotic mitochondrial NFUs for example to human and yeast NFU1. The physiological 
role of NFU4 and NFU5 in Arabidopsis has never been previously investigated.  
Glutaredoxins (Grxs) are small proteins that act as redox enzymes, usually as 
oxidoreductases (Ströher & Millar 2012). They classically function to deglutathionylate 
proteins, thereby removing a modification that protects sensitive thiols during oxidative 
stress. Certain Grxs were also hypothesised to have a role in FeS assembly.  A study in 
2002 suggested Grx5 in Saccharomyces cerevisiae was required for mitochondrial FeS 
assembly (Rodríguez-Manzaneque et al. 2002). Additionally, it was shown that some 
Grxs could bind FeS clusters (Lillig et al. 2005). Since then numerous other studies 
supported the involvement of Grxs in FeS assembly. Grx proteins now commonly appear 
in FeS assembly pathway models in both the mitochondria, cytosol and chloroplast. 
Sometimes they enjoy a central role: for example, directly receiving the nascent FeS 
cluster from Isu1, and passing it to other downstream carriers (Uzarska et al. 2013; 
Couturier et al. 2013; Stehling et al. 2014; Braymer & Lill 2017). In other models, they 
take a more peripheral role, being one of many potential FeS carriers (Balk & Schaedler 
2014; Maio & Rouault 2015; Rouault & Maio 2017). 
The Arabidopsis thaliana homolog of yeast Grx5, is GRXS15. It is one of 31 Grxs 
encoded by the Arabidopsis thaliana genome. The localisation of GRXS15 was uncertain  
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Figure 5.1: Mitochondrial ISC pathway in Arabidopsis thaliana 
(A) Outline of the mitochondrial ISC pathway in Arabidopsis thaliana. FeS carrier proteins are 
highlighted in blue, other ISC pathway components are highlighted in orange. FeS clusters are 
shown as red and yellow circles. Mitochondrial inner membrane is indicated with a solid grey line, 
the mitochondrial out membrane is indicated with a dashed grey line. 
(B) Schematic of the modular protein NifU from Azotobacter vinelandii as well as the eukaryotic 
proteins ISU, FDX and NFU (adapted from Benz et al. 2016). The N-terminal section of NifU is 
homologous to the eukaryotic ISU proteins (blue boxes) and contains three conserved cysteines 
which coordinate a transient [2Fe-2S] cluster. The central section is homologous to the eukaryotic 
FDX proteins (red boxes) and contains four conserved cysteines which coordinate a permanent 
[2Fe-2S] cluster. The C-terminal section of NifU is homologous to the eukaryotic NFU proteins 
(green boxes) and contains two conserved cysteines which coordinate a transient [2Fe-2S] 
cluster. Additionally, conserved aspartate residues have been proposed to aid the transfer of 
newly formed FeS clusters. 
 
Table 5.1: Mitochondrial ISC pathway in Arabidopsis thaliana 
Name Gene id Homologs 
(yeast/human) 
Proposed function 
NFS1 AT5G65720 Nfs1/NFS1 Cysteine desulfurase 
ISD11 AT5G61220 Isd11/ISD11 Helper protein for NFS1 
ISU1 AT4G22220 Isu1/ISCU FeS scaffold 
ADXR AT4G32360 Arh1/FDXR Electron donation 
ADX1 AT4G21090 Yah1/FDX2 Electron donation 
ADX2 AT4G05450 Yah1/FDX2 Electron donation 
HSCA1 AT4G37910 Ssq1/HSPA9 Chaperone 
HSCA2 AT5G09590 Ssq1/HSPA9 Chaperone 
HSCB AT5G06410 Jac1/HSC20 Chaperone 
NFU4 AT3G20970 Nfu1/NFU1 FeS carrier 
NFU5 AT1G51390 Nfu1/NFU1 FeS carrier 
ISCA1A AT2G16710 Isa1/ISCA1 FeS carrier 
ISCA1B AT5G03905 Isa1/ISCA1 FeS carrier 
ISCA2 AT2G36260 Isa2/ISCA2 FeS carrier 
GRXS15 AT3G15660 Grx5/GLRX5 FeS carrier/ redox reactions 
BOLA4 AT5G17560 Aim1/BOLA3 FeS carrier/ interact with Grx 
INDH AT4G19540 Ind1/NUBPL FeS carrier 
IBA57 AT4G12130 Iba57/IBA57 FeS carrier 
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for a long time, with some reports placing it in the mitochondria (Bandyopadhyay et al. 
2008; Klodmann et al. 2011; Salvato et al. 2014), others in the chloroplast (Cheng 2008; 
Huang et al. 2013) and one in both (Couturier et al. 2014). Two recent papers (Moseler 
et al. 2015; Stroeher et al. 2015) conclude that GRXS15 is localized in the mitochondrial 
matrix. Moseler et al. show that GRXS15 protein is able to coordinate and transfer a 
[2Fe-2S] cluster in vitro and that mutation of the conserved Lys83 led to a ~50% 
decreased activity of aconitase, an enzyme that requires a FeS cluster. Based on this 
the authors concluded that “GRXS15 is essential for iron-sulfur protein maturation”. 
Stroher et al. also showed the ability of GRXS15 to bind a [2Fe-2S] cluster and that 
knock-down mutants had defects in certain lipoate containing enzymes, but not complex 
I or aconitase. The lack of defect in aconitase is surprising as it is the opposite of what 
is observed in the Moseler et al. study. Additionally, they report an increased sensitivity 
to arsenic. However, despite the strong in vitro evidence that GRXS15 coordinates an 
FeS cluster, and the severe growth phenotype observed for both the K83A and knock-
down mutants, the FeS defects are surprisingly mild for a protein of central importance 
in FeS assembly. This suggests that GRXS15 may not play as central a role in FeS 
assembly as is currently thought. 
5.2 Results 
5.2.1 Characterisation of the isu1-1 mutant 
In order to study the role of ISU1 a T-DNA insertion mutant was investigated for growth 
and biochemical defects.  
The isu1-1 T-DNA insertion line (SALK_006332) (Table 5.2) was previously obtained 
from the Nottingham Arabidopsis stock centre. Homozygous plants isolated were by 
genotyping PCR analysis and initial analysis carried out (Unpublished data: Delphine 
Bernard, Jo Harrison, Inga Kruse, Janneke Balk). The exact insertion site of the T-DNA 
was determined by sequencing (Figure 5.2A) to be 64 bp upstream of the ATG 
sequence, in the 5’ UTR. Western blot analysis using an antibody against ISU1 showed 
a significant decrease in protein levels (Figure 5.2B). This was quantified to be 
approximately 18% of WT levels. 
A previous study in cucumber, Cucumis sativis, showed that iron deficiency led to a 
dramatic decrease in complex I activity and assembly (Vigani et al. 2009). Therefore, it 
is reasonable to assume that defects in the FeS pathway may lead to a decrease in 
abundance of complex I, II and III as well a decrease in activity. The abundance of 
respiratory complexes in isu1-1 was analysed using BN-PAGE and coomassie staining  
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Figure 5.2: Analysis of isu1-1 mutant 
(A) Gene model of ISU1 and the positions of the T-DNA insertion. Black bars represent exons, 
grey bars are the 5’ and 3’ untranslated regions of the transcript. Triangle represent T-DNA 
insertion, its orientation is marked with an arrow to indicate the outward facing left border primer 
LBb1.3.  
(B) SDS-PAGE followed by Immunolabelling of mitochondrial FeS proteins in purified 
mitochondria samples isolated from callus lines. 
(C) Respiratory complexes I, III and V separated by BN-PAGE and visualised with coomassie 
staining (left-hand panel) and by complex I NADH/NBT activity staining (right-hand panel) in wild-
type (Col-0) and isu1-1 mitochondria samples isolated from callus lines. 
(D) Growth phenotype of 4-week old isu1-1 T-DNA insertion line and corresponding WT, Col-0. 
Scale bar = 2 cm.  
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(Figure 5.2C). No decreases of any respiratory complexes were observed. Activity 
staining with NBT/NADH, to visualise complex I levels, again showed no decreases. 
Western blot analysis on isolated mitochondria showed no effect on protein levels of FeS 
binding proteins aconitase, NFU4, NFU5, INDH and GRXS15 (Figure 5.2B). TOM40 was 
used as a control for equal loading and transfer. 
In order to evaluate the importance of ISU1 on growth, the isu1-1 mutant was grown on 
soil under long-day conditions (Figure 5.2D). No growth phenotype was observed. 
Taken together these data show that, despite an ~80% decrease in ISU1 protein levels, 
the isu1-1 mutant does not have a clear phenotype. 
5.2.2 NFU4 and NFU5 are localised to the mitochondrial matrix  
Arabidopsis thaliana contains five NFU genes. Two of them, NFU4 and NFU5, are 
predicted to encode proteins that are targeted to the mitochondria. Through GFP 
localisation studies NFU4 has been shown to the mitochondrially targeted (Léon et al. 
2003). However, the localisation of NFU5 has yet to be confirmed. To confirm the 
localisation of NFU5 Western blot analysis was performed on total protein, mitochondrial 
and chloroplastic fractions using antibodies that bind both NFU4 and NFU5 (Figure 
5.3A). Both NFU4 and NFU5 were enriched in the mitochondrial fraction, similarly to 
GRXS15 which has previously been shown to be mitochondrially localised. The cytosolic 
marker NBP35 was enriched in the total protein fraction. No NFU4 or NFU5 was found 
in the chloroplastic fraction, identified by the enrichment of Rubsico on the ponceau stain. 
In order to elucidate the mitochondrial sub-compartment where NFU4 and NFU5 reside, 
mitochondria were separated by freeze-thawing into a soluble matrix fraction and 
insoluble pellet fraction followed by Western blot analysis. NFU4 and NFU5 were 
enriched in the soluble fraction (Figure 5.3B), similar to the FeS proteins ISU1 and INDH, 
which have previously been shown to be matrix localised (Wydro et al. 2013). 
Additionally, GRXS15 was enriched in this fraction. By contrast, the cox2 subunit of 
complex IV was as expected enriched in the membrane fraction.  
Taken together these data indicate that NFU4 and NFU5, as well as GRXS15, are 
localised to the matrix of the mitochondria. 
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Figure 5.3: NFU4 and NFU5 are localised in the mitochondrial matrix 
(A) Western blot analysis of NFU4 and NFU5 in cell fractions. Equal amounts of protein from total 
leaf extract, chloroplasts and mitochondria were separated by SDS-PAGE and immunolabelled 
with antibodies against the indicated proteins. NBP35 was used as a cytosolic marker, GRXS15 
as a mitochondrial marker and the ponceau stain of Rubsico as a chloroplastic marker. 
(B) Western blot analysis of NFU4 and NFU5 in soluble and membrane fractions in mitochondria. 
Purified mitochondria were separated into soluble supernatant and insoluble pellet fractions by 
freeze-thaw cycles and centrifugation. Protein was then separated by SDS-PAGE and labelled 
with antibodies against NFU4 and NFU5, GRXS15, ISU1 and INDH (soluble matrix proteins) and 
cox2 (a membrane bound protein). 
 
Table 5.2: Summary of mutant alleles 
Locus Allele Polymorphism Mutation 
AT3G20970  nfu4-1 SALK_035493 T-DNA insertion (exon 6 +56) 
(NFU4) nfu4-2 SALK_061018 T-DNA insertion (intron 1 +84) 
 nfu4-4 SAIL_1233_C08 T-DNA insertion (intron 3 +230) 
AT1G51390  nfu5-1 WiscDsLoxHs069_06B T-DNA insertion (exon 3 +173) 
(NFU5) nfu5-2 SK24394 T-DNA insertion (promoter -250) 
 nfu5-3 GT_3_2834 T-DNA insertion (exon 2 +435) 
AT4G22220 
(ISU1) 
isu1-1 SALK_006332 T-DNA insertion (promoter -64) 
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5.2.3 Genetic analysis of NFU4 and NFU5 mutants 
To investigate the functions of NFU4 and NFU5, T-DNA insertion mutants were obtained 
from Arabidopsis stock centres. Homozygous plants were isolated by genotyping PCR 
analysis and the exact insertion site was determined by sequencing (Figure 5.4A, Table 
5.2). Mutants nfu4-1, nfu4-2, nfu4-4 and nfu5-1 are in the Columbia-0 (Col-0) 
background, nfu5-2 is in the Columbia-4 (Col-4) background and nfu5-3 is in the 
Landsberg (Ler) background. RT-PCR confirmed the absence of full length NFU4 
transcript in nfu4-1, and the substantial decrease of full length NFU4 in nfu4-2 and nfu4-
4 (Figure 5.4B). The remaining transcript in nfu4-2 and nfu4-4 is likely due to 
contamination of the PCR reaction or spill-over as it is unlikely any product could be 
amplified over the length of the T-DNA.  No NFU5 transcript was detected in nfu5-1 and 
nfu5-3. Transcript levels in nfu5-2 were indistinguishable from WT when looked at by 
RT-PCR. However, subsequent qRT-PCR (performed by Dr. Robert Green) analysis 
showed approximately 81% NFU5 transcript compared to WT. This is consistent with the 
placement of the T-DNA 251 bp upstream of the ATG start codon in the 3’UTR of the 
previous gene, AT1G51380, which may affect promoter activity of NFU5. 
Western blot analysis was performed using an antibody that was raised against 
recombinant NFU4 but which detects both NFU4 and NFU5 (Supplied by Dr. Nicolas 
Rouhier). In a 15% SDS-polyacrylamide gel both proteins can be easily detected due to 
their different sizes (Figure 5.4C). Taking into account the predicted mitochondria 
targeting sequence (MTS) cleavage site (prediction from Uniprot), NFU4 was calculated 
to be 25.5 kDa and NFU5 23.4 kDa, in agreement with the apparent mobility. Using 
Western blot analysis, the absence of NFU4 protein in nfu4-2 and nfu4-4 and the 
absence of NFU5 protein in nfu5-1 and nfu5-3 was confirmed (Figure 5.4C). NFU5 
protein levels in the nfu5-2 mutant were decreased to around 80% of Col-4. The T-DNA 
insertion in nfu4-1 is located in the last exon of NFU4 and so may result in a truncated 
protein product. If this truncated protein product is of similar size to NFU5, it would be 
hard to detect by Western blot analysis, and would only be visible in combination with 
the nfu5-1 mutant. This double mutant was created, but was not yet analysed, and so 
nfu4-1 will no longer be investigated. 
These data show that nfu4-2, nfu4-4, nfu5-1 and nfu5-3 can be considered knock-out 
mutants. nfu5-2 is a partial mutant. nfu4-1 contains no full-length transcript but may retain 
truncated protein product. 
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Figure 5.4: Genetic analysis of Arabidopsis thaliana mutants in NFU4 and NFU5 
(A) Gene model of NFU4 and NFU5 and the positions of T-DNA insertions. Black bars represent 
exons, grey bars are the 5’ and 3’ untranslated regions of the transcript. Triangles represent T-
DNA insertions, their orientation is marked with an arrow to indicate the outward facing left border 
primer. Primers P1 – P4, used for RT-PCR, are also marked by arrows.  
(B) Transcript levels of NFU4 and NFU5 in wild-type seedlings and T-DNA mutants. RNA was 
isolated from 2-week-old seedlings, reverse transcribed to cDNA with an oligo dT primer and PCR 
was performed with primer pairs P1 and P2 for NFU4, and P3 and P4 for NFU5 (see A). ACTIN2 
was used as a control for the amount of cDNA template.  
(C) NFU4 and NFU5 protein levels shown by SDS-PAGE followed by immunolabelling of NFU4 
and NFU5 proteins in purified mitochondria samples isolated from 2-week-old seedlings (left and 
middle panel) and in total protein from 7-week-old plants (right-hand panel). 
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Figure 5.5: Growth analysis NFU4 and NFU5 T-DNA insertion lines 
(A-D) Growth phenotype of 4-week-old plants of T-DNA insertion lines and corresponding wild 
types. nfu4-1, nfu4-2, nfu4-4 and nfu5-1 are in the Columbia 0 (Col-0) background, nfu5-2 is in 
the Columbia 4 (Col−4) background and nfu5-3 is in the Landsberg (Ler) background. Scale bar 
= 2 cm. 
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Figure 5.6: Isolation of nfu5-1 line 
(A) Growth phenotype of 5-week-old plants of Col-0, nfu5-1* (original T-DNA insertion line) and 
nfu5-1BC (re-isolated nfu5-1). Scale bar = 2 cm. 
(B) Genotype and protein levels from lines in (A). The presence of the T-DNA insertion was shown 
by genotyping PCR using primers from the left border of the T-DNA and a genomic primer, and 
the absence of WT NFU5 by two genomic primers. NFU4 and NFU5 protein levels shown by 
SDS-PAGE followed by immunolabelling of NFU4 and NFU5 proteins from total leaf extracts.  
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5.2.4 NFU4 and NFU5 mutants display no growth phenotype 
suggesting functional redundancy 
In order to evaluate the importance of NFU4 and NFU5 for plant growth, all T-DNA 
insertion lines were grown on soil under long-day conditions (Figure 5.5A-D). The nfu4- 
2 and nfu4-4 insertion mutants had no apparent growth phenotype. The nfu5-2 and nfu5-
3 insertion mutants appear indistinguishable from their respective wild types.  
Initially nfu5-1 appeared to have a growth phenotype (nfu5-1*). The plants had narrow 
leaves and were smaller than WT (Figure 5.6A). However, during subsequent 
experiments where this insertion mutant was crossed with different lines I noticed that 
the growth phenotype did not segregate with the nfu5-1 homozygous genotype. This 
suggested that the growth phenotype was due to a secondary mutation, unrelated to the 
NFU5 gene. nfu5-1 homozygous plants re-isolated from a back cross (nfu5-1BC) were 
indistinguishable from WT (Figure 5.6A, B). This showed that the nfu5-1 insertion mutant 
has no growth phenotype, in agreement with normal growth in the nfu5-3 mutant. 
These data suggest that neither NFU4 nor NFU5 individually have a critical role under 
normal growth conditions. 
5.2.5 NFU4 and NFU5 are essential for embryo development. 
Given the lack of a clear growth phenotype in the single mutants, it is likely that NFU4 
and NFU5 play redundant functions. Therefore, efforts were made to create a double 
mutant between knock-out alleles, by reciprocal crosses between nfu5-1 and either nfu4-
2 or nfu4-4. However, in the F2 generation no double mutants could be isolated. 
Therefore, I looked in the siliques of nfu4-2-/-nfu5-1+/- and nfu4-4-/-nfu5-1+/- plants to see 
if embryo development was affected. Approximately one quarter of the immature seeds 
were white, consistent with an expected ratio of 3:1, indicating embryo abortion for nfu4-
2-/-nfu5-1-/- and nfu4-4-/-nfu5-1-/- individuals (Figure 5.7A, Table 5.3). Col-0 and single 
mutants involved in the crosses (nfu4-2, nfu4-4 and nfu5-1), differed significantly from a 
3:1 ratio, and so show no evidence of significant embryo abortion. Therefore, it is likely 
that a complete lack of the NFU4 and the NFU5 protein is lethal and results in embryo 
abortion. 
In order to further investigate the role of NFU proteins in embryo development embryos 
were cleared using Hoyer’s solution and imaged Normanski differential interference 
contrast (DIC) microscopy. To find the terminal phenotype of the aborted embryos I 
looked at both green (normal) and white (aborted) ovules, from the same silique, at a  
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Figure 5.7: Investigation of NFU4 NFU5 double mutant 
(A) Silique pictures, showing seedling development, in wild type (Col-0), nfu4 and nfu5 single 
mutants as well as nfu4-2 -/- nfu5-1 +/- and nfu4-4 -/- nfu5-1 +/-. Scale bar = 500 µm. Black arrows 
indicate aborting seeds. 
(B) An aborted and healthy embryo from the silique of nfu4-2 -/- nfu5-1 +/- . Siliques were cleared 
with Hoyer’s solution and imaged with DIC microscopy. Scale bar = 25 µm (top panel) and 50 µm 
(bottom panel). Performed with Dr. Vasilios Andriotus. 
(C) Western blot analysis of nfu4-4-/-nfu5-1-/- NFU4-HA, showing levels of NFU4, NFU5 and NFU4-
HA protein. 
(D) Growth phenotype and silique morphology of Col-0 and nfu4-4-/-nfu5-1-/- NFU4-HA. Scale bar 
= 1 mm. 
 
Table 5.3: Embryo abortion counts of NFU mutants 
χ2-value for embryo abortion calculated on an expected ratio of 3:1. 
 Normal 
(%) 
Aborted 
(%) 
Not fertilised (%) n χ2-value 
Wild type (Col-0) 99.0 0.7 0.3 408 128 (p<0.001) 
nfu4-2 -/-  97.8 2.2 0.0 359 99   (p<0.001) 
nfu4-4 -/-  99.2 0.5 0.3 386 123 (p<0.001) 
nfu5-1 -/- 99.5 0.0 0.5 430 142 (p<0.001) 
nfu4-2 -/- nfu5-1 +/- 76.8 23.2 0.0 384 0.7 
nfu4-4 -/- nfu5-1 +/- 72.8 26.1 1.1 448 0.5 
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late stage of development in nfu4-2-/-nfu5-1+/- (Performed with help from Dr. Vasilios 
Andriotus). While the green ovules contained embryos at the mature green stage, the 
white ovules contained an embryo arrested at the globular stage (Figure 5.7B). This 
suggests that the globular phase of development is the terminal phenotype. Plants 
without NFU4 and NFU5 cannot survive beyond this point. 
In order to confirm that the embryo lethality phenotype is caused by a lack of functional 
NFU protein, the double mutant was complemented with an C-terminally HA tagged 
NFU4 construct (pBIB plasmid, 35S promoter, from Dr. Nicolas Rouhier). nfu4-4 + NFU4-
HA individuals were crossed with nfu5-1. One complemented individual, nfu4-4-/- nfu5-1-
/- NFU4-HA, out of ~40 individuals, was isolated in the F2 generation (Figure 5.7C). The 
individual was small and stunted and had abnormally small silique. In addition, the silique 
had not been fertilised indicating it is male sterile (Figure 5.7D). The individual’s ability 
to survive and reach reproductive age demonstrates partial complementation of the 
embryo lethal phenotype and subsequent vegetative growth. However, NFU4-HA cannot 
replace the function of endogenous NFU4 during reproduction. 
Overall, these data suggest a critical function for the NFU proteins during a particular 
growth stage. 
5.2.6 Single mutants of NFU4 and NFU5 have no noticeable FeS 
assembly phenotype  
In order to characterise the role of NFU4 and NFU5 in FeS assembly, FeS containing 
proteins and enzymes were investigated. To study the effect of NFU4 and NFU5 mutants 
on a range of FeS containing proteins, Western blot analysis was performed on isolated 
mitochondria.  No decrease in protein levels of the FeS binding proteins aconitase, ISU1, 
INDH and GRXS15, nor on the E1α subunit of pyruvate dehydrogenase was seen 
(Figure 5.8A).  
Lipoate cofactor synthesis is dependent of FeS assembly, because lipoate synthase 
requires an FeS cluster. Therefore, mutants in FeS assembly can have lipoate defect 
phenotypes.  An effect on lipoate synthesis is one of the main defects seen in human 
and Saccharomyces NFU1 mutants so it was decided to study lipoate containing proteins 
in more detail. In Arabidopsis, there are seven lipoate containing proteins: three isoforms 
of the H-protein of the glycine cleavage complex (H1, At2g35370; H2, At2g35120 and 
H3, At1g32470), three E2 proteins from the PDC complex (E2-1, At3g52200; E2-2, 
At3g13930 and E2-3, At1g54220) and an E2 protein from the OGDC enzyme complex 
(At5g55070) (Stroeher et al. 2015). Using antibodies specific to lipoic acid and to H-  
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Figure 5.8: Western blot and BN-PAGE analysis of NFU4 and NFU5 single mutants 
(A) Levels of the mitochondrial proteins NFU4, NFU5, aconitase (ACO), glutaredoxin S15 
(GRXS15), FeS cluster assembly protein 1 (ISU1), FeS protein required for NADH 
Dehydrogenase homolog (INDH), E1α subunit of pyruvate dehydrogenase (PDH) and translocase 
of the outer membrane 40 (TOM40) in wild type (Col-0), nfu4 and nfu5 single mutants, as 
indicated. Mitochondria were purified from 2-week-old seedlings and analysed by immunoblotting 
with specific antibodies.  
(B) Lipoate-binding proteins in mitochondria of wild type (Col-0) and nfu4 or nfu5 single mutants. 
Purified mitochondria from 2-week-old seedlings were subjected to immunolabeling with 
antibodies against lipoate and H-protein. 
(C) Respiratory complexes I, III and V visualised by BN-PAGE and Coomassie staining in wild 
type (Col-0), nfu4 and nfu5 single mutants, as indicated. Mitochondria were purified from 2-week-
old seedlings. 
(D) Respiratory complex I separated by BN-PAGE followed by activity staining with NADH and 
NBT of wild type (Col-0), nfu4 and nfu5 single mutants, as indicated. Mitochondria were purified 
from callus culture. 
(E) Respiratory complex II separated by BN-PAGE followed by activity staining with PMS, 
Succinate and NBT of wild type (Col-0), nfu4 and nfu5 single mutants, as indicated. Mitochondria 
were purified from callus culture. 
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proteins, no decrease in any these proteins or cofactors (Figure 5.8B), except for a slight 
decrease in the lipoate bound to the H2 protein in nfu5-1. 
The abundance of respiratory complexes in nfu4-2, nfu4-4 and nfu5-1 single mutants 
was analysed using BN-PAGE and Coomassie staining (Figure 5.8C). No decreases of 
any respiratory complexes were observed. Activity staining with NBT/NADH, to visualise 
complex I levels, again showed no decreases (Figure 5.8D). Complex II levels were 
visualised with an in gel histochemical stain. Again, no decrease in the nfu4-2 or nfu5-1 
mutants was seen (Figure 5.8E).    
Taken together these data suggests that neither NFU4 nor NFU5 single mutants have 
observable defects in FeS assembly. FeS containing enzymes affected in human and 
Saccharomyces NFU1 mutants were not decreased in activity in Arabidopsis thaliana 
NFU4 or NFU5 single mutants.  
5.2.7 Hemizygous NFU mutant has a decrease in H-protein 
Single mutants in NFU4 and NFU5 do not have observable growth or FeS cluster 
assembly defects. Double knock-out mutants of NFU4 and NFU5 are embryo lethal, 
making further study of their function problematic. Therefore, in order to study the role of 
NFU4 and NFU5, a hemizygous mutant was created. This was done by combining in 
one individual three T-DNA insertions: nfu4-2, nfu5-1 and nfu5-2 (Figure 5.9). This line 
has no NFU4 protein and low levels of NFU5 protein (Figure 5.10B). BN-PAGE and 
Western blot analysis were performed to assess the levels of respiratory complexes and 
FeS proteins. Additionally, a nfu4-2-nfu5-2 double mutant, with no NFU4 protein and 
~80% NFU5 protein, was analysed. 
Similarly to what was seen in the single mutants, no defect was seen in the levels of 
respiratory complexes (Figure 5.10A). The levels of aconitase, ISU1, INDH and 
GRXS15, and the E1α subunit of pyruvate dehydrogenase were unaffected (Figure 
5.10B). However, a substantial decrease was seen in the levels of the H2 protein of GDC 
in both the hemizygous and nfu4-2-nfu5-2 mutants.  
Despite having very low levels of NFU protein growth was unaffected compared to WT 
(Col-0) (Figure 5.10C). 
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Figure 5.9: Creation of the hemizygous NFU mutant 
Schematic detailing genetic composition of the hemizygous mutant. Black triangles indicate T-
DNA insertion. The two black lines under the heading protein depict the relative levels of NFU4 
and NFU5 proteins. 
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Figure 5.10: BN-PAGE and Western blot analysis of hemizygous and nfu4-2 nfu5-
2 double mutants 
(A) Respiratory complexes I, III and V separated by BN-PAGE and visualised with Coomassie 
staining (left-hand panel) and by complex I NADH/NBT activity staining (right-hand panel) in wild 
type (Col-0), hemizygous and nfu4-2 nfu5-2 double mutant. Mitochondria were purified from callus 
culture. 
(B) Levels of the mitochondrial proteins NFU4, NFU5, ACO, GRXS15, ISU1, INDH, H-protein, 
E1α subunit of pyruvate dehydrogenase (PDH) and TOM40 in wild type (Col-0), hemizygous and 
nfu4-2 nfu5-2 double mutant as indicated. Mitochondria were purified from callus culture. 
(C) Growth phenotype of 4-week-old plants of Col-0 and hemizygous mutant. Scale bar = 2 cm 
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5.2.8 GRXS15 mutants do not have a strong FeS assembly 
phenotype 
Recent studies on GRXS15 in Arabidopsis thaliana conclude that it is localized in 
mitochondria and plays a role in FeS assembly in the mitochondria (Moseler et al. 2015; 
Stroeher et al. 2015). However, the two reports described different mutant lines, and the 
findings differ, for example with respect to aconitase activity. To obtain clarity about the 
role of GRXS15 in FeS cluster assembly in plants, the two GRXS15 mutants were grown 
side-by-side and further characterised. This work was initially undertaken with Dr. Inga 
Kruse and Dr. Janneke Balk. Some of the ideas and conclusions here were discussed in 
the thesis of Dr. Inga Kruse, as was the lipoate blot in figure 5.11E, which was undertaken 
jointly. 
First, the RNAi knockdown line described in Stroher et al 2015, amiRNA grxs15, was 
obtained from the group of Prof. Harvey Millar. This line has been shown by multiple 
reaction monitoring analysis to contain approximately 3% of GRXS15 compared to WT 
(Stroeher et al. 2015). Consistent with this, Western blot analysis does not detect any 
GRXS15 protein in this line, as it is below the detection limit (Figure 5.11A, Stroeher et 
al. 2015). The growth phenotype of amiRNA grxs15 is variable, as often seen in RNAi 
lines, but smaller than WT (Figure 5.11F, Dr. Inga Kruse thesis, Stroeher et al. 2015). 
The second line was obtained from the group of Prof. Andreas Meyer. The line was 
created by complementing a knock out line, grxs15-3, with a construct containing 
GRXS15 with a key catalytic residue, lysine 83, mutated to alanine, giving grxs15-3 
UBQ10pro: GRXS15 K83/A. Lys83 is involved in glutathione binding. The mutant line will 
henceforth be referred to as grxs15-K83A. GRXS15 protein levels are higher than in wild 
type because the mutant gene is expressed using the UBIQUITIN promoter (Figure 
5.11A and Moseler et al. 2015). The growth phenotype of grxs15-K83A is small and 
chlorotic (Figure 5.11B, Moseler et al. 2015).  
The abundance of respiratory complexes in both GRXS15 mutants was analysed using 
BN-PAGE and Coomassie staining (Figure 5.11C). No decreases of any respiratory 
complexes were observed in either mutant. 
Previously published results suggested lipoate containing proteins could be affected in 
the amiRNA grxs15 mutant (Stroeher et al. 2015). In order to confirm this result, and test 
to see if the same was true in grxs15-K83A, Western blot analysis was performed with 
antibodies against lipoate and H-protein. No decrease was seen in the levels of H-
protein, unlike in Stroher et al. 2015, however a decrease was seen in the lipoate bound  
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Figure 5.11: Analysis of grxs15-K83A and amiRNA grxs15 mutants 
(A) Protein levels of GRXS15 in Col-0, grxs15-K83A, and amiRNAgrxs15. Mitochondria were 
purified from 4-week-old plants and analysed by immunoblotting with specific antibodies. TOM40 
was used as a marker protein for equal transfer and loading. 
(B) Growth phenotype of 3-week-old grxs15-K83A mutant and corresponding wild type, Col-0. 
Scale bar = 2 cm. 
(C) Respiratory complexes I, III and V separated by BN-PAGE and visualised with Coomassie 
staining in Col-0, grxs15-K83A and amiRNAgrxs15. Mitochondria were purified from 4-week-old 
plants. 
(D) Lipoate and H-protein levels on indicated proteins in Col-0, grxs15-K83A, and amiRNAgrxs15. 
Mitochondria were purified from 4-week-old plants and analysed by immunoblotting 
(E) Levels of the mitochondrial proteins NFU4, NFU5, GRXS15, INDH and TOM40 in Col-0, indh 
and amiRNAgrxs15. Mitochondria were purified from either callus (lane 1 and 2) or 4-week-old 
plants (lane 3) and analysed by immunoblotting with specific antibodies. 
(F) Growth phenotype of 4-week-old amiRNAgrxs15. Scale bar = 2 cm. 
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H-protein 2 of GDC for both mutants (Figure 5.11E). Other lipoate containing proteins 
were unaffected. These data indicate that the lipoate bound to H-protein 2 is decreased 
in both grxs15 mutants, and confirms a defect in lipoate metabolism in GRXS15 mutants, 
even if the pattern of defect is slightly different from that in Stroher et al. 2015.  
Western blot analysis was performed to investigate if the absence of GRXS15 affected 
other FeS carrier proteins. The amiRNA grxs15 line showed normal levels of FeS binding 
proteins NFU4, NFU5 or INDH (Figure 5.11E), suggesting that these act independently. 
The lack of effect on NFU4 protein levels is unexpected given that Stroher et al. 2015 
found that in GRXS15 knock out lines NFU4 protein is decreased 1.7-fold (Stroeher et 
al. 2015). 
Taken together these data show grxs15 mutants have a strong growth phenotype but a 
mild FeS assembly defect. An FeS defect was unobservable except from the decrease 
in lipoate bound to the H-protein 2 of GDC. 
5.3 Discussion 
Here, I found that double knock out mutants of NFU4 and NFU5 were embryo lethal. This 
shows that, together, they play an essential role in FeS assembly. However, it does make 
assigning their exact role in the process problematic. This continues a common pattern 
in FeS assembly research. FeS assembly proteins are highly conserved across the 
eukaryotes and are often essential, therefore mutants are often non-viable. This fact has 
frustrated efforts to study FeS proteins in many different model systems. Innovative 
solutions have been needed to get around this problem and study protein function. In 
Arabidopsis thaliana, there are numerous mutants in FeS assembly that have been found 
to be, at least partially, embryo lethal. These include, from the mitochondrial ISC 
pathway, NFS1 (Frazzon et al. 2007); IBA57 (Waller et al. 2012); GRXS15 (Moseler et 
al. 2015); Frataxin (Busi et al. 2006; Vazzola et al. 2007), ISU1 (Janneke Balk, 
unpublished data); NFU4 and NFU5 (this chapter), the CIA pathway NBP35 (Bych et al. 
2008b; Kohbushi et al. 2009); DRE2 (Bernard et al. 2013); (Varadarajan et al. 2010); 
AE7 (Luo et al. 2012), NAR1 (Cavazza et al. 2008; Luo et al. 2012) and CIA1 (Luo et al. 
2012), and the chloroplastic SUF pathway SUFE1 (Xu & Møller 2006); SUFE3 (Narayana 
Murthy et al. 2007); SUFC/NAP7 (Xu & Moller 2004) and SUFD/NAP7 (Hjorth et al. 
2005). This demonstrates that my findings with NFU4 and NFU5 fit well with previous 
observations of FeS assembly in plants. 
Efforts to overcome embryo lethality phenotypes to study protein function centre around 
two main strategies. The first is to decrease the amount of protein present, either through 
Chapter 5 Functional characterisation of FeS assembly proteins in Arabidopsis thaliana 
mitochondria 
 
 
124 
 
RNAi or different insertion mutants, to low enough levels that a phenotype is seen, but 
not so much that the embryo is unviable. This is the strategy I decided on in creating the 
NFU hemizygous mutant. Western blot analysis showed a dramatic decrease in total 
NFU protein levels (Figure 5.10B). However, the phenotypic effects were mild: no growth 
defect was observed and most FeS proteins were unaffected. Some decrease was seen 
in lipoate containing H2 protein of the GDC. Further work will focus on performing 
enzyme assays on these lines to see if complex II, PDH or GDC are affected.  A similar 
result is seen in investigating isu1-1. Protein levels could be decreased to approximately 
18% without any observable phenotype (Figure 5.2B). This has been observed before 
for FeS proteins. For example, in studying NBP35, RNAi could decrease NBP35 protein 
to approximately 30% of WT, without any detrimental effects on growth or FeS enzymes 
(Bastow et al. 2017). Clearly, in the study of FeS proteins, this strategy has limited 
success, as Arabidopsis thaliana can survive with very low levels of these essential 
proteins. This raises the puzzling question of why the plant produces high levels of them 
when low levels suffice.  
Due to the modular nature of the NifU protein in Azotobacter vinelandii, with homology 
to both Isu1 and Nfu proteins (Agar et al. 2000) double mutants were made in 
Saccharomyces cerevisiae. These double mutants had more severe defects than seen 
in the single mutants (Schilke et al. 1999). Combining isu1 and nfu4 or nfu5, mutants in 
Arabidopsis thaliana may have a similar effect. Despite individual mutants having enough 
protein so that no phenotype is seen, it is hoped that in the double mutant, with 
decreased protein of both ISU1 and NFU4 or NFU5, would allow a mutant phenotype to 
be seen. This work was started, but was not completed in time for inclusion in this thesis. 
The second strategy involves complementing a knock out mutant with a version of the 
protein with a key amino acid residue substituted. This allows minimum functionality 
required to avoid lethality, but also a sufficient decrease in protein function leading to a 
phenotype that is possible to study. This strategy was effectively adopted in studying 
NBP35 where knock out mutants of NBP35 were complemented with a copy of NBP35 
with an amino acid substitution at cysteine 14 (Bastow et al. 2017). This allowed 
phenotypic characterisation of the mutant. This strategy was also used, as previously 
mentioned in studying GRXS15 with the grxs15-K83A mutant (Moseler et al. 2015). Time 
constraints prevented the use of this strategy in studying NFU4 and NFU5, but should 
certainly be considered for future work.  
Before this work was undertaken the role of GRXS15 in plants was uncertain. It was 
suggested to have a role in FeS assembly in the mitochondria based on FeS defects 
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observed in mutants in homologs, for example in Saccharomyces cerevisiae Grx5 
(Rodríguez-Manzaneque et al. 2002) and in Danio rerio Grx5 (Wingert et al. 2005). 
AtGRXS15 could complement yeast grx5∆ (Cheng 2008; Moseler et al. 2015) suggesting 
a similar role. Additionally, numerous Grx proteins have experimentally been shown to 
coordinate FeS clusters, starting with the human dithiol Grx2 (Lillig et al. 2005). Recent 
papers suggest a clear role in FeS assembly in Arabidopsis thaliana (Stroeher et al. 
2015; Moseler et al. 2015). This conclusion is based upon strong in vitro but 
unconvincing in planta evidence. My results suggest GRXS15 does not play a central 
role in the mitochondrial ISC pathway. In two severe mutants, no defects could be found 
in FeS containing proteins. There remains a clear mismatch in the severity of the growth 
phenotype in GRXS15 mutants, and the mildness of the FeS defect observed. The 
implications of this for the model of the mitochondrial ISC pathway will be discussed in 
the general discussion. 
In this section of work, I aimed to study the late acting FeS carrier proteins in 
mitochondria, in order to clarify their role and better understand FeS provision to the 
respiratory complexes. My results suggest that GRXS15 does not play as central a role 
as is currently thought, and that the NFU4 and NFU5 proteins are essential. 
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6 Discussion 
6.1 The function of Ind1 in complex I assembly 
6.1.1 The role of Ind1 is evolutionarily conserved but the molecular 
function is unclear 
The function of Ind1 was first investigated in the aerobic yeast Yarrowia lipolytica in 2008 
(Bych et al. 2008). Due to its similarity to cytosolic FeS assembly scaffolds NBP35 and 
CFD1, and its ability to coordinate a [4Fe-4S] cluster in vitro it was proposed to insert 
FeS clusters into complex I, but not other FeS proteins. Along with the human homolog 
NUBPL, it has been consistently labelled as the provider of FeS clusters in complex I 
ever since. However, there are three problems with this view that need addressing. The 
first is that in both Yarrowia lipolytica, human and Arabidopsis thaliana, when 
Ind1/NUBPL/INDH is knocked out, residual complex I activity remains. For example, in 
Yarrowia lipolytica, between 20-30% of complex I persists in ind1∆. Enzymatic activity of 
complex I, measured using an assay which utilises the entire FeS chain, matches up 
with complex I levels. This means the complex I that is present is fully functional. In 
Arabidopsis thaliana, in callus tissue, complex I is clearly visible in the indh mutant 
(chapter 4). These data strongly suggest that other factors also contribute to supply FeS 
clusters. Secondly, Ind1 has never been found in direct association with a complex I 
assembly intermediate or subunit (for example using the complexome studies carried out 
in humans: (Guerrero-Castillo et al. 2016); or in Arabidopsis thaliana: (Senkler et al. 
2016). It would be assumed that to deliver FeS clusters it would have to physically 
associate with complex I subunits at some point in the assembly process. However, it 
may simply be that this interaction is transient and cannot be detected using the 
techniques commonly employed. Finally, recent studies have implicated other FeS 
assembly proteins, namely HSC20, as the only provider of FeS clusters to complex I 
(Maio et al. 2017) (see section 6.2.2). In summary, Ind1 is unlikely to be the sole provider 
of FeS clusters to complex I, and no direct experimental evidence has been found that 
FeS clusters are inserted into complex I by Ind1. 
It is therefore timely to ask the question: what is the molecular function of Ind1? In an 
attempt to answer this I will take into account the published data across many species, 
and the data presented in this thesis. The assumption is that Ind1 has the same mode 
of action in every eukaryotic species. This seems reasonable given that in all three 
species in which it has been characterised there is a specific and substantial complex I 
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defect (Bych et al. 2008; Sheftel et al. 2009; Wydro et al. 2013). However, there may be 
some differences seen in plants (see section 6.1.3).  
6.1.2 A direct role in complex I assembly 
The first question is whether Ind1 plays a direct or indirect role in complex I assembly. If 
Ind1 plays a direct role in complex I assembly, either inserting FeS cluster or some other 
role, the natural question is at which stage in the assembly process. This can be inferred 
from assembly intermediates. Note, the exact mode of action may differ between yeast 
and humans, as they have different assembly pathways (Vogel et al. 2007).  
In Yarrowia lipolytica, ind1∆, as well as ind1∆ variants, (chapter 3), accumulate a Q 
module assembly intermediate, but can still make a larger assembly intermediate, as 
well as a small amount of mature complex I.  This could imply a defect in the Q module, 
whereby the subunits are attached but cannot have their cluster inserted, although a 
subset do, and make the larger assembly intermediate and mature complex I. 
Alternatively, it could indicate a defect in the N module, where Q module is made but is 
in excess as there is not enough N module to attach to. It is also possible there is a 
membrane arm defect, and so matrix arm assembly intermediates are in excess. 
Distinguishing between these possibilities can be helped by comparing the defects seen 
in ind1∆ with other examples in the literature. For example, the pattern of assembly 
intermediates is reminiscent of those seen in complexome sequencing of n7bm∆ (human 
NDUFA12), n7bml∆ (human assembly factor NDUFAF2), and to a lesser extent numm∆ 
(human NDUFS8) (Kmita et al. 2015 supplemental figure 2). Indeed, n7bml∆ strongly 
accumulates a Q module intermediates, similar in size to that seen in ind1∆. n7bm∆ also 
accumulates Q module intermediates, as well as a higher ~500 kDa intermediate 
containing N, Q and membrane arm subunits, again highly reminiscent of those seen in 
ind1∆. N7BM is a N module subunit and the N7BML human homolog NDUFAF2 has a 
putative role binding the N module to the Q module. The similarity of ind1∆ to these 
mutants points to a role for Ind1 in assembly of the matrix arm. Interestingly in the same 
paper, (Kmita et al. 2015), a role for N7BML in keeping subunits in an open state while 
FeS clusters were inserted was proposed. A role for the zinc binding NUMM subunit in 
this process was also proposed.  
In humans and plant, different assembly intermediates are seen, although the overall 
picture is similar. Analysis of patient complex I assembly profiles (Kevelam et al. 2013) 
suggest there is no accumulation of the matrix arm, in contrast to what I see in Yarrowia 
lipolytica. They suggest that NUBPL play a role early in the assembly process, inserting 
clusters into subunits, before they are assembled into larger intermediates. Analysis in 
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HeLa cells, where NUBPL has been silenced, indicates an accumulation of an 
intermediate containing membrane subunits (Sheftel et al. 2009). Additionally, the 
protein levels of matrix arm subunits are decreased, whereas the membrane arm ones 
are relatively unaffected (Sheftel et al. 2009; Stehling et al. 2014). Similarly, in 
Arabidopsis thaliana, intermediates containing membrane subunits were found (Wydro 
et al. 2013). Together these data suggest a defect in the assembly of the matrix arm, 
where the FeS clusters are contained.  
In summary, the main mutant phenotype appears to be defective formation of the matrix 
arm of complex I, suggesting a putative role for Ind1 as an assembly factor for the matrix 
arm. A role for insertion of FeS clusters cannot be shown without interaction studies. 
6.1.3 A role for INDH in mitochondrial translation 
INDH was thought to play a direct role, but a recent study in plants suggests another 
possibility. That study, (Wydro et al. 2013), suggests a role in mitochondrial translation. 
INDH mutants had lower levels of mitochondrial translation, as shown by 35S-Met 
labelling. In addition, gametogenesis phenotypes more closely resembled the 
phenotypes of mutants in mitochondrial translation rather than complex I. Finally, INDH 
protein levels and complex I reassembly rates did not correlate, indicating a more indirect 
role in complex I assembly. The idea is that a defect in translation would impact the 
production of mitochondrially encoded complex I subunits, and so impact complex I 
assembly. Complex I would be worst affected of the respiratory complexes, as it has the 
greatest number of mitochondrially encoded subunits (9 in Arabidopsis thaliana). 
Something similar can be seen in humans, where mutations in mt-tRNAs lead to complex 
I deficiency, whilst the other respiratory complexes are unaffected (Da Pozzo et al. 2009; 
Blakely et al. 2009; Calvo et al. 2010; Swalwell et al. 2011). This shows that translation 
defects can affect complex I specifically, making a role for INDH in translation appear 
plausible. However, a mutant in the gene encoding the ribosomal protein RPS10 in 
Arabidopsis thaliana caused a decrease in mitochondrial translation, resulting in a severe 
decrease in complexes I, IV and V, suggesting a translation defect in plants affects all 
complexes (Kwasniak et al. 2013). It has been shown that if complex I is inhibited with 
rotenone, this can have an effect of mitochondrial translation (Allen et al. 1995). This 
means that complex I deficiency could be the cause, rather than the consequence, of a 
decrease in mitochondrial translation. Wydro et al. realised this possibility and 
supplemented the isolated mitochondria with ATP to overcome the presumed effect of a 
lack of complex I. However, complex I deficiency has other effects. First, (Allen et al. 
1995) showed that a change in the redox state of the mitochondria caused by inhibition 
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of complex I could affect mitochondrial translation. Second, complex I significantly 
contributes to the PMF, which is required for import of the translation machinery. It is 
plausible that with a lower PMF, import is inhibited and so translation decreased. To 
distinguish these possibilities 35S-Met labelling could be carried out on confirmed 
complex I mutants, to see if mitochondrial translation was affected. The 2013 study only 
looked at translation in a partially complemented mutant, with low, but not absent, INDH 
protein levels, so I carried out Western blot analysis on the full knock-out mutant, to 
investigate the protein levels of mitochondrial encoded subunits (Chapter 5). Contrary to 
expectation for a mitochondrial translation mutant, the mitochondrially encoded complex 
I subunit, nad9, was unaffected. In addition, the mitochondrially encoded complex IV 
subunit, cox2, was slightly increased. Additionally, complex IV levels were strongly 
increased, in contrast to that seen in (Kwasniak et al. 2013). These observations do not 
suggest a defect in overall mitochondria translation, but do not preclude a more 
specialised role for INDH in mitochondrial translation. In other species, no evidence has 
been found of a role in translation. In humans, there is evidence of an accumulation of 
membrane intermediates, but a decrease in matrix arm subunits (Sheftel et al. 2009). 
Given that the membrane arm contains the mitochondrially encoded subunits in humans, 
and the matrix arm is nuclear encoded, these data do not suggest a translation defect. 
Taken together these observations show that the possibility of a role for INDH in 
translation cannot be excluded but it is not well understood and needs more 
investigation. Further studies in yeast and humans will be needed to tell if a role in 
translation is conserved or plant specific. In summary, it is hard to say if 
Ind1/NUBPL/INDH is directly or indirectly involved in complex I assembly.  
6.2 FeS provision for the respiratory complexes  
6.2.1 Defects in the ISC pathway impact on respiratory complex 
assembly 
Given there are still unanswered questions about the role of Ind1 in FeS cluster insertion, 
and the almost certainty that other factors are involved, it is a good idea to visit the 
question of FeS cluster delivery to respiratory complexes. Respiratory complexes, as 
well as all mitochondrial FeS proteins, are dependent on the ISC pathway, for example 
the cysteine desulphurase, Nfs1, and the scaffold protein, Isu1. Patients with mutations 
in the human homolog of Isu1, ISCU1, have defects in respiratory complexes I, II and III 
(Haller et al. 1991; Hall et al. 1993; Sanaker et al. 2010). Patients with mutations in 
LYRM4, the human homolog of Isd11, have defective NFS1 and so display defects in 
complexes I, II and III (Lim et al. 2013). The lack of respiratory complex defect seen in 
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the isu1-1 mutant in Arabidopsis (chapter 5), is therefore surprising. However, this was 
only a partial mutant and so sufficient ISU1 protein may be present to support respiratory 
complex formation. This is leant support by the observation that a lack of ISU1 in 
Arabidopsis thaliana is fatal (Delphine Bernard and Janneke Balk, unpublished data). 
Additionally, the two paralogs, ISU2 and ISU3, may have redundant functions and 
compensate for the lack of ISU1. 
The factors in the later part of the ISC pathway are less clear. Good evidence comes 
from patient mutations. For example, Nfu1 patients have a decrease in complex II 
(Navarro-Sastre et al. 2011; Cameron et al. 2011), suggesting Nfu1 is necessary for FeS 
cluster delivery to this respiratory complex. This defect is also seen in Saccharomyces 
cerevisiae (Schilke et al. 1999; Melber et al. 2016). A defect in complex I has also been 
observed in a human patient (Cameron et al. 2011). Nfu1 mutants have also been shown 
in yeast and human to be defective in lipoic acid cofactor containing enzymes (Navarro-
Sastre et al. 2011; Cameron et al. 2011; Melber et al. 2016). In my data from Arabidopsis 
thaliana, the hemizygous nfu4nfu5 mutant was not defective in complex I or II, but did 
have a mild defect in a lipoic acid containing enzyme. From these data it is unclear if 
Nfu1 is a specific FeS carrier for complex II and lipoic acid, or rather simply acts 
downstream of multiple [4Fe-4S] cluster containing proteins.  
Similarly, with Grx5, there is uncertainty. In the model based on data from 
Saccharomyces cerevisiae it plays a central role, meaning a defect in Grx5 should affect 
the majority of FeS containing enzymes. However, in patients with mutations in the 
human homolog, GLRX5, only a subset of FeS containing enzymes are affected. 
Patients display anemia and a defect in lipoic acid containing enzymes (Stehling et al. 
2014), but respiratory complexes were unaffected (Baker et al. 2014) In Arabidopsis 
thaliana, despite a severe growth defect there appear very few FeS defects (Stroeher et 
al. 2015; my data in chapter 5). The respiratory complexes appear entirely unaffected 
and the defects in lipoic acid containing enzymes is mild. This implies that either GRXS15 
in plants plays a different role than in yeast or that it does not play as central a role in 
FeS cluster synthesis as is currently thought.  
Studies on other ISC components can also give clues about supply of FeS clusters to 
the respiratory chain. Depletion of IBA57, ISCA1 or ISCA2 in HeLa cells, resulted in a 
decrease in complex I and complex II levels, as well as other mitochondrial [4Fe-4S] 
proteins (Sheftel et al. 2012). In addition, a patient with a mutation in IBA57 showed 
similar biochemical defects (Bolar et al. 2013). A patient with mutations in ISCA2 
displayed a defect in only complex I (Al-Hassnan et al. 2015), although the 
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characterisation is incomplete, and given the results in HeLa cells it is unlikely ISCA2 
has a complex I specific effect. A recently reported patient with mutations in ISCA1 
(Shukla et al. 2017) similarly was reported to suffer from multiple mitochondrial 
dysfunction syndrome. In Saccharomyces cerevisiae, double mutants of bol1/3∆ are 
defective in complex II and aconitase (Melber et al. 2016; Uzarska et al. 2016). Patients 
with mutations in the human homolog, BOLA3, have defects in complex I, II, III as well 
as other FeS proteins (Cameron et al. 2011). Clearly, defects in ISC machinery can affect 
FeS provision to the respiratory complexes, although the specificity of these defects is 
still unclear. 
6.2.2 LYR motif proteins involved with FeS delivery to respiratory 
complexes 
Recent work in mammalian FeS assembly has suggested specific factors needed for 
FeS insertion into the respiratory complexes. It has been proposed that a complex of 
HSC20-HSPA9-ISCU1 directly inserts clusters into complexes I, II and III (Maio et al. 
2014; Maio et al. 2017). This was first shown for the complex II FeS subunit, SDHB, 
which was shown to bind the HSC20-HSPA9-ISCU1 complex (Maio et al. 2014). This 
interaction was dependent of a conserved LYR motif in the SDHB subunit. Notably this 
motif is also found in other proteins, the LYRM proteins, for example LYRM4 (human 
homolog of Isd11), LYRM7, needed for complex III assembly, and subunits of complex 
I, LYRM3 and LYRM6 (Angerer 2015). Indeed, it has been suggested the LYRM6 subunit 
of complex I could influence FeS incorporation (Angerer et al. 2014; Rouault & Maio 
2017). Further work showed that the HSC20-HSPA9-ISCU1 complex directly binds 
LYRM7, which facilitates FeS transfer to the complex III FeS subunit, UQCRFS1 (Maio 
et al. 2017). That same study showed HSC20 bound to the five FeS subunits of complex 
I (NDUFS1, NDUFS8, NDUFV2, NDUFV1 and NDUFS7), and suggest that the HSC20-
HSPA9-ISCU1 complex directly inserts FeS clusters. Additionally, HSC20 was found to 
bind to numerous other FeS assembly proteins, including ISCA1, IBA57 and NFU1. The 
study dismisses NUBPL as a FeS insertion factor and does not mention it experimentally, 
however a closer look at the proteomic data shows that NUBPL bound to HSC20 in the 
same proportions as ISCA1 and NFU1 (2 unique peptides identified) (Maio et al. 2017), 
supplemental table S1). HSC20 appears to interact with all key players in FeS assembly, 
and care must be taken in assigning specific interactions. Notably, reciprocal co-IP was 
not performed to confirm the interaction between complex I subunits and HSC20. Further 
work is needed to confirm the interaction with the complex I subunits. It is likely that 
HSC20-HSPA9-ISCU1 is needed for FeS cluster incorporation into the respiratory 
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complexes, however further interaction studies are needed to confirm the process for 
complex I.  
Clearly any ISC components essential for FeS generation will affect respiratory complex 
FeS provision. Mutants in numerous other FeS assembly proteins, for example NFU1, 
IBA57, ISCA1, ISCA2, NUBPL, also impact on respiratory complex levels. Recent 
exciting findings suggest a direct role for HSC20-HSPA9-ISCU1 in inserting FeS 
clusters. 
6.3 Distinguishing between two models of FeS cluster assembly 
in the mitochondria 
Two models for the ISC FeS assembly pathway were presented in the introduction. One 
is based mainly on observations from the yeast Saccharomyces cerevisiae, although it 
does incorporate data from human models, whilst the other is based on observations 
from mammals, predominantly humans. The models agree on the first steps in the 
pathway, about FeS generation using Nfs1 and Isu1, but diverge later on the role of the 
FeS carrier proteins that are investigated in this thesis. Some of these differences may 
be due to lineage specific differences in the pathway. For example, in mammals there is 
evidence for a cytosolic ISC pathway, which calls into question the role of the CIA 
pathway (Rouault 2012). 
The pathway in Saccharomyces cerevisiae emphasises many discrete steps, with a 
clearly delineated and separate “late ISC machinery” needed for [4Fe-4S] cluster delivery 
(Braymer & Lill 2017). The mammalian model emphasises the chaperone/co-chaperone 
complex around Isu1 as the major branch point. It suggests clusters are delivered from 
this complex, sometimes with the help of different subsets of intermediary scaffolds (Maio 
& Rouault 2015; Rouault & Maio 2017) (see section 6.2.2). 
Looking at the data gathered in plants in chapter 5, is it possible to distinguish between 
these two models?  The first model, from Saccharomyces cerevisiae, emphasises the 
central role of Grx5 in connecting Isu1 to the late part of the ISC assembly pathway, 
claiming “Grx5 and its bound FeS cluster are required for maturation of all cellular FeS 
proteins” (Uzarska et al. 2013). The second model de-emphasises the role of GLRX5, 
instead listing it as one of many FeS carriers (Maio & Rouault 2015). My data points to 
a very mild defect in FeS assembly in Arabidopsis thaliana GRXS15 mutants, in contrast 
to its severe growth phenotype. In plants, it is likely that GRXS15 does not play a central 
role in the mitochondrial ISC pathway. 
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Interesting lineage specific differences exist. For example, nfu1∆ have comparatively 
mild defects in Saccharomyces cerevisiae, but mutations in human NFU1 can lead to a 
fatal disease. By studying mitochondrial NFU proteins in Arabidopsis thaliana a third data 
point can be taken, allowing us to tell which is the outlier. My data, in chapter 5, suggests 
that a lack of both NFU4 and NFU5 is fatal, similar to humans. This suggests that 
Saccharomyces cerevisiae is an outlier and NFU proteins are very important for FeS 
assembly, although their precise role remains unknown. 
Constructing a general model for eukaryotic FeS assembly is hard. It needs to reconcile 
experimental observations from numerous study systems. Additionally, matters are 
complicated as lineage specific differences are present. The model needs further 
development based on new data. 
6.4 Yarrowia lipolytica as a model for complex I assembly 
For a model organism for complex I research, Yarrowia lipolytica complex I biogenesis 
is relatively understudied. Large scale complexome sequencing to uncover the sequence 
of module creation, like those carried out in humans (Guerrero-Castillo et al. 2016), has 
not been undertaken. Instead, the process must be pieced together from observations 
of assembly intermediates formed in individual mutants, for example in NUMM, N7BM, 
N7BML and NUYM (Kmita et al. 2015; Kahlhöfer et al. 2017) and my own data, chapter 
3. The process of Yarrowia lipolytica complex I assembly can be recreated as follows: 
The N and the Q module are formed separately and then are joined to form the matrix 
arm. These then either attach with the full membrane arm, to form mature complex I, or 
associate with part of the membrane arm before, the remaining membrane arm subunits 
are added, forming mature complex I. 
It has been presumed that Yarrowia lipolytica complex I assembly would be similar to 
that seen in another model yeast, Neurospora crassa, however, there has recently been 
uncertainty about this process. In this case, the process in Yarrowia lipolytica may prove 
instructive for Neurospora crassa complex I assembly, rather than vice versa. It has long 
been thought that in the matrix and membrane arms form independently, and then join 
together to form mature complex I, in contrast to mammals, where the N module is added 
last (Videira & Duarte 2002; Vogel et al. 2007). However, recently it has been proposed 
that the process in Neurospora crassa is similar to mammals and the N module is added 
last (Pereira et al. 2013). My data suggest that the N and Q module form the matrix arm 
first, before associating with the membrane arm, lending support to the first model. 
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Only two assembly factors have been studied in Yarrowia lipolytica: Ind1 (human 
NUBPL) (Bych et al. 2008) and N7BML (human NDUFAF2) (Kmita et al. 2015). 
Homologs exist in Yarrowia lipolytica for 8 out of 16 assembly factors found in humans. 
Many of these will presumably play a similar role to the human version. These homologs 
have yet to be functionally characterised. It is likely there are many, yeast specific, 
assembly factors in Yarrowia lipolytica waiting to be found, to fulfil the functions of the 
assembly factors for which there are no homologs. 
Yarrowia lipoltyica has been used numerous times to study human complex I deficiency, 
usually looking at structural subunits (Ahlers et al. 2000; Kerscher et al. 2004; Varghese 
et al. 2015; Gerber et al. 2016). However, if it is to also be used to study complex I 
assembly deficiency, as it has in this thesis, the process needs to be understood better. 
However, given the differences in assembly between the two groups, Yarrowia lipolytica 
may be of limited use in studying human defect in complex I assembly in the future.
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8 Appendix 
Proteomic data from Chapter 4 
Proteomic data, discussed in chapter 4, displayed as the output from the MASCOT 
server. For each protein, the total number of peptides and number of unique peptides 
that were significant (p<0.05) is shown. For table 8.3 and 8.4, partial lists are displayed, 
showing proteins involved in the respiratory process. For the dataset in table 8.3, there 
were 587 protein hits in total. For the dataset in table 8.4, there were 684 protein hits. 
Table 8.1: mtDNA encoded mitochondrial proteins from Viscum album Percoll-
purified mitochondria 
Gene Description Total peptides (significant) Unique peptides (significant) 
atp1  atp1  ATP synthase F1 subunit 1 42 14 
cox2 cox2  cytochrome c oxidase subunit 2 4 2 
cob cob  apocytochrome b 5 2 
atp8  atp8  ATP synthase F0 subunit 8 3 2 
atp4  atp4  ATP synthase F0 subunit 4 2 2 
cox3 cox3  cytochrome c oxidase subunit 3 1 1 
rps3 rps3  ribosomal protein S3 1 1 
cox1 cox1  cytochrome c oxidase subunit 1 1 1 
Table 8.2: mtDNA encoded mitochondrial proteins from Viscum album crude 
mitochondria 
Gene Description Total peptides (significant) Unique peptides (significant) 
atp1 atp1 ATP synthase F1 subunit 1 86 19 
cox2 cox2 cytochrome c oxidase subunit 2 8 4 
atp4 atp4 ATP synthase F0 subunit 4 6 4 
cob cob apocytochrome b 5 3 
atp8 atp8 ATP synthase F0 subunit 8 3 2 
rps3 rps3 ribosomal protein S3 4 4 
cox1 cox1 cytochrome c oxidase subunit 1 3 2 
cox3 cox3 cytochrome c oxidase subunit 3 3 2 
rps4  rps4 ribosomal protein S4 4 3 
rpl16 rpl16 ribosomal protein L16 1 1 
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Table 8.3: Mitochondrial proteins identified based on the Arabidopsis thaliana 
database in Viscum album Percoll purified mitochondria 
Gene Description Total 
peptides 
(significant) 
Unique 
peptides 
(significant) 
AT5G08670.1  ATP synthase alpha/beta family protein  14 5 
ATMG01190.2 edited ATP1 16 6 
AT5G66760.1 SDH1-1 succinate dehydrogenase 1-1  9 6 
AT4G21490.1 NDB3 NAD(P)H dehydrogenase B3  3 2 
AT3G27240.1 Cytochrome C1 family  2 1 
ATMG00160.1 COX2 cytochrome oxidase 2  1 1 
 
Table 8.4: Mitochondrial proteins identified based on the Arabidopsis thaliana 
database in Viscum album crude mitochondria 
Gene Description Total 
peptides 
(significant) 
Unique 
peptides 
(significant) 
AT5G08670.1  ATP synthase alpha/beta family protein  39 8 
ATMG01190.2  edited ATP1 20 7 
AT5G66760.1 SDH1-1 succinate dehydrogenase 1-1  15 7 
AT5G64210.1 AOX2 alternative oxidase 2  2 1 
AT5G57815.1  Cytochrome c oxidase, subunit Vib family protein 5 2 
AT5G40810.1  Cytochrome C1 family 5 2 
AT4G21490.1 NDB3 NAD(P)H dehydrogenase B3  4 3 
ATMG00160.1 COX2 cytochrome oxidase 2 1 1 
AT5G13430.1  Ubiquinol-cytochrome C reductase iron-sulfur subunit  3 3 
AT4G10040.1 CYTC-2 cytochrome c-2  1 1 
ATMG01170.1 ATP6-2 ATPase, F0 complex, subunit A protein  1 1 
AT5G08740.1 NDC1 NAD(P)H dehydrogenase C1  2 2 
AT5G40650.1 SDH2-2 succinate dehydrogenase 2-2  1 1 
AT3G22370.1 AOX1A, ATAOX1A alternative oxidase 1A  1 1 
 
 
 
 
